Daily Scientific Programme Tuesday 11 June, 2019 Tuesday 11 June, 2019

DAILY SCIENTIFIC PROGRAMME TUESDAY 11 JUNE, 2019 TUESDAY 11 JUNE, 2019

AMBER 1 07:00-08:00 07:36 Hair Transplantation: European Perspective Vincenzo Gambino (ITALY) SIDAPA: Environmental Dermatology in Italy: 07:48 Discussion IS unwanted effects of sea and ground fauna CO-CHAIRS: Caterina Foti (ITALY), Cataldo Patruno (ITALY) AMBER 5+6 07:00-08:00 07:00 Skin reactions caused by coelenterates Domenico Bonamonte (ITALY) GRUPPO SIDeMaST MST E DERMATOLOGIA IS INFETTIVA: Guidelines on Sexually transmitted 07:15 Ectoparasitoses induced by mites diseases: Highlights and Shadows Luca Stingeni (ITALY) CO-CHAIR: Valeria Gaspari (ITALY) 07:30 Ectoparasitoses induced by microhymenoptera ROUND TABLE: Monica Corazza (ITALY) Antonio Cristaudo (ITALY) Marco Cusini (ITALY) 07:45 Discussion Sergio Delmonte (ITALY) Marina Drabeni (ITALY) AMBER 3 07:00-08:00 Francesco Drago (ITALY) Manuela Papini (ITALY) Giuliano Zuccati (ITALY) GRUPPO SIDeMaST DI DERMATOLOGIA IS VASCOLARE E ULCERE: Chronic Wound Management AMBER 7+8 07:00-08:00 CO-CHAIRS: Valentina Dini (Italy), Cosimo Misciali (ITALY) ADOI: Psychological implications in patients 07:00 The Wound Bed Preparation IS with hidradenitis suppurativa (HS) Afsaneh Alavi (CANADA) CO-CHAIRS: Aurora Parodi (ITALY), Mariella Fassino (ITALY) 07:15 Bacteria and Wound healing Robert Kirsner (UNITED STATES) 07:00 Quality of life, emotional regulation, personality traits and psychiatric symptom in patients 07:30 Adjuvant devices in wound management affected by HS Tommaso Bianchi (ITALY) Giulia Merlo (ITALY) 07:45 Skin substitutes 07:15 Impact of HS on patients’ emotion Marco Romanelli (ITALY) Giulia Gasparini (ITALY), Anna Burroni (ITALY)

AMBER 4 07:00-08:00 07:45 HS patients assessed by 36-item short form health survey (SF-36) SITRI: New Horizon of Hair Science and Francesca Sampogna (ITALY) IS Restoration CO-CHAIRS: Torello Lotti (ITALY), Piero Tesauro (ITALY) BROWN 1 07:00-08:00 07:00 Long Term result in Hair Surgery Piero Tesauro (ITALY) GRUPPO SIDeMaST STORIA DELLA IS DERMATOLOGIA E VENEREOLOGIA: History of 07:12 Neuropeptidergic insight into the hair follicle - Dermatology from the bench to the office CO-CHAIRS: Carlo Gelmetti (ITALY), Torello Lotti (ITALY) Aldo Di Carlo (ITALY)

07:24 Estrone and Hair 07:00 History of Dermatology in United States of Andrea Marliani (ITALY) America Lawrence-Charles Parish (UNITED STATES) TUESDAY 11 JUNE, 2019

07:20 History of moulages in Dermatology 08:30 Dermoscopy of skin coloured papules; an aid to Michael Geiges (SWITZERLAND) diagnosing the little bumps! S. Daruwalla (INDIA) 07:40 The studies on syphilization in Europe Daniel Wallach (FRANCE) 08:45 Transition from pemphigus vulgaris to pemphigus foliaceus: the possible role of anti TNF-α and varicella zoster virus AMBER 1 08:00-10:45 D. Didona (GERMANY) 09:00 Analysis of Toll-like receptors and Microbiome inﬂammasomes in allergic contact dermatitis to SY CHAIR: Heidi Kong (UNITED STATES) methylchloroisothiazolinone/methylisothiazo- CO-CHAIRS: Thomas Bieber (GERMANY), linone Amy Paller (UNITED STATES) H. Freitas de Oliveira Góes (BRAZIL) 08:00 Introduction to the Human Skin Microbiome 09:15 Outcomes of Contoured Staged Excision for Heidi Kong (UNITED STATES) Lentigo Maligna of the Head and Neck 08:05 Impaired recognition of microbiome products A. Liu (CANADA) by epidermal dendritic cells in AD 09:30 Clinical efficacy of antibiotic mono-therapy in HS. Thomas Bieber (GERMANY) E. Rosi (ITALY) 08:25 Staph toxins in atopic dermatitis 09:45 Long-term exposure in polluted environment Yumi Matsuoka-Nakamura (JAPAN) exacerbate and accelerate skin aging 08:45 Interventional approaches for atopic dermatitis J. Soeur (FRANCE) (AD) 10:00 Treatment of Cafe-au-lait Spots using Q Johannes Ring (GERMANY) switched Alexandrite Laser an Analysis of 09:05 Bleach baths in AD Clinical Characteristics of 471 Children Amy Paller (UNITED STATES) B. Zhang (CHINA)

09:25 Q&A – AD 10:15 Anti-Programmed cell death-1 therapy associated bullous disorders: a systematic 09:35 Chronic mucocutaneous candidiasis review of the literature and classiﬁcation Claudia Traidl-Hoffmann (GERMANY) P. Fernandez Penas (AUSTRALIA) 09:55 Human polymaviruses (Merkel cell, HPyV6 and 7) 10:30 Pityriasis rosea: A pediatric case series Isaac Brownell (UNITED STATES) K. Damevska (MACEDONIA) 10:15 The gut-brain-skin-axis Marco Pignatti (ITALY) AMBER 3 08:00-10:45 10:35 Q&A - fungi and viruses

Migrant Health AMBER 2 08:00-10:45 SY CHAIR: Aldo Morrone (ITALY) CO-CHAIRS: Bernard Naafs (NETHERLANDS), Aisha Sethi (UNITED STATES) FELLOW FORUM 1 FF CO-CHAIRS: Heliana Freitas de Oliveira Góes 08:00 The other face of skin diseases in the time of (BRAZIL), Claudio Feliciani (ITALY) conﬂict and emigration Seyed Naser Emadi (IRAN) 08:00 Effectiveness of subcision using carboxytherapy plus fractional carbon dioxide laser 08:20 Human Mobile Population and Skin Diseases resurfacingin the treatment of atrophic acne Aldo Morrone (ITALY) scars: Comparative split face study 08:40 Imported skin diseases in Migrants I. Abdelkareem (EGYPT) Bernard Naafs (NETHERLANDS) 08:15 Dermatology training across the globe 09:00 Tropical Diseases in Migrants K. Ashack (UNITED STATES) Paulo Cunha (BRAZIL) TUESDAY 11 JUNE, 2019

09:20 STIs in Migrants AMBER 5+6 08:00-10:45 Ismael Maatouk (LEBANON)

09:40 Migration and Health in America What's New in Paediatric Dermatology? Aisha Sethi (UNITED STATES) SY CHAIR: Annalisa Patrizi (ITALY) CO-CHAIRS: Carlo Gelmetti (ITALY), 10:00 When skin creams migrate with human beings Peter Hoeger (GERMANY) Shyam Verma (INDIA) 08:00 Introduction & Welcome by the Chair 10:40 Q&A Annalisa Patrizi (ITALY)

08:05 What's New in Psoriasis? AMBER 4 08:00-10:45 Amy Paller (UNITED STATES) 08:25 What's New in Atopic Dermatitis? The Epidemiology of Psoriasis Lawrence Eichenﬁeld (UNITED STATES) SY CHAIR: Tamar Nijsten (NETHERLANDS) CO-CHAIRS: Arnon Cohen (ISRAEL), 08:45 Hidden dangers of topical drugs and cosmetics Claudia De La Cruz (CHILE) in pediatric age Carlo Gelmetti (ITALY) 08:00 Pro’s & con’s of big data use in psoriasis Tamar Nijsten (NETHERLANDS) 09:05 What's New in Infantile Haemangioma? Peter Hoeger (GERMANY) 08:20 Q&A 09:25 What's New in Skin Infections? 08:23 Psoriasis treatment in Latin America: The Access Iria Neri (ITALY) Issue Claudia De La Cruz (CHILE) 09:45 What's New in Genetic Diseases? Christine Bodemer (FRANCE) 08:43 Q&A 10:05 What's New in Vascular Anomalies? 08:46 Herpes Zoster in Patients with Psoriasis Eulalia Baselga (SPAIN) Receiving Biologic and System Medications Arnon Cohen (ISRAEL) 10:25 Q&A 09:06 Q&A

09:09 Systemic drug use for psoriasis in daily practice AMBER 7+8 08:00-10:45 in France Emilie Sbidian (FRANCE) Surgical management of Keratinocyte cancer: SY BCC and SCC 09:29 Q&A CHAIR: Paul Salmon (NEW ZELAND) 09:32 Treatment impact on cardiovascular CO-CHAIRS: Suzanne Olbricht (UNITED STATES), comorbidities in psoriasis Nicole Kelleners-Smeets (NETHERLANDS) Alexander Egeberg (DENMARK) 08:00 Choosing the right modality for this BCC in this 09:52 Q&A patient Nicole Kelleners-Smeets (NETHERLANDS) 09:55 What we have learned from BADBIR Christopher Griffiths (UNITED KINGDOM) 08:12 People of colour: What you need to know for ideal surgical outcomes 10:15 Q&A Caroline Brandao (BRAZIL)

10:18 EIME in psoriasis 08:22 We got this! Surgical Principles and Aesthetic Kenji Kabashima (JAPAN) Pearls for BCCs of the trunk and extremities 10:38 Q&A Wal Hussain (UNITED KINGDOM) 10:41 Discussion 08:32 Surgical Principles and Aesthetic Pearls for lesions on the face Aleksandar Krunic (UNITED STATES) TUESDAY 11 JUNE, 2019

08:42 Best practice for use of antibiotics and 09:00 Non-melanoma skin cancer: from the anticoagulants in the perioperative period microscope to the bedside Severin Laeuchli (SWITZERLAND) Alessandro Di Stefani (ITALY)

08:52 Choosing the right modality for this SCC in this 09:30 Wolf in Sheep’s Clothing patient Nilukshi Wijesuriya (UNITED KINGDOM) Chrysalyne Schmults (UNITED STATES) 09:50 Pitfalls in diagnosis of skin cancer 09:04 Adjuvant Radiotherapy: when and where, and Rino Cerio (UNITED KINGDOM) how to communicate with your radiotherapist 10:10 The many faces of malignant melanoma Neil Mortimer (NEW ZELAND) Carlo Cota (ITALY) 09:14 The truth about AKs and how to treat Crusty 10:30 Q&A Critters Paul Salmon (NEW ZELAND) 09:24 Treating SCC on the lower leg; better results BLUE 2 08:00-10:45 David Francis (AUSTRALIA) Laser I: Pigment and Hair 09:34 Treating SCC on the scalp: Getting it closed, CO CHAIR: Elizabeth McBurney (UNITED STATES) getting it cured CO-CHAIRS: Rosalina Nadela (PHILIPPINES), Christian L. Baum (UNITED STATES) Keyvan Nouri (UNITED STATES) 09:44 SCC on the temple and Forehead: How you can 08:00 Biophotonics: a novel tool in Dermatology do it better Steven Nisticò (ITALY) Suzanne Olbricht (UNITED STATES) 08:25 Current update on laser treatment of congenital 09:56 Beyond the wedge: Aesthetic options for nevi treating SCC on the lip Elizabeth McBurney (UNITED STATES) Anna Bar (UNITED STATES) 08:40 Laser treatment of pigmented lesions 10:06 Treating SCC on the Ear: Best techniques for Henry Hin Lee Chan (HONG KONG) Cure and Aesthetics Abel Gonzalez (UNITED STATES) 09:00 Laser treatment of Melasma Rosalina Nadela (PHILIPPINES) 10:16 Treating SCC on the Nose: Best techniques for Cure and Aesthetics 09:20 Laser treatment of scars Paul Salmon (NEW ZELAND) Keyvan Nouri (UNITED STATES)

10:26 Keeping costs down and results up: Pearls for 09:35 Laser Tattoo Removal low cost surgery Purita Paz-Lao (PHILIPPINES) Susan Weinkle (UNITED STATES) 10:00 Laser Hair Removal/Hair Growth 10:36 Wrap and Questions Keyvan Nouri (UNITED STATES) Paul Salmon (NEW ZELAND) 10:25 Panel Discussion/Questions

BLUE 1 08:00-10:45 BROWN 1 08:00-10:45 Basic Dermatopathology Management of skin disease in pregnancy CO CHAIR: Rino Cerio (UNITED KINGDOM) SY CHAIR: Sam Vaughan-Jones (UNITED KINGDOM) CO-CHAIRS: Alessandro Di Stefani (ITALY), CO-CHAIRS: Jenny Murase (UNITED STATES), Helmut Beltraminelli (SWITZERLAND) Corinna Rigoni (ITALY) 08:00 The principles of morphology in 08:00 Physiological Changes and Common Skin dermatopathology Diseases in Pregnancy Helmut Beltraminelli (SWITZERLAND) Sam Vaughan-Jones (UNITED KINGDOM) 08:30 Biopsy Tips and Diagnostic Tools in 08:25 Speciﬁc Dermatoses of Pregnancy Dermatopathology Christina Ambros-Rudolph (AUSTRIA) Catherine M. Stefanato (UNITED KINGDOM) TUESDAY 11 JUNE, 2019

08:50 Skin Infections in Pregnancy BROWN 3 08:00-10:45 Robert Mullegger (AUSTRIA)

09:15 Moles and Melanoma in Pregnancy Acne Vulgaris and Acneiform Eruptions Linda Martin (AUSTRALIA) SY CHAIR: Mario E. Lacouture (UNITED STATES) CO-CHAIRS: Gabriella Fabbrocini (ITALY), 09:40 A New Approach to Drug Safety in Pregnancy Patricia Troielli (ARGENTINA) Jenny Murase (UNITED STATES) 08:00 Impact and measurement of Acne on quality of 10:05 Cosmetic problems in pregnancy life Corinna Rigoni (ITALY) Davide Fattore (ITALY)

10:30 Q&A 08:25 Acne grading and treatment in Europe and US Alison Layton (UNITED KINGDOM) BROWN 2 08:00-10:45 08:50 Acne management in Asia Chia-Yu Chu (CHINESE TAIPEI)

New Topical Immunomodulators 09:15 Acneiform rash to cancer therapies SY CHAIR: Andreas Wollenberg (GERMANY) Vincent Sibaud (FRANCE) CO-CHAIRS: Anthony Gaspari (UNITED STATES), 09:40 The microbiota in acne Christian Vestergaard (DENMARK) Hanna-Leena Kelhala (FINLAND) 08:00 Targets for topical immunomodulating 10:05 Acne scarring agents Vicente Torres (MEXICO) Christian Vestergaard (DENMARK) 10:30 Roundtable discussion 08:22 Reactive and proactive treatment with TCI and TCS Andreea Boca (ROMANIA) RED 1 08:00-10:45 08:39 Phosphodiesterase blocking agents Andreas Wollenberg (GERMANY) Update on Lasers and Other Light Sources CHAIR: Tina Alster (UNITED STATES) 08:56 Topical JAK inhibitors and AhR agonists SY CO-CHAIRS: Zeina Tannous (LEBANON), Robert Bissonnette (CANADA) Nicola Zerbinati (ITALY) 09:13 Combination therapy in atopic dermatitis – 08:00 Laser Scar Revision emollients plus, topical immunomodulators, Tina Alster (UNITED STATES) and targeted therapy Magdalena Trzeciak (POLAND) 08:15 Novel Use of Lasers and Light Sources for Hair and Nail Indications 09:30 Break Pravit Asawanonda (THAILAND) 09:37 Topical TLR agonists 08:30 Picosecond Laser Technology: Tattoos and Anthony Gaspari (UNITED STATES) Beyond 09:54 Immunomodulation and anti-infective treatment Christine Dierickx (BELGIUM) for infectious skin diseases 08:45 Laser Wound Healing Carolina Talhari (BRAZIL) Daniel Galimberti (ARGENTINA) 10:11 Tuberculin and Candida antigen immunotherapy 09:00 Fractional Lasers and Drug Delivery for viral warts Merete Haedersdal (DENMARK) Noufal Raboobee (SOUTH AFRICA) 09:15 Laser Side Effects & Complications 10:28 Hapten sensitization for treatment of alopecia Monica Ky Li (CANADA) areata Kyu Han Kim (KOREA, REPUBLIC OF) 09:30 Laser Treatment of Hyperpigmentation Jose Tabush (COSTA RICA)

09:45 Laser Treatment of Basal Cell Carcinomas Zeina Tannous (LEBANON) TUESDAY 11 JUNE, 2019

10:00 Laser Treatment of Pigmented Skin SILVER 08:00-10:45 Rungsima Wanitphakdeedecha (THAILAND)

10:15 Laser Treatment of Vaginal Disorders Facial Rejuvenation: Fillers and Toxins Nicola Zerbinati (ITALY) SY CHAIR: Kyle Seo (KOREA, REPUBLIC OF) CO-CHAIRS: Susan Weinkle (UNITED STATES), 10:30 Q&A Maya Vedamurthy (INDIA)

08:00 Facial Evaluation RED 2 08:00-10:45 Susan Weinkle (UNITED STATES) 08:30 Anatomy Revisited - Upper Face Life Threatening Drug Reactions Susan Weinkle (UNITED STATES) SY CHAIR: Neil Shear (CANADA) CO-CHAIRS: Riichiro Abe (JAPAN), 08:46 Anatomy Revisited - Middle Face Jean Francois Nicolas (FRANCE) Maya Vedamurthy (INDIA)

08:00 Welcome 09:02 Anatomy Revisited - Lower Face Neil Shear (CANADA) Anthony Benedetto (UNITED STATES)

08:02 Introduction of speakers 09:18 Q&A Riichiro Abe (JAPAN) 09:33 Combination Treatments - Upper Face 08:05 Drug-induced alopecia: diagnostic tips and its Diane Berson (UNITED STATES) pathophysiology 09:49 Combination Treatments - Middle Face Misaki Kinoshita-Ise (JAPAN) Kyle Seo (KOREA, REPUBLIC OF)

08:25 Causality assessment; getting the history and 10:05 Combination Treatments - Lower Face understanding the odds Krishan Mohan Kapoor (INDIA) Neil Shear (CANADA) 10:21 Q&A 08:45 Sequelae of severe drug reactions Roni Dodiuk-Gad (ISRAEL) 10:37 Complications Abhay Talathi (INDIA) 09:05 Discussion for the ﬁrst 3 presentations and intro for the next 3 Jean Francois Nicolas (FRANCE) SPACE 1 08:00-10:45 09:12 What are the steps from drug to rash? Scientiﬁc advances Basic Dermoscopy Axel Villani (FRANCE) CO CHAIR: Susana Puig (SPAIN) CO-CHAIRS: Horacio Cabo (ARGENTINA), 09:32 Cytotoxic lymphocytes in delayed drug allergy. Ashfaq Marghoob (UNITED STATES) From gene to clinic Wen-Hung Chung (CHINESE TAIPEI) 08:00 Introduction Susana Puig (SPAIN) 09:52 Update of DIHS/DRESS: clinical and basic Sylvia Martinez-Cabriales (MEXICO) 08:10 Principles, equipment and NPD vs PD Alon Scope (ISRAEL) 10:12 TEN vs Sepsis: How can and we tell? Nouf Almuhanna (ARABIA) 08:25 Terminology: analytical & metaphoric Harald Kittler (AUSTRIA) 10:32 Discussion for last 4 speakers Riichiro Abe (JAPAN) 08:40 Histopathology correlations Ashfaq Marghoob (UNITED STATES) 10:42 Closing comments Neil Shear (CANADA) 09:00 Dermoscopy in BCC diagnosis & treatment Aimilios Lallas (GREECE)

09:15 Actinic keratosis and SCC diagnosis Alicia Barreiro (SPAIN) TUESDAY 11 JUNE, 2019

09:30 SK, DF, angioma, CCA, seb hyp 09:48 Soft tissue surgery for ingrowing toenails Vincenzo De Giorgi (ITALY) Bertrand Richert (BELGIUM)

09:45 Cases for the audience 09:58 What onychoscopy adds to your diagnosis Gabriel Salerni (ARGENTINA) Michela Starace (ITALY)

09:55 Cases for the audience 10:08 Update on diagnosis and molecular testing of Elvira Moscarella (ITALY) melanocytic lesions of the nail unit Dong-Youn Lee (KOREA, REPUBLIC OF) 10:05 Cases for the audience Horacio Cabo (ARGENTINA) 10:18 Parasitic infestations of the nail not to be missed Archana Singal (INDIA) 10:15 Melanoma diagnosis in high risk patients Josep Malvehy (SPAIN) 10:28 Clinical case Soumiya Chiheb (MOROCCO) 10:30 Discussion 10:34 How to submit a nail specimen to get best information from your pathologist SPACE 2 08:00-10:45 Beth Ruben (UNITED STATES)

Nail Update SY CHAIR: Bertrand Richert (BELGIUM) SPACE 3 08:00-10:45 CO-CHAIRS: Patricia Chang (GUATEMALA), Adam Rubin (UNITED STATES) Infectious Diseases 1 FC CO-CHAIRS: Fernando Gatti (ARGENTINA), 08:00 Cosmetic nail disorders: what's new? Misore Venkaratam (INDIA) Phoebe Rich (UNITED STATES) 08:00 Introduction 08:10 Update on onychomycosis, lasers included Boni Elizabeth Elewski (UNITED STATES) 08:05 Clinical and mycological proﬁle of dermatophytoses and its therapeutic 08:20 Update on pediatric nail disorders implications-a study Jane Bellet (UNITED STATES) K. Banodkar (INDIA) 08:30 Indications & limitations of Moh’s surgery at the 08:15 Primary cutaneous nocardiosis a case series of nail unit clinic and species diversity Eckart Haneke (GERMANY) Y. Ran (CHINA) 08:40 When microscopy enlightens the clinic 08:25 Intralesional sodium stibogluconate under Adam Rubin (UNITED STATES) inhaled anesthesia for the treatment of 08:50 Clinical case cutaneous leishmaniasis in children: André Lencastre (PORTUGAL) A retrospective cohort V. Molho Pessach (ISRAEL) 08:56 Surgery for chronic paronychia Nilton Di Chiacchio (BRAZIL) 08:35 Possible complications in pregnant women with pityriasis rosea 09:06 Clinical case F. Drago (ITALY) Rosamary Soto (CHILE) 08:45 Evaluation of polymorphism of TLR1, TLR2, 09:12 Nail melanoma management in 2019 TLR4, NRAMP, TAP1 AND TAP2 as markers of Bianca Maria Piraccini (ITALY) host-susceptibility in leprosy: molecular 09:22 Update on the management of nail psoriasis epidemiological study in high ancdr district in Dimitris Rigopoulos (GREECE) eastern India D. Nilay (INDIA) 09:32 Proximal nail fold and collagen diseases Patricia Chang (GUATEMALA) 08:55 Global consensus diagnostic criteria for scabies C. Fuller (AUSTRALIA) 09:42 Clinical case Matilde Iorizzo (SWITZERLAND) TUESDAY 11 JUNE, 2019

09:05 Necrotic erythema nodosum leprosum- a rare 08:25 News on diagnostics and prevention of hair dye complication of leprosy in the postleprosy allergy elimination era: A 10-year retrospective clinico Annarita Antelmi (SWEDEN) pathological study from a tertiary care centre in 08:45 Polysensitization India Marie-Louise Schuttelaar (NETHERLANDS) R. Bhattacharjee (INDIA) 09:05 Contact allergy and prognosis of occupational 09:15 Cutaneous infection caused by Fusarium hand eczema lichenicola in a patient with verrucous Tove Agner (DENMARK) hyperplasia vermiculatum manifestation J. Quan Wu (CHINA) 09:25 Costs and quality of life in patients with severe chronic hand eczema 09:25 The role of retinoids for the control of fungal Alicia Cannavo (ARGENTINA) infections E. Campione (ITALY) 09:45 On track of allergic contact dermatitis, Italian experience 09:35 Sabin's Poliomyelitis Vaccine in Recurrent Caterina Foti (ITALY) Herpes Simplex. Randomized double-blind study 10:05 Occupational allergic contact dermatitis in Iran, A. Momeni (IRAN) relating factors and prevention Mansour Nassiri Kashani (IRAN) 09:45 The role of transforming growth factor-β and immunoglobulin-M anti phenolic glycolipid-1 in 10:25 Clinical proﬁle of hand eczema. Case the recurrence of erythema nodosum leprosum presentations from Nigeria M. S. Hamzah (INDONESIA) Erere Otrofanowei (NIGERIA)

09:55 Sustained reduction of scabies and impetigo two years after mass drug administration WHITE 1 08:00-10:45 M. Whitfeld (AUSTRALIA)

10:05 Steroid-dependent erythema nodosum Dermatologic Surgery: video session leprosum on release from treatment borderline FC CO-CHAIRS: Marco Simonacci (ITALY), lepromatus leprosy patient Kay Munte (NETHERLANDS) C. Santosa (INDONESIA) 08:00 Introduction 10:15 Evaluation of the changes in cytokine profile in 08:05 Exeresis of subungual melanoma and immunotherapy treated patients of viral warts reconstruction with cross- hypothenar flap A. Sil (INDIA) F. Satolli (ITALY) 10:25 A study of clinico-mycological correlates of 08:23 Digital photomapping in Mohs micrographic Onycomycosis surgery and the integration into an electronic C. Jain (INDIA) health record 10:35 First case of Trichodysplasia spinulosa in Italy: K. Munte (NETHERLANDS) clinical report and viral characterization 08:41 Dermatofibrosarcoma Protuberans: A Case E. Zavattaro (ITALY) Report Treated With Mohs Tubingen Technique SPACE 4 08:00-10:45 F. Dardano (ITALY) 08:59 Dermal substitutes (Integra) for reconstruction Allergic Contact Dermatitis of deep and extended tissue defect of the scalp SY CHAIR: Tove Agner (DENMARK) C. D'Acunto (ITALY) CO-CHAIRS: Mansour Nassiri Kashani (IRAN), 09:17 Retroauricular interpolation flap (“bridge flap”) Caterina Foti (ITALY) for repair of large helical rim defects 08:00 Introduction J. Hafner (SWITZERLAND) Tove Agner (DENMARK) 09:35 Reconstruction of a Large Scalp Defect Devoid 08:05 Allergic reactions to implant materials of Periosteum Niels De Graaf (NETHERLANDS) C. Bornacina (ITALY) TUESDAY 11 JUNE, 2019

09:53 Italic-S: what is this? 08:23 UV light and melanoma R. Tiberio (ITALY) Amaya Viros (UNITED KINGDOM)

10:11 Reconstruction with Dorsal Nasal Flap for a full 08:43 Q&A thickness nasal defect after Basal Cell 08:46 Special aspects of melanoma in Asian population Carcinoma Excision Yasuhiro Nakamura (JAPAN) G. Proietto (ITALY) 09:06 Q&A 10:29 Derooﬁng and other outpatient procedures for treating simple HS lesions 09:09 Melanoma aspects inﬂuenced by biologic M. Kovács (GERMANY) background Orit Markowitz (UNITED STATES)

YELLOW 1 08:00-10:45 09:29 Q&A 09:32 The role of the immune system in melanoma An Update on Genodermatoses pathogenesis SY CHAIR: Eli Sprecher (ISRAEL) Christoffer Gebhardt (GERMANY) CO-CHAIRS: Johann Bauer (AUSTRIA), 09:52 Q&A Alain Hovnanian (FRANCE) 09:55 An epigenetic switch: from…melanocytes to 08:00 Ichthyoses, between corniﬁcation and melanoma inﬂammation Chunying Li (CHINA) Keith Choate (UNITED STATES) 10:15 Q&A 08:20 Palmoplantar keratodermas: new and old entities Matthias Schmuth (AUSTRIA) 10:18 Pathogenesis of melanoma – a pathological view Daniela Massi (ITALY) 08:40 Peeling off the complexity of peeling skin syndromes 10:38 Q&A Eli Sprecher (ISRAEL) 10:41 Discussion 09:00 The changing landscape of epidermolysis bullosa Johann Bauer (AUSTRIA) GOLD 11:00-12:30 09:20 Inherited disorders of the dermis Jouni Uitto (UNITED STATES) CO-CHAIRS: Veronique del Marmol (BELGIUM), 09:40 Ectodermal dysplasias 2018 PL Andreas Katsambas (GREECE), Antonio Torrelo (SPAIN) Johannes Ring (GERMANY), Seong Jun Seo (KOREA, REPUBLIC OF) 10:00 Genodermatoses: from care to cure Alain Hovnanian (FRANCE) 11:00 Rare genetic and neurodegenerative disease Elena Cattaneo (ITALY) 10:20 Genodermatoses in Africa Daudi Mavura (TANZANIA) 11:30 The Immunobiology of Vitiligo John Harris (UNITED STATES) 10:30 Q&A 11:50 Genetic Approaches to Epidermolysis Bullosa Michele De Luca (ITALY) YELLOW 3 08:00-10:45 12:10 Atopic Dermatitis and Filaggrin: From Barrier to Therapeutic Target Update on Pathogenesis of Melanoma Alan Irvine (IRELAND) SY CHAIR: Amaya Viros (UNITED KINGDOM) CO-CHAIRS: Chunying Li (CHINA) Yasuhiro Nakamura (JAPAN) AMBER 1 14:30-16:30 08:00 Genomine catalogue of melanoma subtypes Thomas Wiesner (AUSTRIA) Psychodermatology for the busy dermatologist 08:20 Q&A WS CHAIR: Jason Reichenberg (UNITED STATES) CO-CHAIRS: Anthony Bewley (UNITED KINGDOM), Se Mang Wong (CANADA) TUESDAY 11 JUNE, 2019

14:30 Therapeutics 14:30 Cutaneous leishmeniasis Se Mang Wong (CANADA) Carolina Talhari (BRAZIL)

14:45 Body dysmorphic disorder 14:50 Immigrant Dermatology Michelle Magid (UNITED STATES) Valeska Padovese (MALTA)

15:00 Recognizing and managing "self harm" 15:10 Nutritional Dermatology-special focus on George Kroumpouzos (UNITED STATES) refugees Andreas Montag (GERMANY) 15:15 Questions and discussion 15:30 Imported Leprosy 15:30 Delusional Infestation Colette Van Hees (NETHERLANDS) Anthony Bewley (UNITED KINGDOM) 15:50 Dengue, Chicungunya, Zika 15:45 Delusional Infestation Vijay Zawar (INDIA) Peter Lepping (UNITED KINGDOM) 16:10 Interesting Imported tropical diseases 16:00 Delusional Infestation Scott Norton (UNITED STATES) John Koo (UNITED STATES) 16:15 Questions and discussion AMBER 4 14:30-16:30

AMBER 2 14:30-16:30 Hyperhidrosis WS CHAIR: Youwen Zhou (CANADA) CO-CHAIRS: Martine Schollhammer (FRANCE), Improving patient safety Dee Anna Glaser (UNITED STATES) WS CHAIR: Alexandra Kimball (UNITED STATES) CO-CHAIRS: Matthias Augustin (GERMANY), 14:30 Epidemiology and pathogenesis of primary Abel Torres (UNITED STATES) hyperhidrosis Yuanshen Huang (CANADA) 14:30 Introduction Alexandra Kimball (UNITED STATES) 15:00 Medical therapy for hyperhidrosis Youwen Zhou (CANADA) 14:35 Do patient needs and preferences interfere with patient safety? 15:30 Physical and Surgical Therapies for hyperhidrosis Matthias Augustin (GERMANY) (Introduction) Martine Schollhammer (FRANCE) 14:55 Disruptive Patient Behavior in the Ambulatory Setting – Safety Implications 15:35 Physical and Surgical Therapies for hyperhidrosis Tony Weiss (UNITED STATES) (Update) Hugues Cartier (FRANCE) 15:20 Panel discussion 16:00 Emerging therapies for hyperhidrosis 15:35 Do CME and certiﬁcation programs improve Dee Anna Glaser (UNITED STATES) patient safety? Abel Torres (UNITED STATES) 15:55 How to train the next generation in the patient AMBER 5+6 14:30-16:30 safety? Arthur Sober (UNITED STATES) Aesthetic and Cosmetic Dermatology 1 CO-CHAIRS: Silvana Guerra (ITALY), 16:15 Panel discussion FC Domenico Piccolo (ITALY)

14:30 The Comparison of dentist drill with chemical AMBER 3 14:30-16:30 reconstruction of skin scars (cross) trichloracetic acid (TCA) on icepickacne scars Tropical Dermatology Imported by Travellers L. Trisnarizki (INDONESIA) WS CHAIR: Toby Maurer (UNITED STATES) 14:40 Understanding the African American Facial CO-CHAIRS: Mahreen Ameen (UNITED KINGDOM), Aesthetic Patient Colette Van Hees (NETHERLANDS) V. Callender (UNITED STATES) TUESDAY 11 JUNE, 2019

14:50 Goldincision a New Approach to Cellulite 14:30 Dermoscopic features of nail psoriasis in 55 Treatment patients (550 ﬁngernails and 440 toenails): An R. Chacur (BRAZIL) observational and analytical study A. Chauhan (INDIA) 15:00 An Anti-Ageing Topical Innovation S. Bashey (UNITED STATES) 14:40 Pigmented lesions of the mucosal area: how reﬂectance confocal microscopy can help in the 15:10 Effectiveness of the combination of TriPollar® diagnosis of these challenging cases Radio-frequency and Hybrid Energy™ on six V. Coco (ITALY) "difficult" anatomical areas of face and body. Open, uncontrolled, prospective observational 14:50 Trichoscopic features of tinea capitis in 98 study children: An observational analytic study E. Fasola (ITALY) P. Kumar (INDIA)

15:20 Effect of intradermal injections with a 15:00 Teledermatology and e-referral grading for combination of polynucleotides, DMAE and non melanoma, a successful model of care cross linked hyaluronic acid on hydration, R. Martin (NEW ZEALAND) firmness and facial elasticity 15:10 Evaluation in reflectance confocal microscopy of A. Luque Acevedo (COLOMBIA) morphology and prevalent patterns of 15:30 Traditional Platelet-rich plasma vs Platelet Rich congenital nevi of the trunk for age groups Plasma Kits in treatment of post-traumatic G. Odorici (ITALY) atrophic Scars: A comparative study 15:20 Line-field confocal optical coherence A. Abdelshafy (EGYPT) tomography: presentation of the technique and its applications in dermatology 15:40 To evaluate the safety and efficacy of oral M. Suppa (BELGIUM) isotretinoin with Jessner’s- 35%Trichloroacetic acid peel (Monheit Technique) for the treatment 15:30 Lesions mimicking melanoma at dermoscopy of acanthosis nigricans in coloured skin confirmed basal cell carcinoma: evaluation with S. Langar (INDIA) reflectance confocal microscopy F. Peccerillo (ITALY) 15:50 Fake Toxins & Fillers – What We Have Learned M. Gold (UNITED STATES) 15:40 Teledermatology improves access to care for uninsured patients and increases efficiency of 16:00 Clinical observation of intense pulsed light volunteer outreach clinics vascular filter in the treatment of facial C. Simpson (UNITED STATES) telangiectasia in China H. Qu (CHINA) 15:50 Two arms randomized clinical trial comparing the performance of dermoscopy and in-vivo 16:10 Hyaluronan hybrid cooperative complexes confocal microscopy versus dermoscopy alone support muscle derived cell differentiation in for the diagnosis of skin tumors in a 3 hospitals vitro: new prospective for regenerative network (NET-2011) medicine R. Pampena (ITALY) C. Schiraldi (ITALY) 16:00 Incidental melanoma detection following 16:20 Combination treatment of atrophic post acne teledermatology consultation for skin lesions in scars with subcision and microneedling in skin patients type III-V T. Tejasvi (UNITED STATES) S. Bhargava (INDIA) 16:10 A teledermatology web platform for early melanoma detection: the iDScore project AMBER 7+8 14:30-16:30 L. Tognetti (ITALY)

Dermatoscopy, Skin Imaging and 16:20 Dermoscopy as an evolving tool to assess FC Teledermatology 1 vitiligo disease activity CO-CHAIRS: Anna Di Landro (ITALY), A. Jha (INDIA) Edgar La Rotta Higueira (VENEZUELA) TUESDAY 11 JUNE, 2019

BLUE 1 14:30-16:30 15:46 The role of PDL in scar prevention and treatment of scars Basic Dermatopathology Joyce Lim (SINGAPORE) CO CHAIR: Rino Cerio (UNITED KINGDOM) 15:54 Scar Management with Picosecond lasers CO-CHAIRS: Helmut Beltraminelli (SWITZERLAND), Nicola Zerbinati (ITALY) Alessandro Di Stefani (ITALY) 16:02 How to use Fractional CO2 laser for scars in 14:30 Clinical-Pathological correlations of darker skin types inﬂammatory dermatoses on African skin Koushik Lahiri (INDIA) Legesse Adane (ETHIOPIA) 16:10 Q&A 15:00 How to achieve a dermatopathological diagnosis Hussein Hassab-El-Naby (EGYPT) BROWN 1 14:30-16:30 15:20 Infective dermatopathology - essentials for clinical practice Cosmetic Dermatology for the General Jehad Alassaf (JORDAN) WS Dermatologist CHAIR: Zoe Draelos (UNITED STATES) 15:50 Imported dermatoses CO-CHAIRS: Jaishree Sharad (INDIA), Chalid Assaf (GERMANY) David Sudarto Oeiria (INDONESIA)

16:10 Q&A 14:30 Cosmeceutical Update 2019 Zoe Draelos (UNITED STATES) BLUE 2 14:30-16:30 14:45 The Dermatologic Value of Microneedling Cosmeceuticals Laser II: Rejuvination and Scars Jaishree Sharad (INDIA) CO CHAIR: Chee Leok Goh (SINGAPORE) 15:00 Combined Cosmetic Dermatology Treatments CO-CHAIRS: Giovanni Cannarozzo (ITALY), David Sudarto Oeiria (INDONESIA) Matteo Tretti Clementoni (ITALY) 15:15 Stem Cells: Are They the Fountain of Youth? 14:30 Lasers and EBD for Skin Rejuvenation: What Patricia Farris (UNITED STATES) Lasers and EBD are used for Skin Rejuvenation Nancy Garcia Tan (PHILIPPINES) 15:30 Cosmetic Dermatology Trends for the Body Sonja Sattler (GERMANY) 14:38 Wrinkles and textural changes – what is the best approach? 15:45 Facial Moisturizer Cosmetic Dermatology Primer Martin Kassir (UNITED STATES) Tamara Griffiths (UNITED KINGDOM)

14:46 Pigmentary disorders from photoaging – what 16:00 Cosmetic Dermatology for Darker Skin devices to use Mukta Sachdev (INDIA) Tokuya Omi (JAPAN) 16:15 The Art of the Cosmetic Consultation 14:54 Skin tightening devices for skin rejuvenation – Marina Landau (ISRAEL) an overview Suzanne Cheng (SINGAPORE) BROWN 2 14:30-16:30

15:02 The role of combined techniques in rejuvenation Management of Skin Cancer in the Matteo Tretti Clementoni (ITALY) WS Immunosuppressed Patient 15:10 Q&A CHAIR: Clark Otley (UNITED STATES) CO-CHAIRS: Charlotte Proby (UNITED 15:30 Lasers and EBD for Scar Treatment: KINGDOM), Marjan Garmyn (BELGIUM) Hypertrophic scar/Keloid prevention/management update 14:30 Surgical management of Nonmelanoma Skin Melissa WP Tan (SINGAPORE) Cancer in Solid Organ Transplant Recipients Fiona Zwald (UNITED STATES) 15:38 Laser/EBD intervention to prevent/improve scar appearance 14:42 Adjuvant Therapy for High Risk SCC in Solid Merete Haedersdal (DENMARK) Organ Transplant Recipients Chrysalyne Schmults (UNITED STATES) TUESDAY 11 JUNE, 2019

14:54 Management of Melanoma in Solid Organ Monoclonal antibody side effect proﬁles and Transplant Recipients longevity of therapeutic responses Marjan Garmyn (BELGIUM) Bruce Strober (UNITED STATES)

15:06 Management of Uncommon Nonmelanoma Skin 16:02 Q&A Cancer in Solid Organ Transplant Patients and in 16:06 Therapeutic stratiﬁcation of monoclonal Immunosuppressed non-organ transplant antibodies for psoriasis patients Nick Reynolds (UNITED KINGDOM) Lucia Brambilla (ITALY) 16:26 Q&A 15:18 Panel discussion and audience questions

15:30 Management of Skin Cancer in Immunosuppressed Patients Who Are Not Solid RED 1 14:30-16:30 Organ Transplant Patients Stefano Piaserico (ITALY) Hair and nail disorders, hyperidrosis 1 FC CO-CHAIRS: Annamaria Offidani (ITALY), 15:42 Prevention and Prophylaxis of Skin Cancer in Nina Otberg (GERMANY) Immunosuppressed Patients Alvin Chong (AUSTRALIA) 14:30 Transverse sectioning study of a common pattern of tractional alopecia among Egyptian 15:54 Topical Therapy for Skin Cancer in females Immunosuppressed Patients H. Abdelraouf (EGYPT) Charlotte Proby (UNITED KINGDOM) 14:40 Non-invasive tecniques for scarring and non 16:06 Systemic Therapy for Skin Cancer in scarring alopecias evaluation and follow-up. A Immunosuppressed Patients retrospective study Luigi Naldi (ITALY) C. Franceschini (ITALY) 16:18 Panel discussion and audience questions 14:50 Microneedling Versus Autologous Platelet - Rich Plasma In Treatment Of Alopecia Areata BROWN 3 14:30-16:30 E. K. Youssef (EGYPT) 15:00 Development and Content Validation of a Novel antibody-based therapies for Clinically Meaningful Patient-Reported Outcome WS inﬂammatory skin disease (PRO) for Scalp Hair Assessment CHAIR: Nick Reynolds (UNITED KINGDOM) B. A. King (UNITED STATES) CO-CHAIRS: Thomas Jung (SWITZERLAND), 15:10 Pemphigus-associated alopecia – a clinical Bruce Strober (UNITED STATES) marker of a more severe course of pemphigus 14:30 Introduction and insights into underlying vulgaris. pathogenic mechanisms of inﬂammatory skin M. Sar-Pomian (POLAND) disease through targeted therapies 15:20 The use and Cost of Alternative Treatments for Thomas Jung (SWITZERLAND) Cicatricial Alopecias 14:50 Q&A A. Manatis-Lornell (UNITED STATES)

14:54 Recent advances in antibody-based therapies 15:30 Risk factors and clinical proﬁle of Brazilian for atopic eczema: an increasing pipeline patients with frontal ﬁbrosing alopecia Emma Guttman (UNITED STATES) H. Miot (BRAZIL)

15:14 Q&A 15:40 Nail Pigmentations Treatment by Using 1064nm Picosecond Laser 15:18 Recent advances in antibody-based therapies K. Sung Tsai (CHINESE TAIPEI) for hidradenitis suppurativa: an increasing pipeline 15:50 Fractional photothermolysis stimulating hair Gregor Jemec (DENMARK) follicle regrowth in alopecia patients: a pilot study 15:38 Q&A N. Mesinkovska (UNITED STATES) 15:42 Psoriasis clinical trials and registries: TUESDAY 11 JUNE, 2019

16:00 Correlation of cardiovascular autonomic 15:04 Cases with the audience function, peripheral vascular endothelial Isabel Tromme (BELGIUM) function and quality of life with disease severity 15:16 Cases with the audience in primary hyperhidrosis Paolo Broganelli (ITALY) S. Singh (INDIA) 15:28 Volar lesions 16:10 Development and validation of a dermoscopy Michael A. Marchetti (UNITED STATES) severity score of female pattern alopecia M. A. Penha (BRAZIL) 15:45 Nail lesions Sebastian Podlipnik (SPAIN) 16:20 Trichoscopic markers of eyebrow loss in alopecia areata and frontal ﬁbrosing alopecia 16:02 Cases for the audience M. Sikora (POLAND) Philipp Tschandl (AUSTRIA)

16:14 Final Test RED 2 14:30-16:30 Susana Puig (SPAIN)

Managing the suspected drug reaction SPACE 2 14:30-16:30 WS CHAIR: Sarah Walsh (UNITED KINGDOM) CO-CHAIRS: Rannakoe Lehloenya (SOUTH Nail Surgery: State of the Art AFRICA), WS CHAIR: David De Berker (UNITED KINGDOM) Michael Ardern-Jones (UNITED KINGDOM) CO-CHAIRS: Phoebe Rich (UNITED STATES), 14:30 Investigation of Drug Reactions: diagnostic Chander Grover (INDIA) testing 14:30 Shave biopsy of the nail unit Michael Ardern-Jones (UNITED KINGDOM) Pauline Lecerf (BELGIUM) 14:55 Discussion 14:47 Grafts in the nail unit 15:00 Gaps and Challenges in the management of Eckart Haneke (GERMANY) SJS/TEN 15:04 Clinical patterns and dermoscopy of nail Haur Yueh Lee (SINGAPORE) dyschromias in dark skins 15:25 Discussion Soumiya Chiheb (MOROCCO)

15:30 TB drug hypersensitivity in HIV: insights from 15:21 Dressings for wounds of the nail unit the clinic and laboratory Dhru Laheru (UNITED KINGDOM) Rannakoe Lehloenya (SOUTH AFRICA) 15:38 Diagnostic nail biopsies: when and how 15:55 Discussion Chander Grover (INDIA)

16:00 Management of DRESS 15:55 When and how to operate for nail ingrowing Olivier Chosidow (FRANCE) Nilton Di Chiacchio (BRAZIL)

16:25 Discussion 16:12 Top ﬁve tips in nail surgery David De Berker (UNITED KINGDOM)

SPACE 1 14:30-16:30 SPACE 3 14:30-15:30 Basic Dermoscopy CO CHAIR: Susana Puig (SPAIN) Early Mycosis Fungoides: Does Treatment Make CO-CHAIRS: Horacio Cabo (ARGENTINA), CN a Difference? Ashfaq Marghoob (UNITED STATES) CHAIR: Jerry Shapiro (UNITED STATES) DISCUSSANT: 14:30 Melanoma in sun damaged non-facial skin Against - Sean Whittaker (UNITED KINGDOM), Danica Tiodorovic (SERBIA) For - Alain Rook (UNITED STATES) 14:47 Melanoma and Facial lesions Giuseppe Argenziano (ITALY) TUESDAY 11 JUNE, 2019

SPACE 3 15:30-16:30 15:10 Comparative study of recipient site preparation with fractional carbon dioxide laser vs. Toxic Epidermal Necrolysis: To Treat or Not to dermabrasion in vitiligo surgery and their effect CN Treat? Immunotherapy Versus Supportive on response to phototherapy using two different Therapy modalities CHAIR: Hu Chung-Hong (CHINESE TAIPEI) N. Jahan Khatoon (INDIA) DISCUSSANT: 15:20 Superiority of occipital donor sites for split Against - Tetsuo Shiohara (JAPAN), thickness skin grafting in dermatosurgery: For - Pierre Wolkenstein (FRANCE) Results of a prospective randomized controlled Speaker - Saskia Oro (FRANCE) study M. Kovacs (GERMANY) SPACE 4 14:30-15:30 15:30 Why do we indicate Mohs micrographic surgery? Retrospective cohort study Platelet Rich Plasma: Does it really work? M. M. Martinez Piva (ARGENTINA) CN CHAIR: Lars E. French (SWITZERLAND) 15:40 Mohs micrografic surgery for treatment of DISCUSSANT: periocular skin cancer Against- Michael Bigby (UNITED STATES), G. Proietto (ITALY) For - Ramon Grimalt (SPAIN) 15:50 Dermatofibrosarcoma Protuberans in Children: The Slow Mohs Micrographic Surgery Approach SPACE 4 15:30-16:30 C. Psomadakis (UNITED KINGDOM) 16:00 Reconstruction of lower eyelid defects with Antibiotics should no longer be used for acne modified horizontal V-Y advancement flap CN CHAIR: Hassan Ibrahim Hassan Galadari (UNITED M. Shiri (IRAN) ARAB EMIRATES) DISCUSSANT: 16:10 Recurrence of periocular keratinocyte Against - Julien Lambert (BELGIUM), carcinoma after Mohs Micrographic Surgery: a For - James Leyden (UNITED STATES) retrospective cohort study M. Wakkee (NETHERLANDS)

16:20 Barbed Sutures: a new suture material applied in WHITE 1 14:30-16:30 Dermatologic Surgery to Modulate Incision Tension and Prevent Scar Formation Dermatologic Surgery S. Zhang (CHINA) FC CO-CHAIRS: Paola Savoia (ITALY), Gilberto Adame (MEXICO)

14:30 The Hinged Turnover Flap is a Versatile and WHITE 2 14:30-16:30 Single-Staged Option for Full-Thickness Defects of the Nasal Ala and Soft Triangle Skin imaging: from OCT to Body Mapping S. Aasi (UNITED STATES) WS CHAIR: Peter Soyer (AUSTRALIA) CO-CHAIRS: Gyohei Egawa (JAPAN), 14:40 Modiﬁed S-plasty (Italic-S plasty) with Steven Tien Guan Thng (SINGAPORE) preventive dog ear correction P. Boggio (ITALY) 14:30 OCT in Dermatology: Imaging of basel cell carcinoma and beyond 14:50 Keloid Fillet Flap: Surgical pearls for a valuable Julia Welzel (GERMANY) technique in keloids management B. Duarte (PORTUGAL) 14:43 Discussion

15:00 Healing by Secondary Intention vs. Other Repair 14:47 Two Photon Microscopy Techniques on the Nose – Comparing Patient Gyohei Egawa (JAPAN) Satisfaction After Mohs Micrographic Surgery for 15:00 Discussion Basal Cell Carcinomas M. Angeliki Gkini (UNITED KINGDOM) 15:04 Photoacoustics Imaging for 3D Mapping of Skin Steven Tien Guan Thng (SINGAPORE) TUESDAY 11 JUNE, 2019

15:17 Discussion 15:30 Morphological classification of melanoma metastasis with reflectance confocal 15:21 Advances in Dermatologic Ultrasound microscopy Ximena Wortsman (CHILE) S. Longhitano (ITALY) 15:34 Discussion 15:40 In-vivo melanoma detection by a simple optical 15:38 Reflectance Confocal Microscopy probe Caterina Longo (ITALY) D. Louie (CANADA)

15:51 Discussion 15:50 The many faces of amelanotic melanoma S. Paget (UNITED KINGDOM) 15:55 Sequential Dermoscopic Imaging Rainer Hofmann-Wellenhof (AUSTRIA) 16:00 Multiparametric analysis of plasma exosomes derived from melanoma patients. Nanometric 16:08 Discussion click of a pathologic status 16:12 3D Total Body Photography G. Paolino (ITALY) Peter Soyer (AUSTRALIA) 16:10 Melanoma targeted radiation therapy by [131I] 16:25 Discussion ICF01012 interacts with antitumoral immunity response and enhances immune checkpoint inhibitor efficacy YELLOW 1 14:30-16:30 J. Rouanet (FRANCE) 16:20 Does preoperative radiological staging prior to Melanoma and Naevi lymph node dissection alter management in FC CO-CHAIRS: Stefano Calvieri (ITALY), patients with sentinel node biopsy-positive Victoria Mar (AUSTRALIA) melanoma? 14:30 Severe Vitamin D deficiency associated with Y. J. Teo (IRELAND) Stage 4 melanoma and BRAF mutation status L. Fearfield (UNITED KINGDOM) YELLOW 2 14:30-16:30 14:40 Pure Desmoplastic melanoma: clinicopathologic analysis and subtype survival analysis Wound Healing and Vascular Diseases M. Howard (AUSTRALIA) FC CO-CHAIRS: Alberico Motolese (ITALY), 14:50 A study of patients presenting with thick Jose Contreras (MEXICO) primary melanoma in Western Australia 14:30 Ex vivo confocal laser scanning microscopy: an C. Quirk (AUSTRALIA) innovative method for direct 15:00 LncRNA CD27-AS promotes proliferation and immunofluorescence of cutaneous vasculitis invasion of melanoma cells through regulating I. S. Bagci (GERMANY) CD27 14:40 Neutrophil extracellular traps are present in the M. Jingjing (CHINA) early phase of immune complex-mediated 15:10 High-resolution MRI demonstrates that most cutaneous small vessel vasculitis and correlate small intracranial melanoma metastases are with the severity of vessel damage located at the interface between the cortex and C. Bergqvist (LEBANON) leptomeninges 14:50 Low rate of keloid recurrences following A. Lasocki (AUSTRALIA) treatment of keloidectomy sites with a 15:20 The immunosuppressive function and biologically effective dose 30 of superficial underlying mechanisms of monocyte-derived radiation tolerogenic langerhans cells on the B. Berman (UNITED STATES) development of melanoma 15:00 Carboxytherapy in the management of malum J. Li (CHINA) perforans pedis in a diabetic patient H. Zelenkova (SLOVAKIA) TUESDAY 11 JUNE, 2019

15:10 A Prospective Case Control Study: 0.1% Timolol or sézary syndrome Gel In Healing Split-Thickness Skin Grafts Donor R. Almukhtar (UNITED STATES) Sites 14:50 Loss of ZEB1 gene in Sezary syndrome G. Ettorre (ITALY) E. Caprini (ITALY) 15:20 The Topical Use of Autologous Bone Marrow 15:00 Identification of identical long copy number Derived Mesenchymal Stem Cells for Venous variations in matched blood and skin in Mycosis Ulcers: A Randomized, Prospective, Double Fungoides and Sezary Syndrome using SNP Blind, Placebo-Controlled Pilot Study arrays A. Grada (UNITED STATES) J. Yoo (UNITED KINGDOM) 15:30 Proxylane, a plant sugar derivative, in proves 15:10 The role of TOX and TOX-regulated genes in wound healing by biomimetic mechanism mycosis fungoides and Sézary syndrome L. Breton (FRANCE) J. Liu (CHINA) 15:40 The development of innovative advanced 15:20 Efficacy of mogamulizumab by prior systemic therapy medicinal product in the treatment of therapy in patients with previously treated Epidermolysis Bullosa and other chronic wounds cutaneous T-cell lymphoma in the phace 3 C. Kowalewski (POLAND) MAVORIC study 15:50 Immunomodulatory effect of stingless bee J. Scarisbrick (UNITED KINGDOM) honey on wound healing mechanism in LPS 15:30 Systematic review and proposal for an in vivo activated RAW 264.7 cells reflectance confocal microscopy assessment H. Ab Habi (MALAYSIA) tool for cutaneous lymphoma 16:00 A Randomized control trial to study the efficacy B. Melhoranse Gouveia (AUSTRALIA) of cultured autologous keranocyte-melanocyte 15:40 Overall Survival and Prognosis in Mycosis transplant versus conservative wound dressing Fungoides: A Systematic Review and Meta in the management of post Analysis D. Mitra (INDIA) A. Mourad (CANADA) 16:10 Side effects of frequently used oral antidiabetics 15:50 Allogeneic hematopoietic stem cell and antihypertensive drugs on wound healing transplantation following reduced-intensity in-vitro conditioning in advanced stage mycosis E. K. Stuermer (GERMANY) fungoides and Sézary syndrome 16:20 Improvements and Correlations in Oral Ulcers, F. Onida (ITALY) Disease Activity, and QoL in Behçet’s Syndrome 16:00 Clinical and pathological characteristic features Patients Treated With Apremilast: A Phase III of primary cutaneous lymphomas: Report of first Randomized, Double-Blind, Placebo-Controlled case series from dermatology referral centers of Study (RELIEF) Nepal A. Mahr (FRANCE) S. Parajuli (NEPAL)

16:10 Infection with human T-cell lymphotropic virus YELLOW 3 14:30-16:30 type-1 in primary cutaneous lymphoma: Should we be testing all patients? Cutaneous Lymphomas B. Rooke (UNITED KINGDOM) FC CO-CHAIRS: MariaTeresa Fierro (ITALY), 16:20 Infections and related risk factors in Sézary Pietro Quaglino (ITALY) syndrome: a retrospective cohort study of 113 14:30 Hematologic Malignancies in Patients With patients Lymphomatoid Papulosis: Retrospective Study C. Cariti (ITALY) from Canada M. AbuHilal (CANADA)

14:40 Gender differences in the risk of secondary malignancies in patients with mycosis fungoides DAILY SCIENTIFIC PROGRAMME WEDNESDAY 12 JUNE, 2019 WEDNESDAY 12 JUNE, 2019

AMBER 1 07:00-08:00 07:00 Best lymphoma cases of the year Emilio Berti (ITALY)

SIDAPA: Contact sensitivity in chronic 07:15 Best granulomatous cases of the year IS inﬂammatory skin diseases: there is a risk? Giorgio Filosa (ITALY) CO-CHAIRS: Luca Stingeni (ITALY), Rosella Gallo (ITALY) 07:30 Best infectious cases of the year Paolo Romanelli (ITALY) 07:00 Psoriasis Caterina Foti (ITALY) 07:45 Best deposition disorder cases of the year Franco Rongioletti (ITALY) 07:15 Acne Monica Corazza (ITALY)

07:30 Hidradenitis suppurativa AMBER 4 07:00-08:00 Maddalena Napolitano (ITALY) ISPLAD: Dermoplastic treatments for body 07:38 Hidradenitis suppurativa IS shaping Cataldo Patruno (ITALY) CO-CHAIRS: Antonino Di Pietro (ITALY), 07:45 Discussion Andrea Romani (ITALY) 07:45 Injectable treatment for localized fat, news in treatment of the neck AMBER 2 07:00-08:00 Alda Malasoma (ITALY)

CORPO RITROVATO: Cutaneous toxicity in 07:12 Use of Diode Laser, Ultrasound and IS oncologic patients Radiofrequency for Body Shaping CO-CHAIRS: Vincent Sibaud (FRANCE), Giuseppe Scarcella (ITALY) Maria Concetta Pucci Romano (ITALY) 07:24 Microwaves in the treatment of body shaping 07:00 IL CORPO RITROVATO: our history, mission and and laxity results Elisabetta Perosino (ITALY) Maria Concetta Pucci Romano (ITALY) 07:36 Non-invasive devices in the treatment of body 07:10 Papulo-pustolar rash: a new dermatology for shaping oncologic patients Miguel Sanchez Viera (SPAIN) Pietro Sollena (ITALY) 07:48 Discussion 07:20 Papulo-pustolar rash: a new dermatology for oncologic patients (clinical cases) Luigia Panariello (ITALY) AMBER 5+6 07:00-08:00

07:30 Papulo-pustolar rash: a new dermatology for GRUPPO SIDeMaST DI FOTODERMATOLOGIA: oncologic patients (clinical cases) IS Update in phototherapy and photodiagnosis Maria Carmela Annunziata (ITALY) CO-CHAIRS: Marina Venturini (ITALY), 07:40 Cutaneous toxicity during Immunotherapy Serena Lembo (ITALY) Gabriella Fabbrocini (ITALY) 07:00 Phototest: the Italian way 07:50 Nail toxicities of anticancer treatments Marina Venturini (ITALY) Vincent Sibaud (FRANCE) 07:15 Photodermatoses: global news Serena Lembo (ITALY) AMBER 3 07:00-08:00 07:30 Phototherapy: new perspective for combined therapy GRUPPO SIDeMaST DERMATOPATOLOGIA Paolo Amerio (ITALY) IS CLINICA: Best cases of Clinico- 07:45 Targeted photoprotection for speciﬁc diseases Dermatopathological correlation of the year Giovanni Leone (ITALY) CO-CHAIRS: Franco Rongioletti (ITALY), Paolo Romanelli (ITALY) WEDNESDAY 12 JUNE, 2019

AMBER 7+8 07:00-08:00 09:30 NOD2-related systemic autoinﬂammatory granulomatosis, Blau syndrome ADOI: Clinical Research in the Hospital Setting Sanami Takada (JAPAN) IS CO-CHAIRS: Ornella De Pità (ITALY), 09:50 Neutrophilic urticarial dermatosis: an entity Giovanna Malara (ITALY) bridging monogenic and polygenic 07:00 PRP: use and perspectives in the hospital setting autoinﬂammatory disorders, and beyond Giovanna Malara (ITALY) Karoline Krause (GERMANY)

07:15 Autoimmune Blistering Diseases: new 10:10 Pyoderma gangrenosum and other rarer therapeutic options neutrophilic dermatoses as paradigm of Giuseppe Cianchini (ITALY) autoinﬂammation Angelo Valerio Marzano (ITALY) 07:30 Hydradenitis suppurativa: epidemiological data and new therapeutic options 10:30 Q&A Vincenzo Bettoli (ITALY) 07:45 Discussion AMBER 2 08:00-10:45

Occupational Dermatoses BROWN 1 07:00-08:00 SY CHAIR: Swen Malte John (GERMANY) CO-CHAIRS: Hiroo Yokozeki (JAPAN), GRUPPO SIDeMaST STORIA DELLA Kaushal K. Verma (INDIA) IS DERMATOLOGIA E VENEREOLOGIA: History of Dermatology 08:00 Occupational skin diseases: What are the CO-CHAIRS: Luigi Valenzano (ITALY), challenges? Gioachino Alessandro Caresana (ITALY) Swen Malte John (GERMANY)

07:00 Gods, Saints and Venereal diseases 08:16 The need for European OSD minimum standards Carlo Gelmetti (ITALY) Ana Gimenez-Arnau (SPAIN)

07:20 The long hystory of mycobacterium ulcerans 08:32 Individual factors for occupational contact infection dermatitis Giorgio Leigheb (ITALY) Richard Brans (GERMANY)

07:40 Giovan Cosimo Bonomi and the “bacarelli” 08:48 Discussion Aldo Di Carlo (ITALY) 08:58 Clinical aspects of occupational dermatitis Thomas Rustemeyer (NETHERLANDS) AMBER 1 08:00-10:45 09:14 Occupational dermatitis in ﬁeld workers Kaushal K. Verma (INDIA)

Auto-inflammatory Diseases 09:30 Discussion SY CHAIR: Dan Lipsker (FRANCE) CO-CHAIRS: Naotomo Kambe (JAPAN), 09:40 Prevention of occupational skin diseases from a Isabelle Kone-Paut (FRANCE) social insurance perspective Bettina Lindemann (GERMANY) 08:00 Autoinflammatory syndromes: introduction, classification and a focus on pustular rashes with 09:56 Epidemiology and prevention of occupational episodic fevers non-melanoma skin cancer Isabelle Kone-Paut (FRANCE) Alberto Modenese (ITALY)

08:30 Classic hereditary fevers: FMF, TRAPS, 10:12 UV measurements in outdoor workers as mevalonate kinase deﬁciency: presentation and prevention incentive treatment Marc Wittlich (GERMANY) Marco Gattorno (ITALY) 10:28 Discussion

09:00 Type-1 interferon-mediated diseases and 10:38 Wrap Up cutaneous signs of other rare autoinﬂammatory Swen Malte John (GERMANY) syndromes Antonio Torrelo (SPAIN) WEDNESDAY 12 JUNE, 2019

AMBER 3 08:00-10:45 08:48 Surgical site infections Keyvan Nouri (UNITED STATES)

Paraneoplastic Disorders: From Pruritus to Tripe 09:04 Guidelines for optimal anatomic and cosmetic SY Palms results CHAIR: Rokea El-Azhary (UNITED STATES) Aleksandar Krunic (UNITED STATES) CO-CHAIRS: José Antonio Sanches (BRAZIL), Ana Clara Torre (ARGENTINA) 09:20 Risk of tumor recurrence Ally-Khan Somani (UNITED STATES) 08:00 Paraneoplastic Pemphigus in 2019 - it's changing 09:36 Postoperative scar management Grant Anhalt (UNITED STATES) Severin Laeuchli (SWITZERLAND)

08:25 Dermatomyositis as a paraneoplastic condition 09:52 Nail surgery complications Ricardo Romiti (BRAZIL) Olivier Cogrel (FRANCE)

08:40 New Paraneoplastic associations 10:08 Complications of cosmetic procedures Julio Sartori (UNITED STATES) Jorge Ocampo-Candiani (MEXICO)

08:55 Hair, nails and malignancy 10:24 Complications in dermatologic surgery Antonella Tosti (UNITED STATES) procedures performed by physician extenders 09:10 Paraneoplastic Erythroderma: It goes beyond George Hruza (UNITED STATES) skin-deep Joyce Lee (SINGAPORE) 10:40 Q&A

09:25 Q&A

09:33 Dermatopathology: a window into systemic AMBER 5+6 08:00-10:45 diseases Doina Ivan (UNITED STATES) Superﬁcial Fungal Infections SY CHAIR: Adebola Ogunbiyi (NIGERIA) 09:48 Pruritus as a paraneoplastic sign CO-CHAIRS: Koji Sayama (JAPAN), Mahira El Sayed (EGYPT) Shyam Verma (INDIA)

10:03 Genetic diseases and malignancy in pediatric 08:00 Rare superﬁcial fungal infections population Stefano Veraldi (ITALY) Jennifer Hand (UNITED STATES) 08:20 Epidemic of Dermatophytosis in India 10:18 Pyoderma Gangrenosum as a paraneoplastic Shyam Verma (INDIA) condition Ana Clara Torre (ARGENTINA) 08:40 Dermatophyte infections in immunocompromised patients 10:33 Q&A, Round up and Summary Ditte Marie Saunte (DENMARK)

09:00 Tinea Capitis; Clinical and Dermoscopic ﬁndings AMBER 4 08:00-10:45 in Sub-Saharan Africa Adebola Ogunbiyi (NIGERIA)

Management of Surgical Complications 09:20 Superﬁcial fungal infections during treatment SY CHAIR: Severin Laeuchli (SWITZERLAND) with IL-17 inhibitors CO-CHAIRS: George Hruza (UNITED STATES), Koji Sayama (JAPAN) Jorge Ocampo-Candiani (MEXICO) 09:40 Onychomycosis: What can I do when nothing 08:00 Preoperative evaluation principles works Richard Motley (UNITED KINGDOM) Dimitris Rigopoulos (GREECE)

08:16 How to avoid and manage Bleeding 10:00 Recalcitrant Dermatophytosis: A macroscopic complications and microscopic Michael Muhlstaedt (SWITZERLAND) Ricardo Galimberti (ARGENTINA) 08:32 Management of necrosis and dehiscence Siqi Fu (CHINA) WEDNESDAY 12 JUNE, 2019

10:20 Antifungal stewardship: superﬁcial fungal 09:15 Fat removal devices infections Kyle Coleman (UNITED STATES) Abir Saraswat (INDIA) 09:32 Does instrumentation matter in liposuction 10:40 Q&A surgery Gerhard Sattler (GERMANY)

AMBER 7+8 08:00-10:45 09:49 Lipoﬁlling of the face Lisa Donofrio (UNITED STATES)

Common drug reactions 10:06 Update on cellulite treatment SY CHAIR: Vinod Sharma (INDIA) Doris Hexsel (BRAZIL) CO-CHAIRS: Furen Zhang (CHINA), 10:23 Q&A Dean Naisbitt (UNITED KINGDOM)

08:00 Introduction to Drug Reactions Vinod Sharma (INDIA) BLUE 2 08:00-10:45 08:07 Diagnosis and investigations in drug reactions: Laser III: Vascular an update CO CHAIR: Agneta Troilius Rubin (SWEDEN) Neil Shear (CANADA) CO-CHAIRS: Roy Geronemus (UNITED STATES), 08:37 Drug-speciﬁc T-cells in cutaneous reactions and Davide Brunelli (ITALY) the immune regulatory pathways 08:00 Introduction Dean Naisbitt (UNITED KINGDOM) Agneta Troilius Rubin (SWEDEN) 09:07 Drug reactions in China and approach to 08:03 Laser & IPL treatments of vascular anomalies management Agneta Troilius Rubin (SWEDEN) Furen Zhang (CHINA) 08:21 Laser of vascular malformation in infancy 09:37 Management of SJS-TEN Roy Geronemus (UNITED STATES) Vinod Sharma (INDIA) 08:39 Laser treatment of regressed hemangiomas 10:07 Drug Reactions to newer drugs and biologics residuals Lalit Gupta (INDIA) Davide Brunelli (ITALY) 10:37 Concluding Remarks 08:57 Laser & IPL treatment of darker skintypes IV and V Furen Zhang (CHINA) Ashraf Badawi (CANADA)

09:15 Laser & IPL Treatment of molluscum, lupus BLUE 1 08:00-10:45 tumidus, verrucae, granuloma telangiectaticum Pablo Boixeda (SPAIN) Lipodistribution 09:33 Laser & IPL of radiation dermatitis CO CHAIR: Lisa Donofrio (UNITED STATES) Nicola Zerbinati (ITALY) CO-CHAIRS: Giacomo Urtis (ITALY), Kyle Coleman (UNITED STATES) 09:51 Adjuvant vascular laser & IPL treatments of autoimmune diseases 08:00 Important Anatomy for Liposuction Surgeons Christine Dierickx (BELGIUM) Andrè Braz (BRAZIL) 10:09 Vascular lasers for scar prevention 08:17 Lipedema: patterns and treatment Keyvan Nouri (UNITED STATES) Loek Habbema (NETHERLANDS) 10:27 Future treatment trends for vascular lesions 08:34 Vaser and body contouring Rox Anderson (UNITED STATES) Giacomo Urtis (ITALY)

08:46 Vaser and body contouring Alberto Di Giuseppe (ITALY)

08:58 The 3 Liposuction cases I learned the most from Kyle Coleman (UNITED STATES) WEDNESDAY 12 JUNE, 2019

BROWN 1 08:00-10:45 09:10 Pathogenesis of rosacea Kenshi Yamasaki (JAPAN)

The Multi-disciplinary Approach to Melanoma 09:40 Rosacea management recommendations SY CHAIR: Claus Garbe (GERMANY) Martin Schaller (GERMANY) CO-CHAIRS: John Kelly (AUSTRALIA), Jean Jacques Grob (FRANCE) 10:10 Perioral dermatitis update Julie Harper (UNITED STATES) 08:00 Clinical and dermoscopic diagnosis Josep Malvehy (SPAIN) 10:35 Summary Jerry Tan (CANADA) 08:20 Discussion

08:23 New diagnostic devices Allan Halpern (UNITED STATES) BROWN 3 08:00-10:45

08:43 Discussion Sexually Transmitted Infections 08:46 Genetic markers and biomarkers SY CHAIR: Michel Janier (FRANCE) Mohammed Kashani-Sabet (UNITED STATES) CO-CHAIRS: Marco Cusini (ITALY), Alexey Kubanov (RUSSIAN FEDERATION) 09:06 Discussion 08:00 What’s new in STIs 2019 09:09 Indications and recommendations for surgical Marco Cusini (ITALY) treatment John Kelly (AUSTRALIA) 08:18 Clinical Spectrum of early syphilis Stephan Lautenschlager (SWITZERLAND) 09:29 Discussion 08:36 Non gonococcal urethritis, practical 09:32 The new adjuvant treatments management Jean Jacques Grob (FRANCE) Electra Nicolaidou (GREECE)

09:52 Discussion 08:54 Antimicrobial resistance of Neisseria 09:55 Is metastatic melanoma curable? gonorrhoeae: global problem Claus Garbe (GERMANY) Alexey Kubanov (RUSSIAN FEDERATION)

10:15 Discussion 09:12 Research into practice-new insights into HSV infections 10:18 Essentials of melanoma surveillance Rajul Patel (UNITED KINGDOM) Elvira Moscarella (ITALY) 09:30 STIs in transgender individuals 10:38 Discussion Fabrice Bouscarat (FRANCE)

10:41 Final remarks 09:48 PrEP: PRO Henry De Vries (NETHERLANDS) BROWN 2 08:00-10:45 10:00 PrEP: CONTRA Eric Caumes (FRANCE)

Rosacea and Perioral Dermatitis 10:12 Discussion SY CHAIR: Jerry Tan (CANADA) Eric Caumes (FRANCE) CO-CHAIRS: Martin Schaller (GERMANY), Gita Faghihi (IRAN) 10:17 Global strategy for control and prevention of STIs 08:00 Introduction and Update on rosacea diagnosis Igor Toskin (SWITZERLAND) and classiﬁcation Jerry Tan (CANADA) 10:35 Discussion

08:30 Epidemiology of rosacea Giuseppe Micali (ITALY)

08:50 Co-morbidities of rosacea Vincenzo Bettoli (ITALY) WEDNESDAY 12 JUNE, 2019

RED 1+2 08:00-10:45 08:56 Embryology of melanoma Aimilios Lallas (GREECE)

Alopecia Areata 09:10 Trichoscopy SY CHAIR: Amos Gilhar (ISRAEL) Lidia Rudnicka (POLAND) CO-CHAIRS: Ulrike Blume-Peytavi (GERMANY), Maria Hordinsky (UNITED STATES) 09:24 Inﬂammoscopy Enzo Erricchetti (ITALY) 08:00 Introduction 09:38 Pigmented actinic keratoses and lichen planus 08:08 Integrated behavioral healthcare for the like keratoses alopecia areata patient Nisa Akay (TURKEY) Maria Hordinsky (UNITED STATES) 09:52 Dermatoscopy as a guidance for therapeutic 08:28 Q&A decisions 08:33 Alopecia areata: current understanding and Iris Zalaudek (AUSTRIA) future directions 10:05 Dermatoscopy of lesions on the scalp and breast Taisuke Ito (JAPAN) Wilhelm Stolz (GERMANY)

08:53 Q&A 10:18 Selected cases from special sites 08:58 Therapeutic advances in AA Masaru Tanaka (JAPAN) Brett King (UNITED STATES) 10:32 In-situ versus invasive squamous cell carcinoma 09:18 Q&A Zoe Apalla (GREECE)

09:23 g/d T cells and ILCs in the pathogenesis of AA Amos Gilhar (ISRAEL) SPACE 2 08:00-10:45 09:43 Q&A Current Management of Urticaria and 09:48 Trichoscopy - a valuable tool in preventing SY Angioedema diagnostic errors in alopecia areata CHAIR: Marcus Maurer (GERMANY) Nino Lortkipanidze (GEORGIA) CO-CHAIRS: Michihiro Hide (JAPAN), 10:08 Q&A Emek Kocaturk Goncu (TURKEY)

10:13 Alopecia areata over the Life Cycle - clinical 08:00 Introduction implications Marcus Maurer (GERMANY) Ulrike Blume-Peytavi (GERMANY) 08:05 Who is behind the wheal? An update on the 10:33 Q&A classiﬁcation and pathogenesis of urticaria and angioedema 10:38 Closing Zuotao Zhao (CHINA)

08:18 Discussion

SPACE 1 08:00-10:45 08:21 Chronic spontaneous urticaria – global differences in clinical features and subtypes and Advanced Dermoscopy burden of disease CO CHAIR: Harald Kittler (AUSTRIA) Christian Vestergaard (DENMARK) CO-CHAIRS: Aimilios Lallas (GREECE), Masaru Tanaka (JAPAN) 08:34 Discussion

08:00 Clues to non-pigmented lesions 08:37 Wheals but no urticaria - Angioedema but no Harald Kittler (AUSTRIA) wheals? How not to miss autoinﬂammatory diseases and Bradykinin-mediated angioedema 08:14 Rare neoplasms with speciﬁc patterns – and how to treat them? Pedro Zaballos (SPAIN) Michihiro Hide (JAPAN)

08:28 Non-pigmented cases 08:50 Discussion Ashfaq Marghoob (UNITED STATES) 08:53 Chronic inducible urticaria – subtypes, 08:42 Childhood & Pediatric Melanomas diagnostic work up and treatment Cristina Carrera (SPAIN) Kulthanan Kanokvalai (THAILAND) WEDNESDAY 12 JUNE, 2019

09:06 Discussion 09:40 Management of complication in the use of ﬁller: the role of hyaluronidase 09:09 Chronic urticaria – How do I measure disease Maurizio Cavallini (ITALY) activity and impact? How do I monitor treatment responses? 10:05 Medical indemnity and cosmetic procedures Karsten Weller (GERMANY) Mark Henley (UNITED KINGDOM)

09:22 Discussion 10:30 Q&A

09:25 In line with the guideline – How to treat antihistamine - resistant patients with chronic SPACE 4 08:00-10:45 urticaria? Marcus Maurer (GERMANY) HS Follicular Occlusion Tetrad 09:38 Discussion SY CHAIR: Marius Rademaker (NEW ZELAND) CO-CHAIRS: Errol Prens (NETHERLANDS), 09:41 How to manage urticaria and angioedema in Ginette Okoye (UNITED STATES) patients who are pregnant or breastfeeding? Emek Kocaturk Goncu (TURKEY) 08:00 Pathophysiology Michelle Lowes (UNITED STATES) 09:54 Discussion 08:15 Wound management 09:57 Urticaria Day, Urticaria Networks, Urticaria Afsaneh Alavi (CANADA) Registries, Global Urticaria Forum, Urticaria Guidelines – an update on global urticaria 08:30 Indiginous populations initiatives Geoffrey Cains (AUSTRALIA) Roberta Fachini Jardim Criado (BRAZIL) 08:45 Epidemiology/ PROMS 10:10 Discussion Gregor Jemec (DENMARK)

10:13 What will the future hold? How we will treat 09:00 Break urticaria and angioedema in 2020 and beyond 09:05 Surgery Ana Gimenez-Arnau (SPAIN) Falk Bechara (GERMANY) 10:26 Discussion 09:20 Medical treatments, incl. biologics 10:29 Discussion and Summary Hessel Van Der Zee (NETHERLANDS)

09:35 Follicular/adnexal pathology SPACE 3 08:00-10:45 Andrea Szegedi (HUNGARY) 09:50 Clinical classiﬁcations/phenotypes Managing complications of aestheic procedures Barbara Horvath (NETHERLANDS) SY CHAIR: Tamara Griffiths (UNITED KINGDOM) 10:05 Microbiome CO-CHAIRS: Koenraad DeBoulle (BELGIUM), Hans Christian Ring (DENMARK) Maurizio Cavallini (ITALY) 10:20 Discussion 08:00 Top tips on how to manage problematic cosmetic patients Henry Hin Lee Chan (HONG KONG) WHITE 1 08:00-10:45 08:25 Botulinum toxin: common mistakes and how to correct Disorders of Hyperpigmentation Koenraad DeBoulle (BELGIUM) SY CHAIR: Evangeline Handog (PHILIPPINES) CO-CHAIRS: Antonio Torrelo (SPAIN), 08:50 Pitfalls with lasers and devices - prevention and Michael Fitz-Henley (JAMAICA) treatment Rungsima Wanitphakdeedecha (THAILAND) 08:00 Welcome and Introduction Evangeline Handog (PHILIPPINES) 09:15 Dermal ﬁllers and adverse events: the real data Izolda Heydenrych (SOUTH AFRICA) 08:05 The Challenges: Disorders of Hyperpigmentation in Children Antonio Torrelo (SPAIN) WEDNESDAY 12 JUNE, 2019

08:20 Disorders of Hyperpigmentation in Adolescents: 09:50 Q&A Prevalence & how it affects the quality of life 09:55 Vascular abnormalities in systemic sclerosis Michael Fitz-Henley (JAMAICA) Yoshihide Asano (JAPAN) 08:35 Disorders of Hyperpigmentation in Adult: 10:10 Q&A Differential Diagnosis of Facial Melanosis Ibrahim Galadari (UNITED ARAB EMIRATES) 10:15 Immunological abnormalities in systemic sclerosis 08:50 Melasma and Post inﬂammatory Takashi Matsushita (JAPAN) Hyperpigmentation Juliet Macarayo (PHILIPPINES) 10:30 Q&A

09:05 Approach: Melasma: Etiopathogenesis, and 10:35 Epigenetic abnormalities in systemic sclerosis Update Hai Long (CHINA) Andrew Alexis (UNITED STATES) 10:43 Q&A 09:20 Dermoscopy and Confocal Microscopy Salvador Gonzalez (SPAIN) YELLOW 1 08:00-10:45 09:35 Topical Management of Melasma Mercedes Florez-White (UNITED STATES) Eosinophilic Dermatoses 09:50 Oral Skin Lightening Agents SY CHAIR: Dagmar Simon (SWITZERLAND) Evangeline Handog (PHILIPPINES) CO-CHAIRS: Delphine Staumont-Salle (FRANCE), Susanne Radonjic-Hosli (SWITZERLAND) 10:05 Gadgets and Lasers: Do they work? Markus Bohm (GERMANY) 08:00 Introduction

10:20 Summary 08:05 The spectrum of eosinophilic dermatoses Antonio Torrelo (SPAIN) Angelo Valerio Marzano (ITALY)

10:25 Chair and Co-chairs Open Forum 08:25 Discussion

10:43 Closing remarks 08:30 Eosinophils as effector and immunoregulatory Michael Fitz-Henley (JAMAICA) cells Dagmar Simon (SWITZERLAND)

WHITE 2 08:00-10:45 08:50 Discussion 08:55 Diagnostic of eosinophilic dermatoses Scleroderma and Morphea Delphine Staumont-Salle (FRANCE) SY CHAIR: Shinichi Sato (JAPAN) 09:15 Discussion CO-CHAIRS: Heidi Jacobe (UNITED STATES), Alisa N. Femia (UNITED STATES) 09:20 Skin and mucosa involvement in hypereosinophilic syndromes 08:00 Eosinophilic fasciitis and its relationship with Selim Aractingi (FRANCE) morphea Alisa N. Femia (UNITED STATES) 09:40 Discussion

08:15 Q&A 09:45 Drug reaction with eosinophilia and systemic symptoms (DRESS) 08:20 Morphea from the dermatology and Tetsuo Shiohara (JAPAN) rheumatology perspective Heidi Jacobe (UNITED STATES) 10:05 Discussion

09:00 Q&A 10:10 Therapeutic strategies for eosinophilic dermatoses 09:05 Immunological abnormalities in morphea Susanne Radonjic-Hösli (SWITZERLAND) Jack C. O'Brien (UNITED STATES) 10:30 Discussion 09:20 Q&A 10:35 Q&A 09:25 Systemic sclerosis - overview of clinical aspects Thomas Krieg (GERMANY) WEDNESDAY 12 JUNE, 2019

YELLOW 2 08:00-10:45 YELLOW 3 08:00-10:45

FELLOW FORUM 2 Essential Medicines in Dermatology FF CO-CHAIRS: Anna Balato (ITALY), SY CHAIR: Luigi Naldi (ITALY) Myrto-Georgia Trakatelli (BELGIUM) CO-CHAIRS: Nicola Magrini (SWITZERLAND), Robert Dellavalle (UNITED STATES) 08:00 Disease severity and survival following a diagnosis of AIDS - related Kaposi’s sarcoma in 08:00 Aims and modalities of the WHO initiative on Kenia Essentials Medicines D. Seth (UNITED STATES) Nicola Magrini (SWITZERLAND)

08:15 5 years’ experience using a porcine animal 08:25 The Global Burden of Disease initiative and model for scabies: what did we learn to improve health needs in Dermatology. Indications for the the therapeutic management of human scabies? Essential Medicine initiative C. Bernigaud (FRANCE) Robert Dellavalle (UNITED STATES)

08:30 Further evidence of the role of HLA-DRB1*04:11 08:50 The existing WHO List of Essential Medicines for in the susceptibility to Heck’s disease in Mayans Dermatology and its limitations infected by HPV 13 Roderick Hay (UNITED KINGDOM) L. Mena-Hernández (MEXICO) 09:15 The case of scabies. Why ivermectin should be 08:45 The efficacy of autologous non-cultured added to the WHO Essential Medicines list? epidermal cell suspension combined with Modalities of prescription platelet rich ﬁbrin and platelet rich plasma for Olivier Chosidow (FRANCE) the treatment of stable vitiligo 09:40 Psoriasis management and needs for a revision A. Nareswari (INDONESIA) of the current WHO Essential Medicines List 09:00 Secondary syphilis with neurosyphilis: Luigi Naldi (ITALY) importance of anamnesis and examination 10:05 Opportunities and costraints when T. Novoa Gomes Jaeger (BRAZIL) implementing a List of Essential Medicines in a 09:15 A Retrospective Cross-Sectional Review of limited resource country Cases of Verruca Vulgaris Treated with Pulsed Ousmane Faye (MALI) Dye Laser in St. Luke’s Medical Center- Quezon 10:30 Discussion City and Global City from January 2011 to December 2017 F. J. Posadas Dy (PHILIPPINES) GOLD 11:00-12:30 09:30 Palpebral chronic lupus erythematous: about three cases CO-CHAIRS: Pearl Grimes (UNITED STATES), S. Salim (MOROCCO) PL Lidjia Kandolf Sekulovic (SERBIA), Mark Lebwohl (UNITED STATES), 09:45 Serration pattern analysis revealed a Suzanne Olbricht (UNITED STATES) challenging diagnosis: Immunoglobulin A mediated Epidermolysis bullosa acquisita 11:00 The beginning and end of the universe S. Senatore (ITALY) Thomas Boller (GERMANY)

10:00 Association between Dietary Patterns and 11:30 Beyond “nevus ﬂammeus” and “port-wine Keratinocyte Cancers in Organ Transplant stains”: toward a better understanding of Recipients cutaneous vascular stains E. Shao (AUSTRALIA) Ilona Frieden (UNITED STATES)

10:15 Evaluation of the efficacy and safety for 11:50 The Multimodality Approach to Facial moderate and severe axillary bromhidrosis Rejuvenation treatment by microwave ablation Susan Weinkle (UNITED STATES) Y. Zhou (CHINA) 12:10 How Autoantigens Drive Cutaneous 10:30 Beyond the severity of psoriatic Autoimmune Disorders symptoms:psychiatric correlates of disability Michel Gilliet (SWITZERLAND) and reduced quality of life E. Del Duca (ITALY) WEDNESDAY 12 JUNE, 2019

AMBER 1 14:30-16:30 AMBER 3 14:30-16:30

Lymphoedema How to manage the photosensitive patient WS CHAIR: Stanley Rockson (UNITED STATES) WS CHAIR: Bernhard Ortel (UNITED STATES) CO-CHAIRS: Dimitris Dionysiou (GREECE), CO-CHAIRS: Piergiacomo Calzavara Pinton Stefano Gentileschi (ITALY) (ITALY), Leihong Flora Xiang (CHINA)

14:30 Diagnosis and Management of Lymphedema 14:30 Clinical progress in solar urticaria, hydroa Stanley Rockson (UNITED STATES) vacciniforme, and EPP Piergiacomo Calzavara Pinton (ITALY) 14:50 Genetics of the Primary Lymphedemas Stanley Rockson (UNITED STATES) 14:45 New developments in PLE, actinic prurigo, photoallergy and chronic actinic dermatitis 15:10 Surgical Treatment of Early Stage Lymphedema Bernhard Ortel (UNITED STATES) Stefano Gentileschi (ITALY) 15:00 Phototesting procedures for photosensitive 15:30 Microsurgical Management of Lymphedema patients Dimitris Dionysiou (GREECE) Sally H. Ibbotson (UNITED KINGDOM) 15:50 Research Advances in Lymphedema 15:15 Photoprotection: Sunscreens, photoprotective Therapeutics clothing, and behavior modiﬁcation Stanley Rockson (UNITED STATES) Yolanda Gilaberte (SPAIN)

15:30 Principles of therapeutic management in AMBER 2 14:30-16:30 photodermatoses Marina Venturini (ITALY) Hair Transplantation 15:45 Systemic new and experimental therapies in WS CHAIR: Eileen Tan (SINGAPORE) photosensitivity disorders CO-CHAIRS: Arthur Tykocinski (BRAZIL), Peter Wolf (AUSTRIA) Vincenzo Gambino (ITALY) 16:00 Q&A 14:30 Introduction

14:40 Emerging Treatments in Hair Restoration Jerry Shapiro (UNITED STATES) AMBER 4 14:30-16:30 15:00 Q&A Merkel Cell Carcinoma: Management Update 15:05 Hair Transplantation: European Perspective WS CHAIR: Celeste Lebbe (FRANCE) Vincenzo Gambino (ITALY) CO-CHAIRS: Kotaro Nagase (JAPAN), Nicole Fischer (GERMANY) 15:20 Q&A 14:30 Introduction 15:25 Hair Transplantation – Asian Perspective Celeste Lebbe (FRANCE) Eileen Tan (SINGAPORE) 14:35 Merkel cell polyomavirus: prevalence and 15:40 Q&A tumorigenic potential 15:45 Surgery Pearls to Avoid Pitfalls in Hair Nicole Fischer (GERMANY) Transplantation 14:50 MCC new clues to cellular ancestry Nina Otberg (GERMANY) Axel Zur Hausen (NETHERLANDS) 16:05 Q&A 15:05 Do we have relevant biomarkers for the 16:10 Challenging and Atypical Hair Transplantation management of MCC Cases Mahtab Samimi (FRANCE) Arthur Tykocinski (BRAZIL) 15:20 MCC prognosis and new AJCC staging 16:25 Q&A Kotaro Nagase (UNITED STATES)

15:35 Role of radiotherapy in the management of MCC Christopher Bichakjian (UNITED STATES) WEDNESDAY 12 JUNE, 2019

15:50 Immune therapy for MCC progress and 15:30 Topical and systemic drugs in combination: to challenges do or not to do? Celeste Lebbe (FRANCE) Lars Iversen (DENMARK)

16:05 MCC evolving scape – Final Remarks 15:45 Q&A Kotaro Nagase (JAPAN) 15:50 Complex treatment made simple – integrating 16:15 Q&A patient and physician Jo Lambert (BELGIUM)

16:05 Q&A AMBER 5+6 14:30-16:30 16:10 Drug treatment as part of psoriasis management Ulrich Mrowietz (GERMANY) New Drugs for Atopic Eczema 16:25 Q&A WS CHAIR: Emma Guttman (UNITED STATES) CO-CHAIRS: Jennifer Huang (UNITED STATES), Graham Ogg (UNITED KINGDOM) BLUE 1 14:30-16:30 14:30 Introduction: New era for AD therapeutics Graham Ogg (UNITED KINGDOM) Vitiligo Surgery CO CHAIR: Iltefat Hamzavi (UNITED STATES) 14:50 Emerging Systemic Treatments for AD CO-CHAIRS: Davinder Parsad (INDIA), Emma Guttman (UNITED STATES) Ahmed Mohammed Al Issa (SAUDI ARABI) 15:10 New Topical treatments for AD 14:30 Non cultured extracted hair follicle outer root Valeria Aoki (BRAZIL) sheath cell suspension for vitiligo 15:30 New developments for the pediatric AD Davinder Parsad (INDIA) population 14:40 Modiﬁcations used for suction epidermal Mike Cork (UNITED KINGDOM) grafting in vitiligo 15:50 Prevention strategies for AD Somesh Gupta (INDIA) Jonathan Silverberg (UNITED STATES) 14:50 Comparison between tissue and cellular grafting 16:10 Q&A Goh Boon Kee (SINGAPORE)

15:00 Vitiligo Surgery: Cellular grafting Tips and Trics AMBER 7+8 14:30-16:30 Nanja Van Geel (BELGIUM) 15:10 Blister grafting for vitiligo When and How to use Biologic and Small Abdallah Marwah (EGYPT) WS Molecule Therapies 15:20 Discussion CHAIR: Ulrich Mrowietz (GERMANY) CO-CHAIRS: Alice Gottlieb (UNITED STATES), 15:30 How to measure response to surgery Richard Langley (CANADA) Amit Pandya (UNITED STATES)

14:30 What is new for psoriatic arthritis 15:40 Long term response and dressing options for Alice Gottlieb (UNITED STATES) surgical vitiligo Iltefat Hamzavi (UNITED STATES) 14:45 Q&A 15:50 Lasers vs dermabrasion for recipient site 14:50 How to choose the right biologic preparation Richard Langley (CANADA) Albert Wolkerstorfer (NETHERLANDS) 15:05 Q&A 16:00 Cellular preparations: commercial kits vs in 15:10 Infectious complications during systemic house methods therapies Rohit Batra (INDIA) Ricardo Romiti (BRAZIL)

15:25 Q&A WEDNESDAY 12 JUNE, 2019

16:10 Punch grafting for vitiligo surgery 16:10 Emerging Treatments with chemical peels: Richard Huggins (UNITED STATES) chemabrasion, combination peels, microneedling, microdermabrasion laser and 16:20 Discussion light devices (case studies) Cheryl Burgess (UNITED STATES) BLUE 2 14:30-16:30 16:15 Q&A 16:20 Emerging Treatments with chemical peels: Chemical Peels chemabrasion, combination peels, CO CHAIR: Cheryl Burgess (UNITED STATES) microneedling, microdermabrasion laser and CO-CHAIRS: Ines Verner (ISRAEL), light devices (case studies) Claudia Borelli (GERMANY) Ines Verner (ISRAEL) 14:30 Overview of chemical peels: superﬁcial, medium 16:25 Q&A and deep preparations Gary D. Monheit (UNITED STATES) 14:40 Complications and contraindications of chemical BROWN 1 14:30-16:30 peels Sahar Ghannam (CANADA) The Molecular Revolution in Dermatopathology WS CHAIR: Thomas Wiesner (AUSTRIA) 14:50 Medical uses for cosmetic peels CO-CHAIRS: Mar Llamas-Velasco (SPAIN), Dee Anna Glaser (UNITED STATES) Iwei Yeh (UNITED STATES) 15:00 Chemical peels in cosmetic rejuvenation 14:30 The Genetic Underpinnings of Intermediate and Tatjana Pavicic (GERMANY) Borderline Melanocytic Tumors 15:10 Chemical peels in skin of color Iwei Yeh (UNITED STATES) Jeanine Downie (UNITED STATES) 14:50 New Insights into the Molecular Evolution of 15:20 Chemical peels in acne and acne scarring Melanoma Marina Landau (ISRAEL) Amaya Viros (UNITED KINGDOM)

15:30 Chemical peels in melasma 15:10 Molecular Diagnostics of Vascular Tumors of the Claudia Borelli (GERMANY) Skin Mar Llamas-Velasco (SPAIN) 15:40 Segmental Croton oil/phenol peels for Periorbital and Perioral Rejuvenation 15:30 Dermatopathology in Africa – Infectious Peter Rullan (UNITED STATES) Diseases and Beyond Moussa Diallo (SENEGAL) 15:45 Q&A 15:50 Molecular Insights into the Pathogenesis of 15:50 Emerging Treatments with chemical peels: Adnexal Carcinoma chemabrasion, combination peels, Klaus Griewank (GERMANY) microneedling, microdermabrasion laser and light devices (case studies) 16:10 Non-Genetic Events Driving Tumor Progression Mary Lupo (UNITED STATES) in Skin Cancer Thomas Wiesner (AUSTRIA) 15:55 Q&A

16:00 Emerging Treatments with chemical peels: chemabrasion, combination peels, BROWN 2 14:30-16:30 microneedling, microdermabrasion laser and light devices (case studies) Management of the Itching Patient Marina Landau (ISRAEL) WS CHAIR: Jacek Szepietowski (POLAND) CO-CHAIRS: Tim Berger (UNITED STATES), 16:05 Q&A Sonja Ständer (GERMANY)

14:30 New Aspects of Itch Pathogenesis Kenji Kabashima (JAPAN) WEDNESDAY 12 JUNE, 2019

14:50 Prurigo Nodularis: What is New? M. Wu (CHINESE TAIPEI) Sonja Ständer (GERMANY)

15:10 Itch in Atopic Dermatitis 15:50 Improvement in Psoriasis Scalp Severity Index Jacek Szepietowski (POLAND) (PSSI) during Maintenance Treatment with Mirikizumab 15:30 Itch in Psoriasis L. Ramsey (UNITED STATES) Gil Yosipovitch (UNITED STATES) 16:00 Systematic review and meta-analysisi of anti 15:50 Itch in Elderly interleukin-17 in psoriasis and psoriatic arthritis Tim Berger (UNITED STATES) F. Giuliani (ITALY) 16:10 Discussion 16:10 Elderly psoriatic patients under biological therapies: an Italian experience. BROWN 3 14:30-16:30 F. Ricceri (ITALY) 16:20 Interleukin-22 and skin: from epidermal Psoriasis 1 homoestasis to psoriasis FC CO-CHAIRS: Annunziata Dattola (ITALY), F. Prignano (ITALY) Ahmad Jalili (SWITZERLAND)

14:30 Psoriasis is associated with signiﬁcant SPACE 1 14:30-16:30 hospitalization for psychiatric illnesses and mental health emergencies: A national inpatient Advanced Dermoscopy sample CO CHAIR: Harald Kittler (AUSTRIA) J. I. Silverberg (UNITED STATES) CO-CHAIRS: Aimilios Lallas (GREECE), 14:40 Fine mapping and subphenotyping implicates Masaru Tanaka (JAPAN) ADRA1B gene variants in psoriasis susceptibility 14:30 Digital monitoring in a Chinese population Davide Altamura (ITALY) X. Fan (CHINA) 14:47 Computer vision 14:50 Risankizumab is Associated With Low and Philipp Tschandl (AUSTRIA) Consistent Infection Rates in Patients With Moderate-to-Severe Psoriasis: Analysis of Short 15:04 Live match: Dermatologists versus Computer Term and Long-Term Pooled Clinical Trial Data Harald Kittler (AUSTRIA) B. Strober (UNITED STATES) 15:21 Recurrent lesions 15:00 The impact of different severity deﬁnitions for Rainer Hofmann-Wellenhof (AUSTRIA) psoriasis in real-world healthcare 15:38 When does confocal help and when not? M. Augustin (GERMANY) Francesca Farnetani (ITALY) 15:10 Long-term safety of tildrakizumab in patients 15:55 Predictive dermatoscopy with moderate-to-severe psoriasis: incidence of Susana Puig (SPAIN) major adverse cardiovascular events through 148 weeks from reSURFACE 1 and reSURFACE 2 16:12 My best and my worst cases phase 3 trials Giuseppe Argenziano (ITALY) P. C. Ignasi (SPAIN)

15:20 Elevated self-disgust in psoriasis patients SPACE 2 14:30-16:30 S. F. Moschogianis (UNITED KINGDOM)

15:30 TNFA, IL4, IL10, IL12B gene polymorphisms in Pigmentation and Lasers psoriasis and psoriatic arthritis in Caucasians of FC CO-CHAIRS: Eman Sanad (EGYPT), East Siberia Steven Nisticò (ITALY) A. A. Barilo (RUSSIAN FEDERATION) 14:30 A Randomized control trial to study the efficacy 15:40 Change in body weight and body mass index in of non cultured versus cultured autologous psoriasis patients receiving biologics: a meta melanocyte transplant in the management of analysis stable vitiligo WEDNESDAY 12 JUNE, 2019

D. Mitra (INDIA) SPACE 3 14:30-16:30 14:40 The Role of Lasers in Connective Tissue and Inflammatory Dermatoses: A 10 Year Skin Cancer Retrospective Review of 52 Patients in a UK FC CO-CHAIRS: Laura Eibenschutz (ITALY), Tertiary Laser Clinic Zeljco Mijuscovic (SERBIA) L. Asfour (UNITED KINGDOM) 14:30 Pembrolizumab with or without vismodegib for 14:50 Picosecond laser for scars and photoaging: advanced basal cell carcinoma: an investigator monitoring of effects by means of in invio initiated, proof-of-concept study reflectance confocal microscopy A. Chang (UNITED STATES) S. Guida (ITALY) 14:40 Clinical profile of Langerhans cell histiocytosis 15:00 Sucrose dilaurate suppresses melanosome at a tertiary care children hospital: Study of 126 transportation and accumulation of advanced cases glycation end-products via autophagy S. Dhar (INDIA) activation 14:50 Duration of response (DoR) analysis of T. Hakozaki (UNITED STATES) cemiplimab, a human monoclonal anti-PD-1, in 15:10 Iron-Induced Accidental Tattoos and Laser the phase 2 study of patients with advanced Therapy: Experience at a Tertiary Referral cutaneous squamous cell carcinoma (CSCC) Centre M. R. Migden (UNITED STATES) L. Imhof (SWITZERLAND) 15:00 The use of sentinel node biopsy and novel 15:20 Analysis of clinical effect of Q-switched ruby molecular approaches to improve triage in high laser dot matrix mode combined with needle risk cutaneous SCC of the head and neck free injection of TXA in treating melisma R. Martin (NEW ZEALAND) Z.Jian (CHINA) 15:10 Review of blood-classification proposed by the 15:30 New approaches to treatment of vascular lesions National Cancer Center Network versus the S. Mazzilli (ITALY) European Organization for Research and Treatment of Cancer in Mycosis Fungoides and 15:40 Oral Tranexamic Acid as adjuvant in Melasma: A Sézary Syndrome Boon or Bane!!! M. E. Martinez-Escala (UNITED STATES) K. Minni (INDIA) 15:20 Electrochemotherapy in the treatment of 15:50 The efficacy of a combined therapy: calcium ulcerated malignant tumors: Results from the hydroxylapatite based filler and energy based InspECT registry device for treatment of acne scars C. Kunte (GERMANY) O. Artzi (ISRAEL) 15:30 The role of ultra high-frequency ultrasound in 16:00 Effect of Laser Therapy on Quality of Life in non-melanoma skin cancers Patients with Radiation-Induced Breast T. Oranges (ITALY) Telangiectasias A. Rossi (UNITED STATES) 15:40 ALA-PDT enhances the antitumor effect during squamous cell carcinoma by inducing CXCL13 16:10 Homocysteine levels in blood and severity of chemokine production in CAF vitiligo before and after NBUVB phototherapy G. Zhang (CHINA) J. Taneja (INDIA) 15:50 The role of Interventional Radiotherapy 16:20 A comparative study between fractional Erbium (BRACHYTHERAPY) in the multidisciplinary laser (2940 nm) and fractional Erbium laser management of the mid face skin and mucosal followed by application of 10% TCA for the tumors treatment of melasma L. Tagliaferri (ITALY) R. Uddin (BANGLADESH) 16:00 Radioisotope P32/Re188 incorporated radioactive skin patches for treatment of basal cell carcinoma K. Verma (INDIA) WEDNESDAY 12 JUNE, 2019

16:10 Cardiovascular drug use and risk of actinic genetic patterns keratosis D. Vekic (AUSTRALIA) O. Warszawik-Hendzel (POLAND) 16:10 The relationship between rosacea and dietary 16:20 Dermatologic radiotherapy: its role in XXI factors: A Multi-center Retrospective Case century Control survey R. Piccinno (ITALY) L. Ji (CHINA)

16:20 A Comparative study of efficacy and safety of SPACE 4 14:30-16:30 autologous fat grafting versus platelet rich plasma in the treatment of post acne scars V. H. Shetty (INDIA) Hidradenitis suppurativa, acne and rosacea FC CO-CHAIRS: Concetta Potenza (ITALY), Gerd Plewing (GERMANY) WHITE 1 14:30-16:30 14:30 Effect of oral isotretinoin on the nucleo cytoplasmic distribution of FoxO1- and FoxO3 Leprosy in the 21st Century proteins in sebaceous glands of patients with WS CHAIR: Robert Modlin (UNITED STATES) acne vulgaris CO-CHAIRS: Cesare Massone (ITALY), N. Agamia (EGYPT) Alireza Firooz (IRAN)

14:40 Identiﬁcation of Autoantibodies in Patients with 14:30 Global leprosy strategy 2016–2020, and then? Hidradenitis Suppurativa Using PhIP-Seq Maria T. Ochoa (UNITED STATES) L. A. Barnes (UNITED STATES) 14:50 Host defense mechanisms in leprosy 14:50 Consensus deﬁnitions of typical lesions in Robert Modlin (UNITED STATES) hidradenitis suppurativa 15:10 Leprosy now and in the coming years, seen by a M. Daxhelet (BELGIUM) clinician 15:00 Rates of Antibiotic Resistance in Hidradenitis Bernard Naafs (NETHERLANDS) Suppurativa Patients 15:25 New Insight into the Pathogenesis of Erythema M. Manfredini (ITALY) Nodosum Leprosum 15:10 Experimental, Prospective, Open, Monocenter, Steve Walker (UNITED KINGDOM) Clinical Trial For The Evaluation Of A Non 15:40 Leprosy in HIV Steroidal Cream To Improve The Condition Of Sinesio Talhari (BRAZIL) Seborrheic Dermatisis Topically Applied On Face And Chest In Patient 15:55 Leprosy relapse and reinfection after multidrug A. Balato (ITALY) therapy Filippo La Rosa (ITALY) 15:20 Long-term Mortality in Hidradenitis Suppurativa Patients 16:10 Leprosy in the future J. Kohorst (UNITED STATES) Anupam Das (INDIA)

15:30 Revealing barrier alterations in rosacea skin at 16:25 Q&A the molecular level A. Szegedi (HUNGARY) WHITE 2 14:30-16:30 15:40 Complete Draft Genome Sequence of Cutibacterium (Propionibacterium) acnes Type The Role of Art in Dermatology Strain ATCC6919 WS CHAIR: Kalman Watsky (UNITED STATES) H. Tang (CHINA) CO-CHAIRS: Helen Young (UNITED KINGDOM), 15:50 Characterization and Analysis of the Skin Massimo Papi (ITALY) Microbiota in Rosacea 14:30 Introduction K. Thompson (CHINA) Kalman Watsky (UNITED STATES) 16:00 The inﬂammatory drive underpinning 14:35 Creative overview/visual essay Hidradenitis Suppurativa: histological Helen Young (UNITED KINGDOM) assessment, cytokine proﬁling and global WEDNESDAY 12 JUNE, 2019

14:45 Dermart in Rome scalp/forehead: a randomized comparative Massimo Papi (ITALY) clinical trial H. Abi Rached (FRANCE) 15:05 The approach of painters to skin color Giuseppe Micali (ITALY) 14:40 Narrow Band UVB Phototherapy for the Treatment of Uremic Pruritus in End-Stage Renal 15:20 Training dermatologists using art in Manchester Disease Patients: A Retrospective Cohort Study and London E. Araoye (UNITED STATES) Helen Young (UNITED KINGDOM) 14:50 Nicotinamide Regulates Energy Metabolism and 15:37 Training dermatologists using art in Manchester Controls the Stemness/Differentiation Balance, and London Aging and Photoaging of Human Primary Sarah Walsh (UNITED KINGDOM) Keratinocytes 15:55 Musical art: deep inside dermatologists S. Bellanger (SINGAPORE) Ruben Guarda (CHILE) 15:00 MHY1485 ameliorates UV-induced skin cell 16:05 Teaching observational skills at Yale damages via activating mTOR-Nrf2 signaling Kalman Watsky (UNITED STATES) B. Cheng (CHINA)

15:10 Epidermal barrier function improves during YELLOW 1 14:30-16:30 narrow band UVB phototherapy in patients with psoriasis R. Darlenski (BULGARIA) Ethical dilemmas in dermatology WS CHAIR: Miriam Weinstein (CANADA) 15:20 Proteomic identiﬁcation of peptide signatures CO-CHAIRS: Toshiyuki Yamamoto (JAPAN) of photodamage in skin proteins Jane Grant-Kels (UNITED STATES) A. Eckersley (UNITED KINGDOM)

14:30 Ethical dilemmas in Skin Cancer Screening 15:30 Janus Kinase 1 expression in vitiligo & psoriasis Toshiyuki Yamamoto (JAPAN) before and after narrowband UVB; a case control study 14:50 Discussion M.F. Elmasry (EGYPT) 15:00 Ethical dilemmas in Aesthetic procedures in 15:40 Clinical and spectrophotometric evaluation of Minors skin photoadaptation in vitiligo patients after a Miriam Weinstein (CANADA) short cycle of NB-UVB phototherapy 15:20 Discussion M. Fusano (ITALY)

15:30 Ethical dilemmas in Residency Training in 15:50 The Necessity of Photoprotection Beyond Dermatology Ultraviolet Radiation: Clinical, Spectroscopic Andrew Finlay (UNITED KINGDOM) and Histologic Evidence I.H. Hamzavi (UNITED STATES) 15:50 Discussion 16:00 Does phototherapy change long term clinical 16:00 Ethical dilemmas of Corporatization of outcomes in vitiligo? A ten-year follow up study dermatology practices L. Novakovic (UNITED KINGDOM) Jane Grant-Kels (UNITED STATES) 16:10 A new protocol in photodynamic therapy for the 16:20 Discussion treatment of onychomycosis C. Pedrinazzi (ITALY) YELLOW 2 14:30-16:30 16:20 A prospective, randomised, within-subject study of ALA-PDT Photobiology and Phototerapy O. Zaar (SWEDEN) FC CO-CHAIRS: Pier Alessandro Fanti (ITALY), Darell Rigel (UNITED STATES)

14:30 Light emitting fabrics photodynamic therapy for the treatment of actinic keratosis of the WEDNESDAY 12 JUNE, 2019

YELLOW 3 14:30-16:30 15:30 Dermatophyte onychomycosis in children of less than 7 years of age in Montreal, Canada: A 19 Hair and nail disorders 2 year review FC CO-CHAIRS: Alfredo Rossi (ITALY), D. Marcoux (CANADA) Mubki Thamer (SAUDI ARABIA) 15:40 Efficacy of Topical Tofacitinib in Promoting Hair 14:30 Lichen planopilaris beyond scalp: a case series Growth in Non-scarring Alopecia with dermoscopy-histopathology correlations J. Meephansan (THAILAND) A. Arshdeep (INDIA) 15:50 Tofacitinib for chronic, refractory, moderate to 14:40 Frontal ﬁbrosing alopecia: prospective study of severe alopecia areata. A retrospective review 40 cases of 127 patients H. BayBay (MOROCCO) L. Photiou (AUSTRALIA)

14:50 Sunscreen and facial skin care products in 16:00 Melanogenesis markers expression in premature frontal ﬁbrosing alopecia: a case control study graying of hair- a cross-sectional study W. Cranwell (AUSTRALIA) P.S.S. Ranugha (INDIA)

15:00 Repeated mocroneedling enhances hair 16:10 Results from the Alopecia Areata Symptom regrowth in men with aga Impact Scale and Correlation with the Severity R. Dhurat (INDIA) of Alopecia Tool at 24 Weeks in a Phase 2a Study of Two Oral Janus Kinase Inhibitors in 15:10 Hair styling practices in patients with scarring Alopecia Areata and non-scarring alopecia R. Winnette (UNITED STATES) H. Hagigeorges (UNITED STATES) 16:20 Efficacy and tolerability of nail bedmethotre- 15:20 Role of dynamic optical coherence tomography ate injections in isolated nail psoriasis: for in vivo investigation of nails conventional drug via an unconventional route V. D. Mandel (ITALY) C. Grover (INDIA) DAILY SCIENTIFIC PROGRAMME THURSDAY 13 JUNE, 2019 THURSDAY 13 JUNE, 2019

AMBER 1 07:00-08:00 AMBER 3 07:00-08:00

DONNE DERMATOLOGHE ITALIANE: GRUPPO SIDeMaST RICERCA SPERIMENTALE E IS Dermatology and women red face IS BIOINGEGNERIA IN DERMATOLOGIA: Research CO-CHAIRS: Corinna Rigoni (ITALY), snippets in Immune-Mediated and Oncological Norma Cameli (ITALY) diseases CO-CHAIRS: Andrea Chiricozzi (ITALY), 07:00 The Skin aging exposome Francesca Prignano (ITALY) May El Samahy (EGYPT) 07:00 Clinical relevance of the oxidoreductive pathway 07:10 Periorbital rejuvenation with EBD in chronic dermatological diseases Eman El Morsy (EGYPT) Leonardo Pescitelli (ITALY) 07:20 Radiotherapy related dermatoses 07:08 Discussion Nayera Moftah (EGYPT) 07:10 Clinico-pathological characterization of patients 07:30 Borderline lepromatous leprosy: Uncommon with localized scleroderma and response to UVA-1 presentation phototherapy: in vitro and in vivo skin models Elwan Nagwa (EGYPT) Linda Tognetti (ITALY) 07:35 The lady of the rings 07:18 Discussion Claudia Menicanti (ITALY) 07:20 Features of gut microbiota in vitiligo patients 07:40 Burning red face Roberta Colucci (ITALY) Valentina Benzecry (ITALY) 07:28 Discussion 07:45 Genodermatoses of the face Michela Brena (ITALY) 07:30 Genetic susceptibility in pediatric melanoma Cristina Pellegrini (ITALY) 07:48 Genodermatoses of the face Susanna Bernardon (ITALY) 07:38 Discussion

07:50 Red face in cancer patients 07:40 Phenotypical characterization of immune cells Sara Cacciapuoti (ITALY) associated with histological regression in cutaneous melanoma 07:55 The face of inﬂammatory diseases Simone Ribero (ITALY) Maddalena Napolitano (ITALY) 07:48 Discussion

AMBER 2 07:00-08:00 07:50 Molecular characterization of in-transit melanoma metastases and circulating melanoma cells recognizes an expression panel GRUPPO SIDeMaST DERMATOLOGIA ESTETICA: potentially related to disease progression IS Threads in aesthetic dermatology Cristina Rapanotti (ITALY) CO-CHAIRS: Lucia Brambilla (ITALY), Marina Romagnoli (ITALY) 07:58 Discussion

07:00 Biostimulation with threads: how can we armonize facial features with threads, stem cell AMBER 4 07:00-08:00 and stabilised hybrid co-operative complexes of H-HA and L-HA GRUPPO SIDeMaST PATOLOGIA DELLE MUCOSE: Marina Romagnoli (ITALY), Rosalba Russo (ITALY) IS Diagnostic of pigmentary mucosal lesions 07:15 Threads for the treatment of acne scars: a new CO-CHAIRS: Marco Ardigò (ITALY), approach Elisa Cinotti (ITALY) Gabriella Fabbrocini (ITALY) 07:00 Oral lesions 07:30 The right thread for the periocular area Vincenzo De Giorgi (ITALY) Maria Vastarella (ITALY) 07:15 Genital lesions 07:45 Side effects and how to manage them Sabina Vaccari (ITALY) Anna Masarà (ITALY) THURSDAY 13 JUNE, 2019

07:30 Conjunctival lesions 07:40 The Hospital of Santa Maria of the Incurables in Elisa Cinotti (ITALY) Naples, Italy: Its Role in the History of Dermatology 07:45 Confocal microscopy of oral and genital Patrizia Forgione (ITALY) pigmented lesions Marco Ardigò (ITALY) AMBER 1 08:00-10:45 AMBER 5+6 07:00-08:00 Pemphigoid Diseases SY CHAIR: Luca Borradori (SWITZERLAND) AIDA: Reputation and digital dermatological CO-CHAIRS: David Woodley (UNITED STATES), IS professional approach Wataru Nishie (JAPAN) CO-CHAIRS: Saturnino Gasparini (ITALY), Domenico Piccolo (ITALY) 08:00 Epidemiology and associations Li Li (CHINA) 07:00 Social Networking Sites: tools for the dermatologist’s communication 08:25 Clinical spectrum and presentations of the Federica Osti (ITALY) pemphigoid group of diseases Janet Fairley (UNITED STATES) 07:20 Dermatological internet sites: a source of public health 08:50 Pathophysiology Giovanni Menchini (ITALY) Wataru Nishie (JAPAN)

07:40 The inﬂuence of digital media on the 09:15 Diagnostic algorithm for the pemphigoid group dermatologist’s reputation of diseases: practical approach Alessandro Martella (ITALY) Detlef Zillikens (GERMANY)

09:40 Practical management of bullous pemphigoid AMBER 7+8 07:00-08:00 Luca Borradori (SWITZERLAND) 10:05 Bullous pemphigoid: new therapies on the horizon ADOI: Classification of Skin Tumors: Frédérick Caux (FRANCE) IS What’s new? 10:30 Discussion CO-CHAIRS: Cesare Massone (ITALY), Pier Alessandro Fanti (ITALY) 07:00 Updated classification of cutaneous lymphomas AMBER 2 08:00-10:45 Emilio Berti (ITALY) Update on Dermatopathology 07:25 Updated classification of melanocytic tumors SY CHAIR: Eduardo Calonje (UNITED KINGDOM) Lorenzo Cerroni (AUSTRIA) CO-CHAIRS: Philip Leboit (UNITED STATES), 07:50 Discussion Yu-Hung Wu (CHINESE TAIPEI)

08:00 Genodermatoses BROWN 1 07:00-08:00 Dieter Metze (GERMANY) 08:23 Clinicopathological correlation in GRUPPO SIDeMaST STORIA DELLA dermatopathology IS DERMATOLOGIA E VENEREOLOGIA: History of Eduardo Calonje (UNITED KINGDOM) Dermatology 08:46 Update in cutaneous lymphoma CO-CHAIRS: Cataldo Patruno (ITALY), Reuven Bergman (ISRAEL) Valeria Gaspari (ITALY) 09:09 Patterns of drug eruption 07:00 HIV/AIDS in the history of Dermatology and Yu-Hung Wu (CHINESE TAIPEI) Venereology Luigi Valenzano (ITALY) 09:32 Update in cutaneous mucinosis Franco Rongioletti (ITALY) 07:20 The Salernitan School of Medicine, pioneer of the modern medical and dermatologic science 09:55 Molecular insights into the nature and diagnosis Massimo Nacca (ITALY) of melanocytic neoplasms Philip Leboit (UNITED STATES) THURSDAY 13 JUNE, 2019

10:18 Benign mimics of cutaneous lymphoma 08:45 Predictive importance of plasma prolidase, Adriana Garcia (SPAIN) adenosine deaminase and dipeptidyl peptidase- 4 as markers of collagen turnover in relation to 10:41 Q&A - Final discussion the skin core in scleroderma H. Cocic (SERBIA) AMBER 3 08:00-10:45 09:00 A Randomized Controlled Trial of Anti-TNF Alpha Bio-similar Adalimumab versus Deep Fungal Infections Prednisolone in the Management of Leprosy SY CHAIR: Rataporn Ungpakorn (THAILAND) Patients with New Type 1 Lepra Reaction CO-CHAIRS: Boni Elizabeth Elewski (UNITED D. Mitra (INDIA) STATES), Nejib Doss (TUNISIA) 09:15 Adult T-cell leukemia/lymphoma: report of four 08:00 Introduction of speakers cases L. Porfirio (BRAZIL) 08:05 Mycetoma Nejib Doss (TUNISIA) 09:30 Omalizumab versus Cyclosporin-A for the treatment of Chronic Spontaneous Urticaria: is 08:35 Immunology and future application for deep there specific patient characteristics or fungal infections biomarkers to indicate response to treatment? Charussri Leeyaphan (THAILAND) O. Su Kucuk (TURKEY) 09:05 Dimorphic mycoses 09:45 Punctate palmoplantar keratoderma: Lauren Kole (UNITED STATES) characterization of three families with AAGAB 09:35 Superficial fungi causing deep mycoses mutation Roderick Hay (UNITED KINGDOM) R. Pimenta (PORTUGAL)

10:05 Highlights on histopathological diagnosis of 10:00 Prurigo pigmentosa: a clinicopathologic study deep fungal infections of ten Chinese cases Dirk Elston (UNITED STATES) LQ W. Wang (CHINA)

10:35 Q&A and Concluding remarks 10:15 The value of trichoscopy in predicting the treatment outcome in patients with patchy alopecia areata – preliminary results. AMBER 4 08:00-10:45 M. Sikora (POLAND) 10:30 A Patient Survey of photodynamic therapy: FELLOW FORUM 3 experience from two regional services FF CO-CHAIRS: Chun-Wei Lu (CHINESE TAIPEI), B. Ho (UNITED KINGDOM) Anna Campanati (ITALY)

08:00 Factors associated with the severity of acute ocular involvement in Stevens-Johnson AMBER 5+6 08:00-10:45 syndrome and toxic epidermal necrolysis in sub Saharan Africa New Oral Small Molecules A. S. Akakpo (TOGO) SY CHAIR: Lone Skov (DENMARK) CO-CHAIRS: Aleksandar Sekulic (UNITED 08:15 Differential diagnosis of palpable lesions: the STATES), Brett King (UNITED STATES) role of reﬂectance confocal microscopy and optical coherence tomography 08:00 Introduction F. Garbarino (ITALY) 08:10 New Oral Small Molecules for non-melanoma 08:30 Mohs micrographic surgery in Singapore: a skin cancer retrospective review Aleksandar Sekulic (UNITED STATES) W. Ho (SINGAPORE) 08:30 Q&A

08:35 New Oral Small Molecules for melanoma Paola Queirolo (ITALY) 10:35 10:15 09:55 09:35 09:15 09:05 08:45 08:25 08:05 08:00 AMBER 7+8 10:40 10:35 10:15 10:10 09:50 09:45 09:25 09:20 09:00 08:55 THURSDAY 13JUNE,2019 SY Discussion andClosure ofSession PDT for inﬂammatory skindisorders Q&A JAK inhibitors ininﬂammatory skindiseases Q&A PDT intransplant recipients Antimicrobial PDT Aesthetic PDT PDT for non-melanomaskincancer Conclusions New Oral SmallMoleculesfor psoriasis Q&A Discussion PDT for actinickeratoses PDT basics Welcome andIntroduction New Oral SmallMoleculesfor atopic dermatitis Q&A Q&A New Oral SmallMoleculesfor lupusandrelated Stefano Piaserico (ITALY) Yolanda Gilaberte (SPAIN) Nellie Konnikov (UNITEDSTATES) Colin Morton (UNITEDKINGDOM) Lars Iversen (DENMARK) Rolf-Markus Szeimies (GERMANY) Luis Antonio Torezan (BRAZIL) Rolf-Markus Szeimies (GERMANY) Thomas Bieber(GERMANY) CHAIR: Rolf-Markus Szeimies (GERMANY) Photodynamic Therapy Brett King(UNITEDSTATES) besides atopic dermatitisandpsoriasis Marzia Caproni (ITALY) diseases Cheng-Che EricLan(CHINESE TAIPEI) Luis Antonio Torezan (BRAZIL) CO-CHAIRS: Colin Morton (UNITEDKINGDOM),

08:00-10:45

08:46 08:35 08:24 08:13 08:00 BLUE 1 10:35 10:20 10:05 09:53 09:41 09:29 09:18 09:08 08:57 CO Q&A BtxA–TheDosandDon’ts Basicsurface anatomy relevant for injectors Theartandscience ofcosmetic consultation Dowe needautologous products for aging Energy baseddevices –whatshouldbeourfirst Energy based devices –whatshouldbeourfirst Chemicalpeels–why dermatologists must use Female intimate rejuvenation: Thewhy, when What dermatologist shouldknow before Why dermatologists shouldtake care of Thedarksideofdermalfillers–inflammatory Q&A Gary D.Gary Monheit(UNITEDSTATES) Pearl Grimes(UNITEDSTATES) starting to treat a skinofcolor? Marina Landau(ISRAEL) cosmetic patients? Carlos Wambier (BRAZIL) CO-CHAIRS: Joyce Lim(SINGAPORE), CHAIR: MarinaLandau(ISRAEL) Basic Cosmetic Dermatology Martina Kerscher (GERMANY) prevention andrestoration? Chee Leok Goh(SINGAPORE) patients andwhy? choices ofthemachinesintreating Asian Moshe Lapidoth(ISRAEL) why? choices ofequipmentintreating Caucasiansand Carlos Wambier (BRAZIL) them? Joyce Lim(SINGAPORE) and treat and vascular fillerscomplications: how to avoid Nicola Zerbinati (ITALY) and how Doris Hexsel (BRAZIL) Tatjana Pavicic (GERMANY) Nancy Garcia Tan (PHILIPPINES) Dermal fillers–how doIusetheminmy practice?

08:00-10:45

THURSDAY 13 JUNE THURSDAY 13 JUNE, 2019

BLUE 2 08:00-10:45 09:40 Management of rare CTCLs including SPTCL and G/D TCL Basic Dermatological Surgery Pietro Quaglino (ITALY) CO CHAIR: Christopher Arpey (UNITED STATES) 10:00 Approach to management of cutaneous B cell CO-CHAIRS: Luiz Guilherme Castro (BRAZIL), lymphoma Andrea Paradisi (ITALY) Joan Guitart (UNITED STATES)

08:00 Preoperative Considerations 10:20 Current concepts in CD30+ lymphoproliferative Christian L. Baum (UNITED STATES) disorders 08:15 Critical anatomy pearls/Danger zones Alessandro Pileri (ITALY) Luiz Guilherme Castro (BRAZIL) 10:40 Q&A 08:35 Essentials Instruments/Suture Material Ally-Khan Somani (UNITED STATES) BROWN 2 08:00-10:45 08:55 Electrosurgery basics Jerry D. Brewer (UNITED STATES) Bacterial infections of the skin 09:10 Questions SY CHAIR: Francisco Bravo (PERU) CO-CHAIRS: Roshidah Baba (MALAYSIA), 09:20 Local anesthesia tips Alireza Khatami (IRAN) Myrto-Georgia Trakatelli (GREECE) 08:00 Global Burden of bacterial skin 09:40 Biopsy Pearls infections Jenda Ricar (CZECH REPUBLIC) Alireza Khatami (IRAN)

10:00 Suturing Techniques 08:20 Cutaneos tuberculosis Andrea Paradisi (ITALY) Ivonne Arellano Mendoza (MEXICO)

10:20 Cryosurgery 08:40 Buruli ulcer Paola Pasquali Toledo (SPAIN) Filippo La Rosa (ITALY)

10:35 Questions 09:00 Common bacterial infections in outpatients and inpatients Juan Carlos Diez de Medina (BOLIVIA) BROWN 1 08:00-10:45 09:20 Leprosy Cutaneous Lymphoma: Classiﬁcation and Carolina Talhari (BRAZIL) SY Management 09:40 Borreliosis CHAIR: Emilio Berti (ITALY) Almut Boer (GERMANY) CO-CHAIRS: Xavier Rueda (COLOMBIA), Youn Kim (UNITED STATES) 10:00 Bartonellosis, endemic and cosmopolitan Francisco Bravo (PERU) 08:00 Overview of updates in the WHO classiﬁcation Emilio Berti (ITALY) 10:20 Q&A

08:20 Updates in molecular pathogenesis and biomarkers in MF/SS Maarten Vermeer (NETHERLANDS) BROWN 3 08:00-10:45

08:40 Management of early stage mycosis fungoides Neutrophilic Dermatoses (MF) SY CHAIR: Mark Davis (UNITED STATES) Julia Scarisbrick (UNITED KINGDOM) CO-CHAIRS: Alessandro Navarini 09:00 Management of Sézary syndrome (SS) (SWITZERLAND), Angelo Valerio Marzano Youn Kim (UNITED STATES) (ITALY)

09:20 Experience in NK/T-cell lymphomas 08:00 Neutrophilic diseases: an overview Xavier Rueda (COLOMBIA) Mark Davis (UNITED STATES) THURSDAY 13 JUNE, 2019

08:20 Pyoderma gangrenosum SPACE 1 08:00-10:45 Stanislav Tolkachjov (UNITED STATES)

08:40 Sweet’s Syndrome Atopic Eczema: Management Alex Ortega Loayza (UNITED STATES) SY CHAIR: Carsten Flohr (UNITED KINGDOM) CO-CHAIRS: Alan Irvine (IRELAND), 09:00 Syndromic pyoderma gangrenosum and other Giampiero Girolomoni (ITALY) rarer neutrophilic diseases Angelo Valerio Marzano (ITALY) 08:00 When is systemic therapy warranted? Phyllis Spuls (NETHERLANDS) 09:20 Neutrophilic diseases in childhood Antonio Torrelo (SPAIN) 08:25 The place for conventional systemic therapy in the biologic era 09:40 Skin and autoinﬂammation Jorien van der Schaft (NETHERLANDS) Alessandro Navarini (SWITZERLAND) 08:50 Novel systemic therapies 10:00 Treatment of neutrophilic diseases Kenji Kabashima (JAPAN) Philip Hampton (UNITED KINGDOM) 09:15 The role of skin infection in AD: when to treat? 10:20 Discussion Claudia Traidl-Hoffmann (GERMANY)

09:40 Manipulation of the host microbiome RED 1+2 08:00-10:45 Tilo Biedermann (GERMANY) 10:05 Treatment of itch Dermoscopy of Pigmented Lesions Gil Yosipovic (UNITED STATES) SY CHAIR: Iris Zalaudek (AUSTRIA) CO-CHAIRS: Allan Halpern (UNITED STATES), 10:30 Discussion Wilhelm Stolz (GERMANY) 08:00 Advances in skin imaging SPACE 2 08:00-10:45 Allan Halpern (UNITED STATES)

08:15 Genes and patterns of melanoma Management of Androgenetic Alopecia Susana Puig (SPAIN) SY CHAIR: George Cotsarelis (UNITED STATES) CO-CHAIRS: Won-Soo Lee (KOREA, REPUBLIC 08:30 Genes and patterns of nevi OF), Rodney Sinclair (AUSTRALIA) Peter Soyer (AUSTRALIA) 08:00 Systemic Causes of Hair Loss 08:45 Patients with multiple nevi Lynn Drake (UNITED STATES) Iris Zalaudek (AUSTRIA) 08:20 Updates on the management of male AGA 09:00 Implementing dermoscopy in everyday practice Won-Soo Lee (KOREA, REPUBLIC OF) Petr Arenberger (CZECH REPUBLIC) 08:40 Post ﬁnasteride syndrome 09:15 Special anatomic body sites - why and how to Ken Washenik (UNITED STATES) manage Wilhelm Stolz (GERMANY) 09:00 Cicatricial Alopecias Wilma Bergfeld (UNITED STATES) 09:30 Dermoscopy in the treatment decision Aimilios Lallas (GREECE) 09:20 Break

09:45 The many faces of seborrheic keratoses 09:35 Update on Female Pattern Hair Loss Caterina Longo (ITALY) Rodney Sinclair (AUSTRALIA)

10:00 Diagnosis and management of congenital 09:55 Prostaglandins and hair loss melanocytic nevi George Cotsarelis (UNITED STATES) Ashfaq Marghoob (UNITED STATES) 10:15 Pathomechanism of permanent hair loss after 10:15 Dermoscopy of pigmented lesions chemotherapy - priming mobilization and Elisa Cinotti (ITALY) depletion of hair follicle stem cells Ohsang Kwon (KOREA, REPUBLIC OF) 10:30 Q&A 10:35 Q&A THURSDAY 13 JUNE, 2019

SPACE 3 08:00-10:45 09:20 Psoriasis Comorbidities - What do the registries tell us Newly described skin disorders Matthias Augustin (GERMANY) SY CHAIR: Bruce Thiers (UNITED STATES) 09:40 Psychological impact CO-CHAIRS: Abdul-Ghani Kibbi (LEBANON), Francesca Sampogna (ITALY) Sunil Kalia (CANADA) 10:00 Challenging Cases - Psoriasis with 08:00 Introduction Co-Morbidities Bruce Thiers (UNITED STATES) Alessandro Giunta (ITALY)

08:05 Molecular characterization of disease phenotypes 10:20 Q&A Mark C. Udey (UNITED STATES)

08:25 New pediatric diseases Antonio Torrelo (SPAIN) WHITE 1 08:00-10:45

08:45 New infectious diseases Skin imaging other than dermatoscopy Omar Lupi da Rosa Santos (BRAZIL) FC CO-CHAIRS: Agnes Heng (MALAYSIA), 09:05 New insights into bullous pemphigoid Rainer Hofmann-Wellenhof (AUSTRIA) Hideyuki Ujiie (JAPAN) 08:00 Introduction

09:25 Neutrophil-mediated diseases 08:05 Novel technologies to investigate the Dany Nassar (LEBANON) distribution of facial melanin pigmentation 09:45 Syndromic hidradenitis suppurativa W. Arkesteijn (NETHERLANDS) John Ingram (UNITED KINGDOM) 08:15 A super-resolution method for skin imaging 10:05 Inherited cancer syndromes with skin A. Avanaki (UNITED STATES) manifestations 08:25 Resolution of chronic plaque psoriasis with Alexandros Stratigos (GREECE) Secukinumab – a 3-dimensional photographic 10:25 Skin diseases ﬁrst reported by Chinese representation dermatologists R. Sinclair (AUSTRALIA) Jianzhong Zhang (CHINA) 08:35 A Deep Learning approach to automatically classify skin inﬂammation of in vivo confocal images SPACE 4 08:00-10:45 D. Boudier (FRANCE)

Investigation and Management of Psoriasis 08:45 Artificial Intelligence For The Objective SY Associated Comorbidity Assessment Of Acne Grading In Clinical Trials CHAIR: Colin Thiam Seng Theng (SINGAPORE) A. Cherubini (ITALY) CO-CHAIRS: Paolo Gisondi (ITALY), 08:55 Reflectance confocal microscopy: a new Christopher Baker (AUSTRALIA) algorithm to differentiate challenging 08:00 How to build an effective Patient-Physician melanocytic skin lesions relationship in the setting of psoriasis R. de Paula Ramos Castro (BRAZIL) Christine Bundy (UNITED KINGDOM) 09:05 Differentiation of inflammatory 08:20 The role of dermatologist in the management of papulosquamous skin diseases based on skin patients with psoriatic arthritis biophysical and ultrasonographic properties: Paolo Gisondi (ITALY) A decision tree model A. Firooz (IRAN) 08:40 Managing psoriasis in obese patients Peter Foley (AUSTRALIA) 09:15 Assessment of the Lip Barrier: Microspectroscopic Confocal Raman 09:00 Do biologics in patients with psoriasis improve Spectroscopy and Macroscopic Biophysical cardiovascular risk? Measurements Kim Alexander Papp (CANADA) H. Gunt (UNITED STATES) THURSDAY 13 JUNE, 2019

09:25 Development of Artificial Intelligence based 08:35 The role of Hydroxychloroquine Sulfate mobile application for ten common (Plaquenil) therapy in eosive oral Lichen Planus dermatological diseases Z. Khamaysi (ISRAEL) S. Gupta (INDIA) 08:45 Comparative evaluation of efficacy of 09:35 Usefulness of videodermoscopy in the diagnosis intralesional mycobacterium W vaccine versus of demodicosis intralesional measles mumps rubella vaccine O. Karadag Kose (TURKEY) versus autoimplantation therapy in cutaneous warts 09:45 Ultrasound imaging in skin lesions – a non S. Kumar (INDIA) invasive tool R. Konathan (INDIA) 08:55 The Effect of Omalizumab in Mastocytosis Patients. Prospective double-blind, placebo 09:55 Xanthogranulomas and Xanthomas: 23 lesions controlled multicentre study (XOLMA-Study) evaluated by reflectance confocal microscopy J. Maul (SWITZERLAND) A. Lamberti (ITALY) 09:05 Electrochemotherapy in elderly, nonsurgical, 10:05 Quantification of Change in 3D Face Shape With skin malignancies of the Head and Neck Ageing Across Different Ethnic Groups patients: clinical outcome and quality of life P. Matts (UNITED KINGDOM) management 10:15 The Impact of Reflectance Confocal Microscopy A. Bonadies (ITALY) in Xeroderma Pigmentosum 09:15 Cilostazole as a preferred drug in the treatment L. Rocha (BRAZIL) of chilblains 10:25 Utility of High Frequency Ultrasonography M. Shishak (INDIA) (HFUS) in the diagnosis of Nail Diseases 09:25 Effects of hydroxyapatite nanoparticles on S. Tambe (INDIA) proliferation and apoptosis of human squamous 10:35 Cutaneous acute graft-versus-host disease cell carcinoma cell line A431 in vitro and in vivo assessment by confocal video microscopy J. Tang (CHINA) I. Saknite (UNITED STATES) 09:35 Oral itraconazole can down-regulate serum PDGF-A of children with infantile WHITE 2 08:00-10:05 hemangioma Y. Ran (CHINA)

Medical therapies 09:45 Efficacy and Safety of Sirolimus in the Treatment FC CO-CHAIRS: Mauro Salvatore Alessandro Alaibac of Blue Rubber Bled Nevus Syndrome in (ITALY), Kwang Hoon Lee (KOREA, REPUBLIC OF) Pediatric Patients B. Zhang (CHINA) 08:00 Introduction 09:55 Topical proline therapy in Prolidase deﬁciency 08:05 DC-HIL is a novel immune checkpoint and a D. P. Thekkinadeth (INDIA) promising target for treating melanoma and other cancers P. Cruz (UNITED STATES) WHITE 2 10:05-10:45 08:15 CRISPR/Cas9-homologous recombination mediated correction of Epidermolysis Bullosa Epidemiology Simplex mutations FC CO-CHAIRS: Mauro Salvatore Alessandro Alaibac M. Bchetnia (CANADA) (ITALY), Kwang Hoon Lee (KOREA, REPUBLIC OF) 08:25 Extracorporal photopheresis with 5 aminolevulinic acid in patients with chronic 10:05 Chemoprophylaxis and immunoprophylaxis in graft-versus-host disease – preliminary results preventing leprosy in patient contacts from a pilot study R. Baskota (NEPAL) E. Christensen (NORWAY) THURSDAY 13 JUNE, 2019

10:15 Prevalence of Use Of Skin Lightening Agents 08:00 The ichthyoses: genes and phenotypes Among Participants In A Community Outreach In Judith Fischer (GERMANY) South-Eastern Nigeria 08:20 Q&A C. Onyekonwu (NIGERIA) 08:25 Syndromic ichthyoses: genes and phenotypes 10:25 MC1R variants in childhood and adolescent Alain Hovnanian (FRANCE) melanoma: a pooled-analysis from a large worldwide multicenter cohort of patients 08:45 Q&A C. Pellegrini (ITALY) 08:50 Disease pathways and therapeutic approaches in 10:35 Epidemiology of Dry Skin in the General the ichthyoses Population Amy Paller (UNITED STATES) M. Augustin (GERMANY) 09:10 Q&A

09:15 The keratodermas: genes and phenotypes YELLOW 1 08:00-10:45 Yang Yong (CHINA) 09:35 Q&A Sex hormones and the skin SY CHAIR: Christos C. Zouboulis (GERMANY) 09:40 Syndromic keratodermas: genes and phenotypes CO-CHAIRS: Mahira El Sayed (EGYPT), Keith Choate (UNITED STATES) Hironobu Sasano (JAPAN) 10:00 Q&A 08:00 The role of sex hormones in wound healing 10:05 Disease pathways and therapeutic strategies in Matthew J. Hardman (UNITED KINGDOM) the keratodermas 08:19 Sexual hormones and pigmentation David Kelsell (UNITED KINGDOM) Mauro Picardo (ITALY) 10:25 Q&A 08:38 Sexual hormones and alopecia: the follicular 10:30 The epidermal barrier: what have we learnt, interplay where do we go Catherine M. Stefanato (UNITED KINGDOM) Daniel Hohl (SWITZERLAND) 08:57 The role of metabolic syndrome in female 10:40 Q&A pattern hair loss Mahira El Sayed (EGYPT) 09:16 Role of androgens in sebaceous gland YELLOW 3 08:00-10:45 physiology and pathology Hironobu Sasano (JAPAN) The Future of Antimicrobials SY CHAIR: Xinghua Gao (CHINA) 09:35 Hyperandrogenism and acnes CO-CHAIRS: Anna Di Nardo (UNITED STATES), Gabriella Fabbrocini (ITALY) Kenshi Yamasaki (JAPAN) 09:54 Menopause, HRT and skin disorders 08:00 New antibiotics for acne Christos C. Zouboulis (GERMANY) Seemal Desai (UNITED STATES) 10:13 Endocrine-disrupting chemicals and skin 08:25 Antimicrobial peptides at the epithelial interface manifestations Yuping Lai (CHINA) Qiang Ju (CHINA) 08:45 Antimicrobial peptides and their role in dermal 10:32 Q&A cells Anna Di Nardo (UNITED STATES) YELLOW 2 08:00-10:45 09:05 Antimicrobial peptides in autoimmune diseases Michel Gilliet (SWITZERLAND) Ichthyoses and Keratodermas SY CHAIR: David Kelsell (UNITED KINGDOM) 09:25 Antimicrobial peptides in palmoplantar CO-CHAIRS: Daniel Hohl (SWITZERLAND), pustolosis Keith Choate (UNITED STATES) Masamoto Murakami (JAPAN)

09:45 Antimicrobial peptides in rosacea Kenshi Yamasaki (JAPAN) THURSDAY 13 JUNE, 2019

10:05 Clioquinol, basic and clinical reseach as an AMBER 2 14:30-16:30 alternative antimicrobial agent Yuping Ran (CHINA) Pitfalls of diagnosis in skin of colour 10:25 Modulation of Staphylococcus epidermidis WS CHAIR: Seemal Desai (UNITED STATES) bioactivity by Malassezia furfur CO-CHAIRS: Ophelia Dadzie (UNITED KINGDOM), Xinghua Gao (CHINA) Rashmi Sarkar (INDIA) 14:30 Introduction & Welcome by the Chairs GOLD 11:00-12:30 14:41 Ancillary diagnostic tools Ophelia Dadzie (UNITED KINGDOM)

CO-CHAIRS: Martine Bagot (FRANCE), 14:52 Photo protection and Clinical Potpourri PL Matilda Bylaite (LITHUANIA), Ivonne Arellano Mendoza (MEXICO) Christopher Griffiths (UNITED KINGDOM), Abdul-Ghani Kibbi (LEBANON) 15:03 Psoriasis and its mimickers Seemal Desai (UNITED STATES) 11:00 Generational aspects of life Paul Redmond (UNITED KINGDOM) 15:14 Disorders of hypo pigmentation and depigmentation 11:30 Psoriasis in 2019 Pearl Grimes (UNITED STATES) Jonathan Barker (UNITED KINGDOM) 15:25 Melasma and Hyperpigmentation 11:50 Insights into Skin Function: Lessons Learned Rashmi Sarkar (INDIA) from Genodermatoses Leena Bruckner-Tuderman (GERMANY) 15:36 Hair and scalp disorders Amy McMichael (UNITED STATES) 12:10 Can a Dermatologist Practice Without Dermoscopy? 15:47 Pitfalls in Skin of Color Aesthetics Giuseppe Argenziano (ITALY) Sahar Ghannam (CANADA) 15:58 Semiology & grading scales - “one-size does not ﬁt all” AMBER 1 14:30-16:30 Jianzhong Zhang (CHINA)

Mycobacterial infections in the Biologic Era 16:09 Chemical Peels in Skin of Color WS CHAIR: Josè Fernando Barba Gomez (MEXICO) Carlos Wambier (BRAZIL) CO-CHAIRS: Domenico Bonamonte (ITALY), 16:20 Q&A Farhad Handjani (IRAN)

14:30 Cutaneous tuberculosis: an update Francisco Bravo (PERU) AMBER 3 14:30-16:30

14:45 Childhood cutaneous tuberculosis HPV: Warts, Vaccines and Cancer Farhad Handjani (IRAN) WS CHAIR: Mihael Skerlev (CROATIA) 15:00 Diagnosis of cutaneous tuberculosis CO-CHAIRS: Jinhua Xu (CHINA), Eduardo Poletti (MEXICO) Antonio Cristaudo (ITALY)

15:15 Cutaneous tuberculosis and HIV infection 14:30 The global burden of HPV infections and related Archana Singal (INDIA) diseases Electra Nicolaidou (GREECE) 15:30 Latent tuberculosis infection in patient with psoriasis taking biologic therapies 14:45 HPV infection in China: prevalence, research and Omid Zargari (IRAN) perspective Hao Cheng (CHINA) 15:45 Skin infections by nontuberculous mycobacteria Domenico Bonamonte (ITALY) 15:00 Anal and oral HPV infection in the male at risk Antonio Cristaudo (ITALY) 16:00 Atypical Mycobacterial Infections in Mexico Roberto Arenas (MEXICO) 15:15 An update on HPV - associated penile and anal dysplastic lesions 16:15 Discussion Arne Wikström (SWEDEN) THURSDAY 13 JUNE, 2019

15:30 The frustrations and complications of the HPV 15:30 Less explored and experimental treatments for treatments keloid Suzana Ljubojević Hadžavdić (CROATIA) Somesh Gupta (INDIA)

15:45 What is really “old” and really “new” in the HPV 15:42 Combining treatments in the treatment of keloids World? David Ozog (UNITED STATES) Marco Cusini (ITALY) 15:54 Panel discussion with cases 16:00 Nine shades of the HPV prophylaxis Greg Goodman (AUSTRALIA) Mihael Skerlev (CROATIA) 16:18 Q&A 16:15 Discussion

AMBER 7+8 14:30-16:30 AMBER 4 14:30-16:30 Advances in the Management of Melanoma Epidermolysis Bullosa WS CHAIR: Alexander Enk (GERMANY) WS CHAIR: Katsuto Tamai (JAPAN) CO-CHAIRS: Susan Swetter (UNITED STATES), CO-CHAIRS: Peter Marinkovich (UNITED STATES), Hiroshi Koga (JAPAN) Giovanna Zambruno (ITALY) 14:30 New Molecular Techniques for Cutaneous 14:30 Overview of EB diagnosis Melanoma Diagnosis Jouni Uitto (UNITED STATES) Pedram Gerami (UNITED STATES)

14:54 Novel EB subtytpes 14:45 Discussion Giovanna Zambruno (ITALY) 14:50 Artiﬁcial Intelligence for Cutaneous Melanoma 15:18 Overview of EB therapy Detection Leena Bruckner-Tuderman (GERMANY) Susan Swetter (UNITED STATES)

15:42 Regenerative therapy of EB 15:05 Discussion Katsuto Tamai (JAPAN) 15:10 Novel Combination Therapies in Advanced 16:06 Molecular therapy of EB Melanoma Peter Marinkovich (UNITED STATES) Ester Simeone (ITALY)

15:25 Discussion AMBER 5+6 14:30-16:30 15:30 New Aspects of Adjuvant Melanoma Treatment Claus Garbe (GERMANY) Optimising the management of Keloids 15:45 Discussion WS CHAIR: Greg Goodman (AUSTRALIA) CO-CHAIRS: Ardeshir Bayat (UNITED KINGDOM), 15:50 Advanced Imaging Technology in Early Somesh Gupta (INDIA) Melanoma Detection Peter Soyer (AUSTRALIA) 14:30 Recent concepts in the Etiology and pathogenesis of keloids 16:05 Discussion Greg Goodman (AUSTRALIA) 16:10 Mutations, metastasis and the importance of 14:42 Prevention of keloids multidisciplinary management Ardeshir Bayat (UNITED KINGDOM) Victoria Mar (AUSTRALIA)

14:54 Injectable steroids and cytotoxics in the 16:25 Discussion treatment of keloids Christine Dierickx (BELGIUM) BLUE 1 14:30-16:30 15:06 Lasers and energy based devices in the treatment of keloids Advanced Cosmetic Dermatology Matteo Tretti Clementoni (ITALY) CO CHAIR: Andrè Braz (BRAZIL) 15:18 Cryotherapy for keloids CO-CHAIRS: Abdullah Al Eisa (SAUDI ARABIA), Somesh Gupta (INDIA) Sue Ellen Cox (UNITED STATES) THURSDAY 13 JUNE, 2019

14:30 Neuromodulators to the face: how to avoid and 16:00 Common complications and troubleshooting to treat the complications them Doris Hexsel (BRAZIL) Christopher Arpey (UNITED STATES)

14:42 Advanced use of Fillers (HA) to the Upper face 16:20 Questions (Forehead, glabella and temples) Ada Trinidade de Almeida (BRAZIL) BROWN 1 14:30-16:30 14:54 Advanced use of Fillers (HA) to the Mid-face (Tear trough, Malar, zygoma) Confocal Microscopy Vince Bertucci (CANADA) WS CHAIR: Pascale Guitera (AUSTRALIA) 15:06 Advanced use of Fillers (HA) to the lips and CO-CHAIRS: Caterina Longo (ITALY), Salvador perioral region Gonzalez (SPAIN) Hassan Ibrahim Hassan Galadari (UNITED ARAB 14:30 Technique and semiology/pitfall of the EMIRATES) beginner 15:18 Advanced use of Fillers (HA) to the Lower face Alon Scope (ISRAEL) (Chin, pre-jowl, jaw line, jaw angle) 14:42 Q&A Andrè Braz (BRAZIL) 14:45 Tips to integrate RCM in the practice ﬂow & 15:30 Fillers complications, how to manage? when it is worth the time: melanocytic lesions Rebecca Fitzgerald (UNITED STATES) Caterina Longo (ITALY) 15:42 Neck and Chest (biostimulators + 14:57 Q&A neuromodulators) Dee Anna Glaser (UNITED STATES) 15:00 Tips to integrate RCM in the practice ﬂow & when it is worth the time: non-melanocytic 15:54 Use of Fillers to Hands and Body lesions Sue Ellen Cox (UNITED STATES) Salvador Gonzalez (SPAIN) 16:06 Neuromodulators, 20 years experience in 15:12 Q&A middle east Abdullah Al Eisa (SAUDI ARABIA) 15:15 Amelanotic melanoma and differential Pascale Guitera (AUSTRALIA) 16:18 Q&A 15:27 Q&A

BLUE 2 14:30-16:30 15:30 Macules of the face Harald Kittler (AUSTRIA)

Basic Dermatological Surgery 15:42 Q&A CO CHAIR: Christopher Arpey (UNITED STATES) 15:45 Ex vivo confocal microscopy of the skin- CO-CHAIRS: Luiz Guilherme Castro (BRAZIL), prospective Andrea Paradisi (ITALY) Susana Puig (SPAIN) 14:30 Excision and common excisional variations 15:57 Q&A Elena Rossi (ITALY) 16:00 Vitiligo Surgery and Confocal 14:50 Exteriorization techniques Steven Tien Guan Thng (SINGAPORE) Roland Kaufmann (GERMANY) 16:12 Q&A 15:10 Intraoperative considerations Maria Cristina Messina (BRAZIL) 16:15 Difficult cases Anthony Rossi (UNITED STATES) 15:30 Questions 15:40 Postoperative management and wound management Miguel Sanchez Viera (SPAIN) THURSDAY 13 JUNE, 2019

BROWN 2 14:30-16:30 15:50 Threads and Sutures – the long and short of it Fabio Cuiabano (BRAZIL)

Classiﬁcation and Management of Panniculitis 16:05 Discussion WS CHAIR: Mark Pittelkow (UNITED STATES) CO-CHAIRS: Bernhard Zelger (AUSTRIA), 16:10 The role of injectable lipolysis on the face Marcello Menta Simonsen Nico (BRAZIL) Shannon Humphrey (CANADA)

14:30 Panniculitis Overview - Classiﬁcation and 16:25 Discussion Pathology Bernhard Zelger (AUSTRIA) SPACE 1 14:30-16:30 14:50 Lymphoproliferative Panniculitides Joan Guitart (UNITED STATES) Running a Patch Test Clinic 15:10 Panniculitis of Rheumatic Syndromes WS CHAIR: Jason Williams (UNITED KINGDOM) Franco Rongioletti (ITALY) CO-CHAIRS: David Cohen (UNITED STATES), Marlene Isaksson (SWEDEN) 15:30 Lipodermatosclerosis and other sclerosing Panniculitides 14:30 Patch Testing Basics Tania Philips (UNITED STATES) David Cohen (UNITED STATES)

15:45 Erythema Induratum 14:50 Patch Testing Readings Marcello Menta Simonsen Nico (BRAZIL) Jason Williams (UNITED KINGDOM)

16:00 Calciphylaxis-A Unique Thrombosing 15:10 Importance of Data collection and Analysis Panniculitis Francesca Larese (ITALY) Rokea El-Azhary (UNITED STATES) 15:30 Optimal clinic support for Patch testing 16:15 Alpha-1 antitrypsin and Enzymatic Marlene Isaksson (SWEDEN) Panniculitides 15:50 Special Considerations in Occupational contact Mark Pittelkow (UNITED STATES) dermatitis Adriene Lee (AUSTRALIA) BROWN 3 14:30-16:30 16:10 Patch Testing in Brazil Facial Rejuvenation: Beyond Fillers and Toxins Ida Duarte (BRAZIL) WS CHAIR: Fabio Cuiabano (BRAZIL) CO-CHAIRS: Norma Cameli (ITALY), Gary D. Monheit (UNITED STATES) SPACE 2 14:30-16:30

14:30 Chemical peels - are the “modern” twists on this Nail Dermoscopy old standard worthwhile? CO CHAIR: Bianca Maria Piraccini (ITALY) Gary D. Monheit (UNITED STATES) CO-CHAIRS: Luc Thomas (FRANCE), 14:45 Discussion Sergio Hirata (BRAZIL) 14:50 Laser resurfacing - can we get better results 14:30 Nail dermoscopy: procedure and signs without more downtime? Michela Starace (ITALY) Diletta Bonciani (ITALY) 14:46 Onychomycosis 15:05 Discussion André Lencastre (PORTUGAL) 15:10 Photorejuvenation with non ablative lasers and 14:57 Inﬂammatory diseases lights - which technologies for which patients? Je ho Mun (KOREA, REPUBLIC OF) Norma Cameli (ITALY) 15:08 Non-melanocytic nail tumors 15:25 Discussion Luc Thomas (FRANCE) 15:30 My experience with microneedling - where, when 15:19 Nail pigmentations and how to use for best Aurora Alessandrini (ITALY) Otavio Macedo (BRAZIL) 15:30 Melanocytic nail tumors 15:45 Discussion Bianca Maria Piraccini (ITALY) THURSDAY 13 JUNE, 2019

15:41 Intraoperative dermoscopy of pigmented nail SPACE 4 15:30-16:30 Sergio Hirata (BRAZIL)

15:52 Intraoperative dermoscopy of unpigmented nail Atopic Dermatitis: Does early, aggressive conditions CN therapy change the natural history? Amelie Boespﬂug (FRANCE) CHAIR: Omar Lupi da Rosa Santos (BRAZIL) DISCUSSANT: 16:03 Test your skills! Against - Diamant Thaci (GERMANY), Bianca Maria Piraccini (ITALY) For - Lawrence Eichenﬁeld (UNITED STATES) 16:14 Test your skills! Luc Thomas (FRANCE) WHITE 1 14:30-16:30

SPACE 3 14:30-16:30 Sexually transmitted infections, tropical and FC humanitarian dermatology Flaps and Grafts CO-CHAIRS: Sergio Di Nuzzo (ITALY), WS CHAIR: Enrique Herrera Acosta (SPAIN) George Sorin Tiplica (ROMANIA) CO-CHAIRS: Richard Motley (UNITED KINGDOM), 14:30 Diagnosis and identification by PCR-RFLP of Mario Puviani (ITALY) leishmania species isolated from patients with 14:30 Planning and executing flaps, technique and cutaneous leishmaniasis in Venezuela principles behind specific flaps A. Armand Mijares (VENEZUELA) Gaston Galimberti (ARGENTINA) 14:40 Skin as a mirror of arsenic contamination of 14:43 Planning and executing grafts ground water: an observational study Jorge Alonso Suarez Perez (SPAIN) A. Das (INDIA)

14:56 Lip reconstruction 14:50 Collaboration experience between Dermatology Jean Michael Amici (FRANCE) Unit and Infectious Disease Clinic in Modena: optimization strategies for HIV, hepatitis and 15:09 Eyelid reconstruction syphilis screening tests Richard Motley (UNITED KINGDOM) F. Di Tullio (ITALY)

15:22 Forehead and scalp reconstruction 15:00 Cutaneous manifestations of the immune David Ramirez Moreno (SPAIN) reconstitution inﬂammatory syndrome (IRIS): a 15:35 Nose reconstruction case-series Mario Puviani (ITALY) M. Fernández-Sánchez (MEXICO)

15:48 Ear reconstruction 15:10 A study on clinical and sociodemographic Klaus Eisendle (ITALY) features of Trichomoniasis in symptomatic and asymptomatic female patients attending std 16:01 Danger zones reconstruction clinic using wet mount and culture as diagnostic Ramon Pigem (SPAIN) tool 16:14 Discussion and Q&A A. Manohar Prasad (INDIA) 15:20 Unusual clinical pictures of old world cutaneous leishmaniasis SPACE 4 14:30-15:30 A. Momeni (IRAN)

Psoriasis: Can biologics ever be stopped? 15:30 Childhood sexually transmitted diseases CN CHAIR: Brigitte Dréno (FRANCE) P. Mohanty (INDIA) DISCUSSANT: 15:40 Syphilis and leprosy coinfection: a challenging Against - Paolo Gisondi (ITALY) diagnosis For - Phyllis Spuls (NETHERLANDS) A. Maralur Devegowda (INDIA)

15:50 Neglected Tropical Diseases (NTD) or Neglected People Diseases (NPD)? A. Morrone (ITALY) THURSDAY 13 JUNE, 2019

16:00 Australian Aboriginal and Torres Strait Islander 15:50 High levels of ige against tissue factor and dermatology thyroglobulin are reduced by omalizumab in D. F. Sebaratnam (AUSTRALIA) chronic spontaneous urticaria G. Genovese (ITALY) 16:10 Ultrasonography in Hansen’s disease S. Srinivasan (INDIA) 16:00 Evaluation of a low-dose methotrexate added to H1-antihistamines regimen for severe chronic 16:20 Epidemiological and clinical profile Dermatosis spontaneous urticaria: a phase III, randomized, at the malian refugees of Goudebou in Burkina placebo-controlled trial Faso S. Leducq (FRANCE) K. Yamoussa (MALI) 16:10 Effect of Omalizumab Treatment on Disease Activity in Chronic Spontaneous/Idiopathic WHITE 2 14:30-16:30 Urticaria: Results from XTEND-CIU, a Longitudinal Perspective Urticaria and pruritus M. Maurer (UNITED STATES) FC CO-CHAIRS: Monica Corazza (ITALY), 16:20 More Patients Treated with Ligelizumab are Roberta Fachini Jardim Criado (BRAZIL) Angioedema-free compared with Omalizumab: 14:30 Skin lesions, skin care and characteristics of Results of a Phase II Clinical Trial pruritus in patients with uremia undergoing M. Wallace (IRELAND) hemodialysis M. Augustin (GERMANY) YELLOW 1 14:30-16:30 14:40 Autoimmune thyroiditis and stress impairs treatment responses to omalizumab in chronic Autoimmune dermatoses and adverse drug urticaria and patients with angioedema and FC reactions higher body-mass-index may require longer CO-CHAIRS: Fabrizio Guarnieri (ITALY), treatment Mariano Suppa (BELGIUM) P. K. Can (TURKEY) 14:30 Female patients with dermatitis herpetiformis 14:50 Pathophysiology of Itch in Atopic Dermatitis: A showed a reduced diagnostic delay and have 3-Dimensional Study of IL-31 and its Receptors higher sensitivity rates at autoantibody testing and Cutaneous Innervation for celiac disease: a multi-centric Italian study T. Cao (SINGAPORE) E. Antiga (ITALY) 15:00 Subscutaneous auto serum therapy in chronic 14:40 Combination of tetracycline with nicotynamide spontaneous urticaria and clobetasol versus prednisone in bullous K. V. Godse (INDIA) pemphigoid: a retrospective analysis of 106 15:10 Subcutaneous Autologous Serum Therapy vs. patients with long-term follow-up Conventional Intramuscular Autologous Serum K. Woźniak (POLAND) Therapy in Chronic Urticaria: A Randomised, 14:50 Developing classification criteria for cutaneous Controlled Trial Comparing the Effectiveness dermatomyositis and Safety J. S. Concha (UNITED STATES) A. Datta (INDIA) 15:00 Alopecia in Autoimmune Blistering Diseases: A 15:20 Treatment of prurigo nodularis with serlopitant: Systematic Review of Pathogenesis and Clinical impact on itch and pain Features of Disease S. Ständer (GERMANY) D. Xie (AUSTRALIA) 15:30 Activity during sleep measured by a sheet 15:10 Bullous disorders associated with anti-PD-1 and shaped body vibrometer is correlated with anti-PD-L1 therapy: A retrospective analysis severity of atopic dermatitis in adults: A evaluating the clinical and histopathologic comparison with wrist actigraphy measurement features, frequency, and impact on cancer T. Ebata (JAPAN) therapy. 15:40 Interleukin-31 couples itch sensation to J. Leventhal (UNITED STATES) inflammation in allergic skin disease M. Fassett (UNITED STATES) THURSDAY 13 JUNE, 2019

15:20 Prospective HLA-B*13:01 screening to prevent 15:20 Follicular Mycosis Fungoides presenting with dapsone hypersensitivity syndrome Spiky/Keratosis pilaris-like Lesions: An Indolent H. Liu (CHINA) Clinicopathologic Variant of Follicular Mycosis Fungoides 15:30 Implications of co-occurring dermatologic and C. F. Tomasini (ITALY) gastrointestinal toxicity from immune checkpoint inhibition therapy 15:30 Proposal for a staging classification of G.E. Molina (UNITED STATES) histopathological findings in Granulomaatous Cheilitis 15:40 Validating the BIOCHIP and interrater reliability B. Nikam (INDIA) in bullous pemphigoid and pemphigus patients A. Yang (AUSTRALIA) 15:40 SIRT3-dependent mitochondrial dynamic remodeling contributes to oxidative stress 15:50 Cutaneous side effects in the settings of induced melanocyte degeneration in vitiligo hematologic patients treated with Ibrutinib X. Yi (CHINA) A. Pileri (ITALY) 15:50 Poikilodermatous plaque-like hemangioma: a 16:00 Do oro-pharyngeal symptoms correlate with newly defined entity endoscopic findings in patients with pemphigus K. Semkova (UNITED KINGDOM) vulgaris? M. Bohdanowicz (UNITED STATES) 16:00 Cutaneous Rosai-Dorfman Disease: a report of eleven cases from China and a review of the 16:10 Clinical response to JAK inhibition in patients literature with familial chilblain lupus and TREX1 mutation G. Songmei (CHINA) C. Günter (GERMANY) 16:10 Genital basal cell carcinoma, a different 16:20 Major Psychological Complications and pathogenesis from sun-exposed basal cell Decreased Health-Related Quality of Life among carcinoma? A case-control study of 30 cases Survivors of Stevens-Johnson Syndrome and Y. J. Wang (CHINESE TAIPEI) Toxic Epidermal Necrolysis R. P. Dodiuk-Gad (CANADA) 16:20 A retrospective analysis of histopathological features of morphea K. D. Rambhia (INDIA) YELLOW 2 14:30-16:30

Dermatopathology YELLOW 3 14:30-16:30 FC CO-CHAIRS: Carlo Francesco Tomasini (ITALY), Maria Eugenia Mazzei (URUGUAY) Paediatric dermatology, genetics and FC genodermatoses 14:30 Sub Corneal Pustular Dermatoses - A CO-CHAIRS: Anna Belloni Fortina (ITALY), clinicopathological study of 15 patients Jean Kanitakis (FRANCE) V. Gopalakrishnan (INDIA) 14:30 Evidence of common and differential genetic 14:40 Hand foot mouth disease in adults: the biomarkers for Ps and PsA importance of clinicopathological correlation R. Cascella (ITALY) and differential diagnosis J. Kim (AUSTRALIA) 14:40 Iatrogenic skin disorders and related factors in newborn infants 14:50 The contribution of Dermato(patho)logy in the Z. Csoma (HUNGARY) follow-up of Vascularized Composite Tissue Allografts (Hands, Face) 14:50 International survey on neonate hygiene and J. Kanitakis (FRANCE) skin care in Neonatal Intensive Care Units (NICUs) C. de Belilovsky (FRANCE) 15:00 Cutaneous lymphangitis carcinomatosa of breast cancer: about 5 cases 15:00 Insight into Lichen Planus: A retrospective F. Kettani (MOROCCO) analytical study of clinical, histopathological proﬁle and treatment response of 1872 patients 15:10 White lesions in oral cavity: a clinico over 22 years from North India – A Single Centre histopathological insight Experience S. Jaiswal (INDIA) D. Daulatabad Garg (INDIA) THURSDAY 13 JUNE, 2019

15:10 Skin manifestations in paediatric patients 15:50 Hair cross sectioning in uncombable hair treated with TNF-Alpha inhibitor for syndrome: an easy tool for a complex diagnosis inflammatory bowel disease: a retrospective V. Piccolo (ITALY) study 16:00 Irradiated Human Amniotic membrane Allograft A. Genois (CANADA) in patients with Dystrophic Epidermolysis 15:20 Novel Surgical Approach for Management of Bullosa Cutaneous Neurofibroma in Neurofibromatosis N. Radwan (EGYPT) Type 1 16:10 Localized scleroderma (MORPHEA) in children L. Le (UNITED STATES) and adolescents 15:30 A rare cause of recurrent leg ulcers, identified by J. Stojkovic-Filipovic (SERBIA) a novel mutation in PEPD gene: prolidase 16:20 Alopecia in Epidermolysis Bullosa: A Systematic deficiency Review of Pathogenesis and Clinical Features of E. Kiratli Nalbant (TURKEY) Disease 15:40 Kindler's syndrome, a clinical, genetic and D. Xie (AUSTRALIA) laboratory study of 210 cases in Panama, 1986 2017 H. Penagos (PANAMA) DAILY SCIENTIFIC PROGRAMME FRIDAY 14 JUNE, 2019 FRIDAY 14 JUNE, 2019

AMBER 1 07:00-08:00 AMBER 3 07:00-08:00

GRUPPO SIDeMaST DERMATOLOGIA GRUPPO SIDeMaST DI IMMUNOLOGIA IS ONCOLOGICA: Dermato-oncology update IS CUTANEA: Italian Immunopathology Group: CO-CHAIRS: Francesco Lacarrubba (ITALY), working in progress Nicola Pimpinelli (ITALY) CO-CHAIRS: Aurora Parodi (ITALY), Marzia Caproni (ITALY) 07:00 Cutaneous Lymphomas: therapeutic update Nicola Pimpinelli (ITALY) 07:00 Pemphigoid induced by antidiabetics drugs Giovanni Di Zenzo (ITALY) 07:10 Discussion 07:12 Discussion 07:15 Melanoma: news on adjuvant treatment Pietro Quaglino (ITALY) 07:15 Autoantibody Profile of a Cohort of Italian Patients with Linear IgA dermatosis 07:25 Discussion Giulia Gasparini (ITALY) 07:30 Advanced basal cell carcinoma: real life using 07:27 Discussion vismodegib Maria Concetta Fargnoli (ITALY) 07:30 Cutaneous lupus erythematosus: the role of serologic testing in management and 07:40 Discussion monitoring 07:45 Squamous cell carcinoma: news on adjuvant Marzia Caproni (ITALY) treatment 07:42 Discussion Giuseppe Argenziano (ITALY) 07:45 Circulating T helper and regulatory cells in 07:55 Discussion patients with cutaneous adverse drug reactions: a multicentric flow cytofluorimetric study AMBER 2 07:00-08:00 Paolo Fava (ITALY) 07:57 Discussion GRUPPO SIDeMaST PATOLOGIE ANNESSIALI: IS SIDeMaST Group for Annexial Diseases CO-CHAIRS: Bianca Maria Piraccini (ITALY), AMBER 4 07:00-08:00 Alfredo Rossi (ITALY) GILD: Laser application for the genital area 07:00 What’s new on nails at the WCD 2019 IS CO-CHAIRS: Francesca Negosanti (ITALY), Bianca Maria Piraccini (ITALY) Giovanni Cannarozzo (ITALY) 07:07 What’s new on hair at the WCD 2019 07:00 Lasers in the genital pathology Maria Caterina Fortuna (ITALY), Ercole Costanza (ITALY), Mario Sannino (ITALY) Alfredo Rossi (ITALY) 07:10 Lasers in genital lichen Sclerosus 07:14 What’s new on tricoscopy and onychoscopy at Nicoletta Banzola (ITALY) the WCD 2019 Michela Starace (ITALY) 07:20 Lasers in menopause genital syndrome Francesca Negosanti (ITALY) 07:21 Mechanical (Physical) therapy for hair diseases Aurora Alessandrini (ITALY) 07:30 Lasers and urinary disorders Debora Marchiori (ITALY) 07:28 Treatment of nail in growing: from old to new approaches 07:40 Lasers and genital bleaching Paola Monari (ITALY) Miriam Leuzzi (ITALY)

07:35 News on nail unit melanoma 07:50 Discussion Emi Dika (ITALY), Pier Alessandro Fanti (ITALY)

07:42 Inﬂammation: new target of Hidradenitis suppurativa pathogenesis Claudio Marasca (ITALY)

07:49 Discussion FRIDAY 14 JUNE, 2019

AMBER 5+6 07:00-08:00 AMBER 1 08:00-10:45

Dermatology Olympics by AIDNID FELLOW FORUM 4 IS CO-CHAIRS: Alessandro Di Stefani (ITALY), FF CO-CHAIRS: Simone Ribero (ITALY), Caterina Longo (ITALY) Zoe Apalla (GREECE)

Interactive session where dermatologists will 08:00 Efficacy of dual mode quasi-Long Pulsed & Q compete against one another on providing the Switched 1064nm Nd: YAG laser as an adjuvant correct diagnosis based on seeing dermoscopic in management of Active Acne Vulgaris images displayed on a screen. S. Chavan (INDIA) 08:15 Histoid Leprosy: A 12 Year Retrospective AMBER 7+8 07:00-08:00 Clinical-Epidemiological Study and its association to lepra reactions E. Coelho (BRAZIL) ADOI: Precision medicine and biomarkers in IS dermatology 08:30 The impact of speciﬁc anatomical location on CO-CHAIRS: Maurizio Congedo (ITALY), melanoma survival: independent high and low Marina Talamonti (ITALY) risk sites M. Howard (AUSTRALIA) 07:00 Precision medicine in Dermatology: perspectives and problems 08:45 A new therapeutic approach with HIV-positive Angela Filoni (ITALY) and immune compromised patients in the removal of genital warts, which protects doctors 07:20 Precision medicine in the treatment of psoriasis from professional exposure Cristina Albanesi (ITALY) I. Jeremić (SERBIA) 07:40 Atopic Dermatitis and Precision Medicine 09:00 The aquagenic pruritus in polycythemia vera: Giovanni Damiani (ITALY) clinical characteristics E. Lelonek (POLAND) BROWN 1 07:00-08:00 09:15 Melanocyte and melanogenesis features in pigmented an non-pigmented variants of basal GRUPPO SIDeMaST STORIA DELLA cell carcinoma IS DERMATOLOGIA E VENEREOLOGIA: History of K. Martinez-Rosales (MEXICO) Dermatology 09:30 Successful treatment of teriﬂunomide-induced CO-CHAIRS: Patrizia Forgione (ITALY), toxic epidermal necrolysis with accelerated Massimo Nacca (ITALY) elimination of the medication and cyclosporine 07:00 Dermatology from prehistory: psoriasis and R. D. Pride (UNITED STATES) actinic keratosis 09:45 Successful Treatment of Recalcitrant Pediatric Gioachino Alessandro Caresana (ITALY) Generalized Pustular Psoriasis Patients with 07:15 History of gonorrhea anti-TNF-α therapy: A Case Series from a Valeria Gaspari (ITALY) Tertiary Center in Turkey G. P. Sun (TURKEY) 07:30 From Darwin to climate change: the bizarre story of atopic dermatitis 10:00 HLA associations and autoimmune blistering Cataldo Patruno (ITALY) disease: Generality and Heterogeneity Y. Sun (CHINA) 07:45 History of women in Science and Dermatology Sabine Pabisch (ITALY) 10:15 Platelet-rich plasma (PRP) in male and female genital lichen sclerosus: the impact of tissue repair and sex difference in the therapeutic response and quality of life M. Tedesco (ITALY) FRIDAY 14 JUNE, 2019

10:30 Determinants of disease severity among 08:11 Histopathology of non-infectious granuloma patients with atopic dermatitis: association with formation components of the atopic march Istvan Nemeth (HUNGARY) J. Grønlund Holm (DENMARK) 08:33 Granulomatous cutaneous sarcoidosis Peter Elsner (GERMANY) AMBER 2 08:00-10:45 08:55 Necrobiosis lipoidica Cornelia Erfurt-Berge (GERMANY) Parasitic Infections Affecting the Skin 09:17 Granuloma annulare SY CHAIR: Esther Von Stebut (GERMANY) Daniel Torocsik (HUNGARY) CO-CHAIRS: Archana Singal (INDIA), Roberto Arenas (MEXICO) 09:39 Reactive granulomatous dermatitis Misha Rosenbach (UNITED STATES) 08:00 Cutaneous Leishmaniasis: Epidemiology, disease burden, and skin defence mechanisms 10:01 Granulomatous vasculitis Esther Von Stebut (GERMANY) Robert Micheletti (UNITED STATES)

08:15 Discussion 10:23 Granulomatous rosacea Dae Hun Suh (KOREA, REPUBLIC OF) 08:20 Cutaneous Leishmaniasis: clinical presentation and management Archana Singal (INDIA) AMBER 4 08:00-10:45 08:40 Discussion Pruritus 08:49 Tropical lymphoedemas (LF and podoconoiosis) SY CHAIR: Martin Steinhoff (IRELAND) Claire Fuller (UNITED KINGDOM) CO-CHAIRS: Gil Yosipovitch (UNITED STATES), 09:09 Discussion Hiroyuki Murota (JAPAN) 09:18 Loopholes in the management of scabies: 08:00 Pruritus and the Brain-Skin Axis: What is new? lessons from clinics Gil Yosipovitch (UNITED STATES) Vijay Zawar (INDIA) 08:20 Discussion 09:38 Discussion 08:25 Pruritus and the Immune-Skin Axis: an Update 09:47 Head Lice: a practical approach Martin Steinhoff (IRELAND) Roberto Arenas (MEXICO) 08:45 Discussion 10:07 Discussion 08:50 Central transmission of itch 10:16 Guidelines for the treatment of cutaneous larva Pedro Pereira (GERMANY) migrans 09:05 Discussion Stefano Veraldi (ITALY) 09:10 Challenges in pruritus treatment 10:36 Discussion Hiroyuki Murota (JAPAN)

09:30 Discussion AMBER 3 08:00-10:45 09:35 Role of Neurokinins in pruritus Sonja Ständer (GERMANY) Granulomatous Disorders (Non-infectious) SY CHAIR: Lajos Kemeny (HUNGARY) 09:55 Discussion CO-CHAIRS: Misha Rosenbach (UNITED STATES), 10:00 New developments for treatment of pruritus Dae Hun Suh (KOREA, REPUBLIC OF) Thomas Luger (GERMANY) 08:00 The spectrum of non-infectious granulomatous 10:20 Discussion diseases Lajos Kemeny (HUNGARY) 10:25 The itch patient – what we can do to improve quality of life Uwe Gieler (GERMANY)

10:40 Discussion FRIDAY 14 JUNE, 2019

AMBER 5+6 08:00-10:45 10:17 Quality of life in vitiligo: the tip of an iceberg Suresh Joshipura (INDIA)

Photomedicine 10:30 Discussion SY CHAIR: Thomas Schwarz (GERMANY) CO-CHAIRS: Sally H. Ibbotson (UNITED KINGDOM), Henry W. Lim (UNITED STATES) BLUE 1 08:00-10:45 08:00 New developments in photocarcinogenesis Chikako Nishigori (JAPAN) Advanced Dermatopathology CO CHAIR: Omar Sangueza (UNITED STATES) 08:29 New developments in photoprotection CO-CHAIRS: Giorgio Annessi (ITALY), Steven Wang (UNITED STATES) Lorenzo Cerroni (AUSTRIA)

08:58 New developments in visible light 08:00 Cutaneous vasculitis, a brief tour of updated Iltefat Hamzavi (UNITED STATES) experiences 09:27 New developments in phototherapy Lawrence Gibson (UNITED STATES) Peter Wolf (AUSTRIA) 08:30 Pruritus under the microscope 09:56 New developments in PDT Dieter Metze (GERMANY) Yolanda Gilaberte (SPAIN) 09:00 How to approach papulosquamous lesions 10:25 Discussion Yu-Hung Wu (CHINESE TAIPEI) 09:30 Paediatric Dermatopathology Sylvie Fraitag (FRANCE) AMBER 7+8 08:00-10:45 10:00 Unusual cutaneous lymphoproliferative Vitiligo disorders SY CHAIR: Mauro Picardo (ITALY) Lorenzo Cerroni (AUSTRIA) CO-CHAIRS: Samia Esmat (EGYPT), 10:15 Unusual cutaneous lymphoproliferative Suresh Joshipura (INDIA) disorders 08:00 Introduction Omar Sangueza (UNITED STATES) 08:05 Role of genes and epigenetics 10:30 Q&A Rehab Hegazy (EGYPT) 08:18 Immunological aspects of vitiligo BLUE 2 08:00-10:45 Julien Seneschal (FRANCE)

08:31 Non immunological aspects Advanced Dermatological Surgery Mauro Picardo (ITALY) CO CHAIR: Roland Kaufmann (GERMANY) CO-CHAIRS: Gaston Galimberti (ARGENTINA), 08:44 Chemical and Environmental factors Kavita Mariwalla (UNITED STATES) Tamio Suzuki (JAPAN) 08:00 Introduction – Current challenges in 08:57 Classiﬁcation and clinical features: measuring Dermatosurgery vitiligo Roland Kaufmann (GERMANY) Nanja Van Geel (BELGIUM) 08:10 Nose and cheeks 09:10 Discussion Anthony Benedetto (UNITED STATES)

09:25 When is vitiligo an emergency 08:30 Lips and Chin Samia Esmat (EGYPT) Elena Rossi (ITALY)

09:38 Optimizing phototherapy 08:50 Eyelids and Eyebrows Tasneem Mohammad (UNITED STATES) Selma Schuartz Cernea (BRAZIL)

09:51 Philosophy of depigmentation 09:05 Temples and frontal Skin Ahmed Mohammed Al Issa (SAUDI ARABIA) Gaston Galimberti (ARGENTINA) 10:04 New trends in the treatment of vitiligo Thierry Passeron (NETHERLANDS) FRIDAY 14 JUNE, 2019

09:20 Ears 10:38 Conclusions Kavita Mariwalla (UNITED STATES) Jean Krutmann (GERMANY)

09:35 Scalp 10:41 Conclusions Jurg Hafner (SWITZERLAND) Darrell Rigel (UNITED STATES)

09:55 Trunk John Paoli (SWEDEN) BROWN 2 08:00-10:45 10:10 Extremities Roland Kaufmann (GERMANY) Vasculitis and vasculopathy SY CHAIR: Cord Sunderkoetter (GERMANY) 10:25 Microscopically controlled surgery – CO-CHAIRS: Tamihiro Kawakami (JAPAN), Modifications and Indications Warren Piette (UNITED STATES) Kai Munte (NETHERLANDS) 08:00 Nomenclature and provisional classification of vasculitides and vasculopathies BROWN 1 08:00-10:45 Cord Sunderkoetter (GERMANY) 08:20 The Interplay of hemostasis, inflammation, and Photoprotection coagulation, with a clinical approach to SY CHAIR: Giuseppe Monfrecola (ITALY) unraveling the process CO-CHAIRS: Darrell Rigel (UNITED STATES), Warren Piette (UNITED STATES) Jean Krutmann (GERMANY) 08:40 Histological differences between different 08:00 Introduction vasculitides Giuseppe Monfrecola (ITALY) Ko-Ron Chen (JAPAN) 08:05 Photoprotection beyond UV 09:00 Histological differences between different Jean Krutmann (GERMANY) vasculopathies 08:25 Discussion Carlo Francesco Tomasini (ITALY) 08:30 Does higher SPF sunscreen make a significant 09:20 Cutaneous and systemic Vasculitis in Behcet’s difference in UV Protection? disease Darrell Rigel (UNITED STATES) Erkan Alpsoy (TURKEY)

08:50 Discussion 09:40 Diagnostic algorithm for small vessel vasculitis with relation to the new D-CHCC 08:55 Photoprotection for skin diseases: the era of Tamihiro Kawakami (JAPAN) dedicated photoprotectors Giovanni Leone (ITALY) 10:00 Management of immune-complex vasculitides David A. Wetter (UNITED STATES) 09:15 Discussion 10:20 Management of livedo vasculopathy 09:20 Sunscreen as a consumer product: acceptability Mar Llamas-Velasco (SPAIN) and compliance Vincent Richer (CANADA) 10:40 Discussion 09:40 Discussion 09:45 Photoprotection strategy in the prevention of BROWN 3 08:00-10:45 skin aging among Asians Akimichi Morita (JAPAN) Rheumatology for the dermatologist CO CHAIR: Jan Dutz (CANADA) 10:05 Discussion CO-CHAIRS: Maria Sole Chimenti (ITALY), 10:10 The future of photoprotection Robert Strohal (AUSTRIA) Steven Wang (UNITED STATES) 08:00 Introduction – Session structure and topics 10:30 Discussion Jan Dutz (CANADA) 10:35 Conclusions Giuseppe Monfrecola (ITALY) FRIDAY 14 JUNE, 2019

08:05 Clinical Features and Mechanisms of Rheumatic 09:10 Ichthyoses disease: The role of innate and acquired Keith Choate (UNITED STATES) immunity in autoimmune diseases: focus on SLE 09:30 Q&A and Systemic sclerosis Steven O'reilly (UNITED KINGDOM) 09:40 Atopic Dermatitis Sandipan Dhar (INDIA) 08:23 Advances in classiﬁcation and treatment of SLE Paola Conigliaro (ITALY) 10:00 Hemangiomas Eulalia Baselga (SPAIN) 08:41 Dermatomyositis: New features, new treatments Gianfranco Ferraccioli (ITALY) 10:20 Psoriasis Jayakar Thomas (INDIA) 08:59 Vasculitis: Clinical and pathologic features of ANCA positive vasculitis as related to the skin 10:40 Q&A Andrea Saggini (ITALY)

09:17 Q&A SILVER 08:00-10:45 09:22 New Concepts in Psoriatic Arthritis: New pathogenetic mechanisms in Psoriatic arthritis Trichoscopy Augusta Ortolan (ITALY) CO CHAIR: Antonella Tosti (UNITED STATES) CO-CHAIRS: Shigeki Inui (JAPAN), 09:40 Articular manifestations and clinimetric Lidia Rudnicka (POLAND) measures in Psoriatic arthritis Raffaele Scarpa (ITALY) 08:00 Introduction by Chair & Co-Chairs 09:58 Imaging strategies in Psoriatic arthritis 08:05 Basic Trichoscopy structures Maria Sole Chimenti (ITALY) Ana Pedrosa (PORTUGAL)

10:16 Treatments targets and treatments options in 08:15 Alopecia areata Psoriatic arthritis Misaki Kinoshita-Ise (JAPAN) Roberta Ramonda (ITALY) 08:25 Female pattern hair loss 10:34 Q&A Rachita Dhurat (INDIA) 08:35 Trichotillomania RED 1+2 08:00-10:45 Lidia Rudnicka (POLAND) 08:45 Infections and infestations Paediatric Dermatology: From A to Z Hoda Moneib (EGYPT) CO CHAIR: Ruth Murphy (UNITED KINGDOM) 08:55 Tinea capitis CO-CHAIRS: Jayakar Thomas (INDIA), Daniel Asz Sigall (MEXICO) Jemima Mellerio (UNITED KINGDOM) 09:05 LPP and its variants 08:00 Welcome and Overview of paediatric Rodrigo Pirmez (BRAZIL) dermatology from neonates to adolescents Ruth Murphy (UNITED KINGDOM) 09:15 Folliculitis decalvans Sergio Vano-Galvan (SPAIN) 08:10 Welcome and Overview of paediatric dermatology from neonates to adolescents 09:25 Pustular erosive dermatosis Jemima Mellerio (UNITED KINGDOM) Bianca Maria Piraccini (ITALY)

08:20 Welcome and Overview of paediatric 09:35 Misterious black dots dermatology from neonates to adolescents Martin Zaiac (UNITED STATES) Jayakar Thomas (INDIA) 09:42 What Hair Transplant Surgeons Should Know 08:30 Nongenetic neonatal rashes and blisters Chinmanat Tangjaturonrusamee (THAILAND) Danielle Marcoux (CANADA) 09:50 Dermoscopy of black scalp 08:50 Inherited blisters Ncoza Dlova (SOUTH AFRICA) Jemima Mellerio (UNITED KINGDOM) 10:00 Dermoscopy guided biopsies Antonella Tosti (UNITED STATES) FRIDAY 14 JUNE, 2019

10:08 Quiz cases 08:20 Current treatment guidelines for AK Nino Lortkipanidze (GEORGIA) Stephen Schumack (AUSTRIA)

10:18 Quiz cases 08:40 New AK ﬁeld treatments YuliYa Ovcharenko (UKRAINE) Daniel Mark Siegel (UNITED STATES)

10:28 Quiz cases 09:00 How to improve efficacy and tolerability of Tatiana Siliuk (RUSSIAN FEDERATION) photodynamic therapy Maria Concetta Fargnoli (ITALY) 10:38 Final Remarks 09:20 AK in high-risk body sites Nicole Basset-Seguin (FRANCE) SPACE 1 08:00-10:45 09:40 AK in high-risk patient populations Stefano Piaserico (ITALY) Atopic Eczema: pathogenesis and epidemiology SY CHAIR: Tilo Biedermann (GERMANY) 10:00 Long-term management and prevention of AK CO-CHAIRS: Sara Brown (UNITED KINGDOM), Lutz Schmitz (GERMANY) Yoshiki Tokura (JAPAN) 10:20 Discussion 08:00 Epidemiology of atopic eczema and its comorbidities: Have we arrived? Sinead M. Langan (UNITED KINGDOM) SPACE 3 08:00-10:45 08:25 Discussion Dermoscopy of Non Pigmented Lesions 08:33 Where genes drive us: Understanding atopic SY CHAIR: Josep Malvehy (SPAIN) eczema from the geneticist’s perspective CO-CHAIRS: Francisco Paschoal (BRAZIL), Babar Sara Brown (UNITED KINGDOM) Rao (UNITED STATES)

08:58 Discussion 08:00 My dermoscopic approach in non-pigmented lesions 09:06 The cutaneous barrier function in atopic Giuseppe Argenziano (ITALY) eczema: Causes and consequences Yoshiki Tokura (JAPAN) 08:15 Dermoscopic differential diagnosis of the pink lesions of the face 09:31 Discussion Rainer Hofmann-Wellenhof (AUSTRIA) 09:39 The new treatment era of atopic eczema: Where 08:30 Dermoscopic pattern of actinic keratosis do we stand, what can we expect? Francisco Paschoal (BRAZIL) Tilo Biedermann (GERMANY) 08:45 Dermatoscopic features of non-pigmented basal 10:04 Discussion cell carcinoma 10:12 Diversity of atopic eczema: Impact on Monika Arenbergerova (CZECH REPUBLIC) management 09:00 Diagnostic challenges of amelanotic melanoma Kwang Hoon Lee (KOREA, REPUBLIC OF) Josep Malvehy (SPAIN) 10:37 Discussion 09:15 Interactive cases I Babar Rao (UNITED STATES) SPACE 2 08:00-10:45 09:30 Dermoscopic features and patterns of poromas Cristina Carrera (SPAIN) Personalised Medicine for Actinic Keratoses 09:45 RCM and OCT for improving diagnosis and SY CHAIR: Maria Concetta Fargnoli (ITALY) pre-surgical definition of non-pigmented skin CO-CHAIRS: Nicole Basset-Seguin (FRANCE), cancers Thomas Dirschka (GERMANY) Nathalie De Carvalho (BRAZIL) 08:00 Molecular and clinico-pathological definition of 10:00 Dermatoscopy in inflammatory and other skin AK field disorders Thomas Dirschka (GERMANY) Aimilios Lallas (GREECE) FRIDAY 14 JUNE, 2019

10:15 Dermoscopy of vascular lesions 10:05 Tropical viruses Alicia Barreiro (SPAIN) Jose Rios-Yuil (PANAMA)

10:30 Interactive cases II 10:35 Q&A Iris Zalaudek (AUSTRIA)

WHITE 2 08:00-10:45 SPACE 4 08:00-10:45 Pathogenesis of Psoriasis Neonatal Dermatology SY CHAIR: Antonio Costanzo (ITALY) SY CHAIR: Margarita Larralde (ARGENTINA) CO-CHAIRS: Lars Iversen (DENMARK), CO-CHAIRS: Christine Bodemer (FRANCE), Andy Blauvelt (UNITED STATES) Julie Powell (CANADA) 08:00 Genetics in psoriasis 08:00 Common dermatologic manifestations in Antonio Costanzo (ITALY) newborns 08:22 Monogenic forms of Psoriasis: do they exist? Rashmi Sarkar (INDIA) Hervé Bachelez (FRANCE) 08:20 Vascular diseases in neonates 08:44 Cytokine network Julie Powell (CANADA) Andy Blauvelt (UNITED STATES) 08:40 Neonatal tumors that mimic vascular diseases 09:06 Psoriasis: an autoimmune or auto-inﬂammatory Margarita Larralde (ARGENTINA) disease? 09:00 Q&A Johann E. Gudjonsson (UNITED STATES) 09:06 Mastocytosis 09:28 Psoriasis going from an acute to a chronic Christine Bodemer (FRANCE) disease Lars Iversen (DENMARK) 09:26 Blistering disorders in newborns Arti Nanda (KUWAIT) 09:50 Pathogenesis behind the co-morbidities in psoriasis 09:46 Neonatal injuries Paolo Gisondi (ITALY) Mario Cutrone (ITALY) 10:12 Psoriasis: from pathogenesis to targeted 10:06 The different faces of congenital histiocytosis therapies Paula C. Luna (ARGENTINA) Kilian Eyerich (GERMANY) 10:26 View of mosaic diseases in the neonatal period 10:34 Conclusion and vision on the future Veronica Kinsler (UNITED KINGDOM)

WHITE 1 08:00-10:45 YELLOW 1 08:00-10:45 Anogenital Disorders Viruses Affecting the Skin SY CHAIR: Sue Cooper (UNITED KINGDOM) SY CHAIR: Jane Sterling (UNITED KINGDOM) CO-CHAIRS: Lynne Margesson (CANADA), CO-CHAIRS: Jose Rios-Yuil (PANAMA), Gudula Kirtschig (GERMANY) Stephen Tyring (UNITED STATES) 08:00 Introduction and welcome 08:00 Herpes viruses Sue Cooper (UNITED KINGDOM) Omar Lupi da Rosa Santos (BRAZIL) 08:05 Lichen Sclerosus in females: Diagnosis and 08:30 Papillomaviruses management Jane Sterling (UNITED KINGDOM) Gayle Fischer (AUSTRALIA) 09:00 Polyomaviruses 08:25 Lichen sclerosus in males: Diagnosis and Stephen Tyring (UNITED STATES) management 09:30 Q&A Christopher Bunker (UNITED KINGDOM) 09:35 HIV 08:45 Genital Lichen planus: An update Kieron Leslie (UNITED STATES) Sue Cooper (UNITED KINGDOM) FRIDAY 14 JUNE, 2019

09:05 Genital eczema and itch YELLOW 3 08:00-10:45 Aruna Venkatesan (UNITED STATES)

09:25 Hidradenitis Suppurativa HIV Infection and AIDS Ditte Marie Saunte (DENMARK) SY CHAIR: Roy Chan (SINGAPORE) CO-CHAIRS: Anisa Mosam (SOUTH AFRICA), 09:45 Genital ulcers: Diagnosis and management Vincent Piguet (CANADA) Lynne Margesson (CANADA) 08:00 Introduction 10:05 Genital ﬁssures and erosions: Differential diagnosis and treatment 08:03 Update on HIV biology Gudula Kirtschig (GERMANY) Vincent Piguet (CANADA)

10:25 Challenging cases from the clinic 08:18 Review of Global epidemiology of HIV infection Anisa Mosam (SOUTH AFRICA)

08:28 Update on Treatment of HIV infection YELLOW 2 08:00-10:45 Roy Chan (SINGAPORE)

Cutaneous reactions to new drugs 08:43 Update on Prevention of HIV SY CHAIR: Bernhard Homey (GERMANY) Benson Yeo (SINGAPORE) CO-CHAIRS: Jennifer Nam Choi (UNITED 08:53 Inﬂammatory Skin Conditions incl. IRIS STATES), Chia-Yu Chu (CHINESE TAIPEI) Toby Maurer (UNITED STATES)

08:00 Cutaneous reactions to immune checkpoint 09:13 Break inhibitor therapy Jennifer Nam Choi (UNITED STATES) 09:23 Infectious Skin Conditions Ramesh Bhat (INDIA) 08:20 Q&A 09:43 Kaposi’s sarcoma – an update 08:27 Cutaneous adverse events of EGFR inhibitors Anisa Mosam (SOUTH AFRICA) and other tyrosine kinase inhibitors Pietro Sollena (ITALY) 09:53 What's new in STIs in HIV infection Tatsuyoshi Kawamura (JAPAN) 08:47 Q&A 10:13 Update in Adverse Cutaneous Drug Reactions 08:54 Cutaneous adverse events of targeted anti Rannakoe Lehloenya (SOUTH AFRICA) melanoma drugs (BRAFi, MEKi) Mario E. Lacouture (UNITED STATES) 10:28 Q&A

09:14 Q&A 10:43 Round up 09:21 Cutaneous Adverse Reactions Associated with Cancer Targeted Therapies: What's New? Chia-Yu Chu (CHINESE TAIPEI)

09:41 Q&A 09:48 Cutaneous adverse events of other non oncological new drugs Maja Mockenhaupt (GERMANY)

10:08 Q&A 10:15 Interesting cases and management strategies Vincent Sibaud (FRANCE)

10:35 Q&A 10:42 Final remarks FRIDAY 14 JUNE, 2019

GOLD 11:00-12:30 15:30 Impact on Quality of Life in family members of Vitiligo patients CO-CHAIRS: J. Chandni (INDIA) PL Ricardo Galimberti (ARGENTINA), 15:40 HIV epidemic in the Middle East and North Irene Leigh (UNITED KINGDOM), Africa region: can we hide it? Jean-Hilaire Saurat (SWITZERLAND), I. Maatouk (UNITED KINGDOM) Jouni Uitto (UNITED STATES) 15:50 Predatory conferences: Caveat emptor! 11:00 Discover of JAK/STAT pathway M. Pawar (INDIA) John O'Shea (UNITED STATES) 16:00 Dermatitis artefacta in childhood and 11:30 The Molecular Basis of Novel Therapies for adolescence: a spectrum of disease Alopecia P. Mohandas (UNITED KINGDOM) Angela Christiano (UNITED STATES) 16:10 A novel pedagogic approach assessing quality 11:50 Advances in the Treatment of Melanoma of care Caroline Robert (FRANCE) M. Singh (UNITED KINGDOM)

12:10 How Laser and Photonic Technology will change 16:20 Dermatology Referrals from the Emergency Dermatology Department at a Tertiary Care Hospital Rox Anderson (UNITED STATES) J. Tran (CANADA)

AMBER 1 14:30-16:30 AMBER 2 14:30-16:30

Skin Health and Ethics Graft versus Host Disease FC CO-CHAIRS: Martino Neumann (NETHERLANDS), WS CHAIR: Edward Cowen (UNITED STATES) Cecile Clavaud ( FRANCE) CO-CHAIRS: Pietro Rubegni (ITALY), 14:30 Development of a scale to measure the Sharon Hymes (UNITED STATES) psychosocial impact of vitiligo on family 14:30 Introduction: overview of HSCT members Edward Cowen (UNITED STATES) S. Agrawal (INDIA) 14:50 Histopathology and biomarkers of GVHD 14:40 Emotion dysregulation and mood pathology in Alejandro Gru (UNITED STATES) Psoriasis. Implication for disease Management P. Amerio (ITALY) 15:05 Oral manifestations of GVHD Jacqueline Mays (UNITED STATES) 14:50 The Impact of Wikipedia Editing in Dermatology 15:20 Skin-directed management of GVHD (or M.O. Hutton (UNITED STATES) overview of HSCT) Sharon Hymes (UNITED STATES) 15:00 Emerging dermatitis from mesostigmatic (arachnids: acari) in Italian urban settlements 15:40 Management of pediatric GVHD E. Castelli (ITALY) Jennifer Huang (UNITED STATES)

15:10 New insight into the link between skin 15:55 Role of extracorporeal photopheresis in the microbiota and pollution derived clinical treatment of GVHD disorders Pietro Rubegni (ITALY) C. Clavaud (FRANCE) 16:10 Q&A 15:20 Novel point of care diagnostic strategies for skin disease in low resource settings: portable confocal microscopy for Kaposi’s sarcoma AMBER 3 14:30-16:30 E. Freeman (UNITED STATES) Inherited Tumour Syndromes WS CHAIR: Neil Rajan (UNITED KINGDOM) CO-CHAIRS: Giovanni Ponti (ITALY) Raymond Cho (UNITED STATES) FRIDAY 14 JUNE, 2019

14:30 Introduction 16:00 Implications of oils/natural products/shampoo Neil Rajan (UNITED KINGDOM) additives on skin of color patients Amy McMichael (UNITED STATES) 14:33 Xeroderma Pigmentosum: Defects in the DNA Repair Machinery 16:15 Questions and close out John Digiovanna (UNITED STATES) Rodrigo Pirmez (BRAZIL)

14:53 Discussion 14:56 Interaction of inherited variants and somatic AMBER 5+6 14:30-16:30 mutations in cutaneous tumors Raymond Cho (UNITED STATES) Managing Laser Complications WS CHAIR: Vishal Madan (UNITED KINGDOM) 15:16 Discussion CO-CHAIRS: Steven Nisticò (ITALY), 15:19 Mutated epigenetic modiﬁers in CYLD Amin Amer (EGYPT) cutaneous syndrome 14:30 Managing Postinﬂammatory Neil Rajan (UNITED KINGDOM) Hy-perpigmentation in Asian Skin Types 15:39 Discussion Woraphong Manuskiatti (THAILAND) 15:42 Basal cell naevus syndrome 14:45 Management of Risks in Vaginal Lasers John Lear (UNITED KINGDOM) Francesca Negosanti (ITALY)

16:02 Discussion 15:00 Laser tattoo treatments, managing complications and what’s new? 16:05 Birt-Hogg-Dube syndrome Keyvan Nouri (UNITED STATES) Maurice Van Steensel (SINGAPORE) 15:15 Managing complications arising from laser 16:25 Discussion resurfacing (fractional and non fractional) 16:28 Closing comments and summary Mohamed Amer (EGYPT) Neil Rajan (UNITED KINGDOM) 15:30 Assessing the safety of energy based devices (ultrasound, radio frequency, cryo lipolysis) and AMBER 4 14:30-16:30 managing complications Jorge Ocampo-Candiani (MEXICO)

Hair Disorders in Skin of Colour 15:45 Intense pulsed light: risks and management WS CHAIR: Amy McMichael (UNITED STATES) Daniel Galimberti (ARGENTINA) CO-CHAIRS: Rodrigo Pirmez (BRAZIL), 16:00 Improving safety in laser clinics what we must all do? Ncoza Dlova (SOUTH AFRICA) Amin Amer (EGYPT) 14:30 Introduction 16:15 Patient selection in Laser Dermatology - when is Amy McMichael (UNITED STATES) it time to say no! 14:35 Trichoscopy in skin of color Vishal Madan (UNITED KINGDOM) Rodrigo Pirmez (BRAZIL)

14:50 CCCA updates AMBER 7+8 14:30-16:30 Valerie Callender (UNITED STATES)

15:05 FFA and LPPigmentosus in skin of color patients Approach to classiﬁcation and management of Ncoza Dlova (SOUTH AFRICA) WS hypopigmentation CHAIR: Amit Pandya (UNITED STATES) 15:20 Q&A CO-CHAIRS: Michelle Rodrigues (AUSTRALIA), 15:30 Interesting and Challenging Scalp Cases in India Ayesha Akinkube (NIGERIA) Rachita Dhurat (INDIA) 14:30 Presentations, signs of activity and differential 15:45 Impact of relaxers in women diagnosis of vitiligo Sara Salas (MEXICO) Michelle Rodrigues (AUSTRALIA) FRIDAY 14 JUNE, 2019

14:50 Medical management and phototherapy of 15:40 Surgery of the Nail Apparatus vitiligo Judith Dominguez-Cherit (MEXICO) Amit Pandya (UNITED STATES) 16:05 Update on Hair replacement surgery 15:10 Surgical management of vitiligo Sung In Cho (KOREA, REPUBLIC OF) Nanja Van Geel (BELGIUM)

15:30 Q&A BROWN 1 14:30-16:30 15:40 Pityriasis versicolor, post-inﬂammatory hypopigmentation and medication-induced Diagnosis and Management of Dermatomyositis hypopigmentation WS CHAIR: Ruth Ann Vleugels (UNITED STATES) Ayesha Akinkube (NIGERIA) CO-CHAIRS: Hector Chinoy (UNITED KINGDOM), Sueli Carneiro (BRAZIL) 16:00 Nevus depigmentosus and idiopathic guttate hypomelanosis 14:30 Cutaneous Dermatomyositis: Diagnosis Clues for Hee Young Kang (KOREA, REPUBLIC OF) the Dermatologist Alisa N. Femia (UNITED STATES) 16:20 Q&A 14:45 Update on Dermatomyositis and its Relationship with Malignancy BLUE 1 14:30-16:30 Jeffrey Callen (UNITED STATES) 15:00 TIF1-gamma and NXP-2 antibodies and Advanced Dermatopathology correlation with clinical phenotype in CO CHAIR: Omar Sangueza (UNITED STATES) dermatomyositis CO-CHAIRS: Giorgio Annessi (ITALY), Hector Chinoy (UNITED KINGDOM) Lorenzo Cerroni (AUSTRIA) 15:15 Q&A 14:30 Advances in dermatopathology of infectious disorders 15:30 MDA-5 antibody and correlation with clinical Francisco Bravo (PERU) phenotype in dermatomyositis Manabu Fujimoto (JAPAN) 15:00 Histopathologic clues in the differential diagnosis of scarring alopecias 15:45 Advanced Treatment Pearls: Cutaneous Giorgio Annessi (ITALY) Dermatomyositis Ruth Ann Vleugels (UNITED STATES) 15:30 Unusual observations in dermatopathology Lorenzo Cerroni (AUSTRIA) 16:00 Looking Forward: CDASI Validation and Clinical Trials for Dermatomyositis 16:00 Controversial issues on Melanocytic neoplasms Victoria Werth (UNITED STATES) Omar Sangueza (UNITED STATES) 16:15 Q&A

BLUE 2 14:30-16:30 16:25 Concluding Remarks Sueli Carneiro (BRAZIL)

Advanced Dermatological Surgery CO CHAIR: Roland Kaufmann (GERMANY) BROWN 2 14:30-16:30 CO-CHAIRS: Gaston Galimberti (ARGENTINA), Kavita Mariwalla (UNITED STATES) Challenging Naevi 14:30 Sentinel lymph node biopsy – standard WS CHAIR: Jason Rivers (CANADA) approach and new developments CO-CHAIRS: Kelly Cordoro (UNITED STATES), David Ramirez Moreno (SPAIN) Gianluigi Giovene (ITALY)

14:55 Hidradenitis suppurativa – surgical approach 14:30 Challenges in the histologic diagnosis of Falk Bechara (GERMANY) melanocytic nevi Clay J. Cockerell (UNITED STATES) 15:15 Varicose veins – update on available procedures Filippo de Pasquale (ITALY) 14:45 Q&A FRIDAY 14 JUNE, 2019

14:50 Challenging Nevi Through the Ages 15:45 Scars Treatments with Fillers and Toxins Peter Soyer (AUSTRALIA) Joely Kaufman (UNITED STATES)

15:05 Q&A 15:55 Complications of Fillers Joel Cohen (UNITED STATES) 15:10 Challenges in the diagnosis and management of Congenital Nevi 16:05 Complications of Botulinum Toxins in Cosmetic Enzo Erricchetti (ITALY) and Medical Treatments Maurizio Benci (ITALY) 15:25 Q&A 16:15 Q&A 15:30 Challenges in the diagnosis & management of Nail & Acral Nevi Alex Chamberlain (AUSTRALIA) RED 1+2 14:30-16:30 15:45 Q&A Paediatric Dermatology: From A to Z 15:50 Atypical Nevi: State of the art in 2019 CO CHAIR: Ruth Murphy (UNITED KINGDOM) Ashfaq Marghoob (UNITED STATES) CO-CHAIRS: Jayakar Thomas (INDIA), 16:05 Q&A Jemima Mellerio (UNITED KINGDOM) 16:10 Aids to the diagnosis of challenging nevi 14:30 Welcome back Giuseppe Argenziano (ITALY) Ruth Murphy (UNITED KINGDOM)

16:25 Q&A 14:35 Melanocytic nevi Veronica Kinsler (UNITED KINGDOM)

BROWN 3 14:30-16:30 14:57 Cutaneous Leishmaniasis, leprosy and TB Johannes Dayrit (PHILIPPINES)

Advanced Techniques and Risks: Fillers and 15:09 Drug reactions WS Toxins Antonio Torrelo (SPAIN) CHAIR: Doris Hexsel (BRAZIL) 15:31 Alopecia areata and Vitiligo CO-CHAIRS: Rebecca Fitzgerald (UNITED STATES), Brett King (UNITED STATES) Domenico Piccolo (ITALY) 15:53 Connective tissue 14:30 Introduction Ruth Murphy (UNITED KINGDOM) Doris Hexsel (BRAZIL) 16:15 Q&A 14:35 Imaging and Photographic Documentation of Cosmetic Patients Domenico Piccolo (ITALY) SPACE 1 14:30-16:30 14:45 2D to 3D: Ovalizing the Face with Injectable Agents Hidradenitis suppurativa: The spectrum of Rebecca Fitzgerald (UNITED STATES) WS management CHAIR: Gregor Jemec (DENMARK) 14:55 A Natural and Safe Approach with Fillers and CO-CHAIRS: Brian Kirby (IRELAND), Toxins for the Upper Face Klemens Rappersberger (AUSTRIA) Andrè Braz (BRAZIL) 14:30 Which out-comes should we assess 15:05 A natural Approach to Mid face and Tear Trough Linnea Thorlacius (DENMARK) Fillers Vince Bertucci (CANADA) 14:48 Guidelines Gregor Jemec (DENMARK) 15:15 Filling the Nose Davi De Lacerda (BRAZIL) 15:05 Surgery for HS Stanislav Tolkachjov (UNITED STATES) 15:25 Fillers and Toxins for the Lower Face Ada Trinidade de Almeida (BRAZIL) 15:22 Complications in HS surgery and how to avoid them 15:35 Advanced Techniques on Hands Klemens Rappersberger (AUSTRIA) Mitchel Goldman (UNITED STATES) FRIDAY 14 JUNE, 2019

15:39 Biologics beyond TNF blockade 15:34 Difficult Mohs Cases from America Brian Kirby (IRELAND) Brett Coldiron (UNITED STATES)

15:56 Light based therapy 15:48 Difficult Mohs Cases from Italy Hessel Van Der Zee (NETHERLANDS) Antonio Rusciani (ITALY)

16:13 The role of antibiotics 16:02 Difficult Mohs Cases from Spain Dunja Vekic (AUSTRIA) Eduardo Nagore (SPAIN)

16:16 Difficult Mohs Cases from Mexico SPACE 2 14:30-16:30 Jose Fernando Barba Flores (MEXICO)

Skin Signs of Systemic Disease SPACE 4 14:30-15:30 WS CHAIR: Daniela Kroshinsky (UNITED STATES) CO-CHAIRS: Athanassios Kolivras (BELGIUM), Lentigo Maligna: Surgery or Not? Joseph Jorizzo (UNITED STATES) CN CHAIR: David M. Pariser (UNITED STATES) 14:30 Introduction DISCUSSANT: Daniela Kroshinsky (UNITED STATES) Against - Emma Craythorne (UNITED KINGDOM) For - Myrto-Georgia Trakatelli (GREECE), 14:34 Alopecia as a Manifestation of Systemic Cristina Magnoni (ITALY) Disease Athanassios Kolivras (BELGIUM) 14:54 Paraneoplastic Skin Diseases SPACE 4 15:30-16:30 Lindsay Strowd (UNITED STATES) Does Mole Mapping Make a Difference? 15:14 Disseminated cutaneous nodules CN CHAIR: Raúl Alejandro Cabrera Moraga (CHILE) Xinaida Lima (BRAZIL) DISCUSSANT: 15:34 Neutrophilic Dermatoses Against - Jean Jacques Grob (FRANCE), Joseph Jorizzo (UNITED STATES) For - Gabriel Salerni (ARGENTINA)

15:54 Painful skin ulcers in a patient with kidney disease WHITE 1 14:30-16:30 Daniela Kroshinsky (UNITED STATES)

16:14 Q&A Immunobullous Clinic WS CHAIR: Detlef Zillikens (GERMANY) CO-CHAIRS: Evandro Rivitti (BRAZIL), SPACE 3 14:30-16:30 Liangdan Sun (CHINA) 14:30 New insights into the pathogenesis of Mohs Surgery Update pemphigus WS CHAIR: Brett Coldiron (UNITED STATES) Masayuki Amagai (JAPAN) CO-CHAIRS: Eduardo Nagore (SPAIN), Antonio Rusciani (ITALY) 14:50 New insights into the pathogenesis and epidemiology of endemic pemphigus foliaceus 14:30 Introduction Valeria Aoki (BRAZIL) Brett Coldiron (UNITED STATES) 15:10 Current and novel treatment options for 14:38 Mohs Surgery in Brazil pemphigus Luis Tovo (BRAZIL) Pascal Joly (FRANCE) 14:52 Mohs Surgery in Mexico 15:30 New insights into the pathogenesis of Jorge Ocampo-Candiani (MEXICO) pemphigoid diseases 15:06 Mohs Surgery in South Africa Christian Sadik (GERMANY) Pieter Du Plessis (SOUTH AFRICA) 15:50 Mucous membrane pemphigoid: clinical 15:20 Mohs Surgery in Indonesia spectrum and diagnosis Adhimukti Sampurna (INDONESIA) Jane Setterﬁeld (UNITED KINGDOM) FRIDAY 14 JUNE, 2019

16:10 Current and novel treatment options of bullous 16:10 Study of cutaneous manifestations of internal and mucous membrane pemphigoid malignancies and of their treatments– a hospital Matthias Goebeler (GERMANY) based, prospective cross-sectional study N. Prabhu (INDIA)

WHITE 2 14:30-16:20 YELLOW 1 14:30-16:30 Mucosal diseases and skin manifestations of FC internal disorders Infectious diseases 2 CO-CHAIRS: Emanuele Claudio Cozzani (ITALY), FC CO-CHAIRS: Klaus Eisendle (ITALY), Giovanna Zambruno (ITALY) Dilip Shah (INDIA)

14:30 Rituximab in the treatment of Rosai-Dorfman 14:30 Bioterrorism: A Dermatologists Perspective - An Disease with IgG4 Aid to Early Detection H. Al-Kutubi (UNITED KINGDOM) A. Chopra (INDIA)

14:40 Setting future research priorities for lichen 14:40 Cutaneous Histoplasmosis: Review of Cases and sclerosus Clinical Experience R. Simpson (UNITED KINGDOM) A. J. Rodrigues Queiróz (BRAZIL)

14:50 Calciphylaxis in daily practice: deal with it! 14:50 Dermatological manifestations of enterovirus V. Girgenti (ITALY) infection: clinical presentation and possible long term sequelae in adult patients 15:00 Mucocutaneous manifestations in course of G. Ciccarese (ITALY) celiac disease: a clinical study of 280 patients M. Khallaayoune (MOROCCO) 15:00 A comprehensive analysis of testicular dysfunction in Indonesian men affected by leprosy 15:10 Melkersson-Rosenthal syndrome: a H. Gunawan (INDONESIA) retrospective study of 35 patients showing treatment outcomes, and indicating lingua 15:10 Relevance of clindamycin in the skin and soft plicata rather than orofacial swelling as the tissue infections by Beta haemolytic initial sign streptococci S. Kılıç (TURKEY) S. Shenoy (INDIA)

15:20 Cutaneous metastases of internal cancers. 15:20 Pilot Study to Assess the Accuracy and Precision Clinical, videodermoscopical and of Phenolic Glycolipid-I of Mycobacterium histopathological pictures of selected cases with leprae Test Kit in Diagnosing New Leprosy Cases literature review Among Patients at the Jose R. Reyes Memorial M. Maj (POLAND) Medical Center M. Krisha Montenegro (PHILIPPINES) 15:30 Paraneoplastic erythroderma: report of three cases D. Miyashiro (BRAZIL) 15:30 Paediatric leprosy – peek a boo to leprosy transmission 15:40 Study of cutaeneous manifestation in patients of V. Chugh (INDIA) chronic liver diseasec (CLD): a prospective observational study 15:40 Pain related to Varicella Zoster Virus V. Naik (INDIA) reactivation: comparison between typical herpes zoster and zoster sine herpete 15:50 Platelet-rich plasma for the treatment of male A. Herzum (ITALY) genital lichen sclerosus resistant to conventional therapy in Uruguay: Preliminary results from the 15:50 Classical today, unclassical tomorrow - An agent ﬁrst pilot study turning the diagnosis upside down J. Navarrete (URUGUAY) B. Koneti (INDIA)

16:00 Necrobiosis lipoidica beyond diabeticorum: A multi-institution evaluation of the clinical features and comorbidities of 236 patients C. Nelson (UNITED STATES) FRIDAY 14 JUNE, 2019

16:00 Atypical manifestations of cutaneous 16:00 Severe psoriasis is associated with tuberculosis: a case series of seven patients gastrointestinal symptoms, intestinal barrier P. Verma (INDIA) dysfunction and increased plasma concentration of gut microbiota-derived metabolites 16:10 Nail infestation: An atypical presentation of M. Sikora (POLAND) typical scabies Y. Zou (CHINA) 16:10 Clinical response of fumaric acid esters in psoriasis: Registry data from 1,409 patients in 16:20 Leprosy Scenario at a Tertiary Care Hospital in Germany Mumbai: A 5-year Retrospective Study C. Sorbe (GERMANY) U. Zambare (INDIA) 16:20 Involvement of autoinﬂammation in early phases of psoriasis YELLOW 2 14:30-16:30 D. Fanoni (ITALY)

Psoriasis 2 FC CO-CHAIRS: Luca Bianchi (ITALY), YELLOW 3 14:30-16:30 Alessandro Giunta (ITALY) Atopic and contact dermatitis 14:30 Conserved overall effectiveness of systemic FC CO-CHAIRS: Luca Stingeni (ITALY), therapies in elderly psoriasis patients - a two Marina Papoutsaki (ITALY) country, multi-center, prospective, non interventional study 14:30 Achieving an itch-free state with upadacitinib: a C. Sorbe (GERMANY) post-hoc analysis of data from the Phase 2b randomized, double-blind, placebo-controlled 14:40 The prevalence of John Cunningham (JC) virus trial in moderate-to-severe atopic dermatitis antibody positivity in psoriasis patients K. Reich (GERMANY) O. Molloy (IRELAND) 14:40 Atopic Eczema: genetic analysis of COL6A5, 14:50 Immunological and genetic profiles of drug COL8A1 and COL10A1 in Mediterranean induced paradoxical psoriasis populations L. Fania (ITALY) C. Strafella (ITALY) 15:00 Is there any difference between antiTNF-α 14:50 Association of specific dietary behaviours with induced paradoxical psoriasiform reactions and atopic dermatitis in adolescence: Results from psoriasis? the Korea Youth Risk Behavior Web-Based L. L. Tirelli (ARGENTINA) Survey (KYRBWS), 2017 15:10 Topical treatment with vitamin D3 analogue S. Cho (KOREA, REPUBLIC OF) decreases MDR1-expressing T cells infiltrating in 15:00 Tralokinumab Phase 2b study: Effects of the plaque psoriasis anti-interleukin-13 monoclonal antibody on T. Fujiyama (JAPAN) Staph. Aureus skin colonisation and systemic 15:20 Importance of follow up in determining PsA levels of inflammatory biomarkers in patients prevalence of PsA in Turkish psoriasis patients with atopic dermatitis B. Gunes (TURKEY) A. Wollenberg (GERMANY)

15:30 An International Delphi survey to deﬁne 15:10 Claudin-5 Deﬁciency induced by MicroRNA-224 screening for psoriatic arthritis and 5p Contributed to Defective Permeability Barrier measurement of psoriatic arthritis symptoms in in Sensitive Skin psoriasis clinical trials L. He (CHINA) L. Perez-Chada (UNITED STATES) 15:20 12-Week Efficacy and Safety Data of Ruxolitinib 15:40 Risk of Mycosis Fungoides in Psoriasis Patients Cream in Adult Patients With Atopic Dermatitis: C. Massone (ITALY) Results From a Phase 2 Study L. Kircik (UNITED STATES) 15:50 CD8+CD69+ TRM cells hold immunological memory by IL-15 in psoriatic recurrence Z. Shen (CHINA) FRIDAY 14 JUNE, 2019

15:30 Allergic and photoallergic contact dermatitis to 16:00 Study of the association of humanmicrobiome topical non-steroidal anti-inﬂammatory drugs: a with nickel allergies overweight and metabolic case series from Turkey syndrome A. Kutlay (TURKEY) A. Tammaro (ITALY)

15:40 Reconstructed human epidermis models with 16:10 Efficacious and well-tolerated treatment of Langerhans cells (SkinEthic RHE-LC) chronic hand eczema and related itch with C. Pellevoisin (FRANCE) topical delgocitinib P. Elsner (GERMANY) 15:50 Safety of Dupilumab in Moderate-to-Severe Atopic Dermatitis Patients Inadequately 16:20 Identiﬁcation of TMEM232 gene associated with Controlled With, Intolerant to, or Inadvisable for atopic dermatitis through targeted capture Cyclosporine-A: Laboratory Findings From the sequencing and HaCaT cells experiment LIBERTY-AD-CAFÉ Trial F. L. Xiao (CHINA) K. Reich (GERMANY) DAILY SCIENTIFIC PROGRAMME SATURDAY 15 JUNE, 2019 SATURDAY 15 JUNE, 2019

AMBER 1 07:00-08:00 07:00 Cutaneous Lymphomas: therapeutic update Nicola Pimpinelli (ITALY)

GRUPPO SIDeMaST ALLERGIE CUTANEE: 07:10 Laser in capillary malformations Acrylates: Old and new allergens IS Francesca Negosanti (ITALY) CO-CHAIRS: Colombina Vincenzi (ITALY), Paolo Pigatto (ITALY) 07:20 Nevi treatments with lasers Davide Brunelli (ITALY) 07:00 Introduction Paolo Pigatto (ITALY) 07:30 Lasers in Rhinophyma Giovanni Cannarozzo (ITALY) 07:05 Contact allergy to electrocardiogram electrodes caused by acrylic acid without sensitivity to 07:40 Lasers in Neuroﬁbromatosis methacrylates and ethyl cyanoacrylate Giuseppe Lodi (ITALY), Mario Sannino (ITALY) Paolo Romita (ITALY), Caterina Foti (ITALY) 07:50 Discussion 07:15 2-HEMA as screening tool in the detection of (Meth) Acrylates allergy: the Italian experience AMBER 5+6 07:00-08:00 Katharina Hansel (GERMANY), Luca Stingeni (ITALY) GRUPPO SIDeMaST DERMATOLOGIA 07:25 Hands contact dermatitis to (Meth) Acrylates in IS CHIRURGICA: Case reports in Dermatologic dental technicians Surgery Antonio Cristaudo (ITALY) CO-CHAIRS: Klaus Eisendle (ITALY), Mario Puviani (ITALY) 07:35 Contact stomatitis to (Meth) Acrylate in odontoiatric patients 07:00 Squamocellular carcinoma in albino africans Paolo Pigatto (ITALY), Gianpaolo Guzzi (ITALY) Massimo Gravante (ITALY)

07:45 Discussion 07:08 Reconstruction of full thickness nasal alar defect in a patient with sebaceous carcinoma Daniele Dusi (ITALY) AMBER 2 07:00-08:00 07:16 Pac man flap and beyond GRUPPO SIDeMaST DI DERMATOLOGIA PEDIATRICA Klaus Eisendle (ITALY) IS E MALATTIE GENETICHE RARE: Inflammatory, 07:24 Treatment of advanced periocular skin cancer infectious and neoplastic diseases in children Massimo Gattoni (ITALY) CO-CHAIRS: Iria Neri (ITALY), Anna Belloni Fortina (ITALY) 07:32 Island, shark and crab flaps for alar-perialar area Giulio Gualdi (ITALY) 07:00 Contact dermatitis in childhood Anna Belloni Fortina (ITALY) 07:40 Split ear helix advancement flap for lesions of the helical rim and adjacent skin 07:10 Obesity and psoriasis in childhood Mario Puviani (ITALY) Marco Adriano Chessa (ITALY) 07:48 Keystone island flap procedure for leg defect 07:24 Sexually transmitted diseases in adolescents reconstruction Valeria Gaspari (ITALY) Roberto Cecchi (ITALY)

07:36 Mastocytosis in childhood 07:56 Discussion Valeria Brazzelli (ITALY) 07:48 Adalimumab in pediatric psoriasis: a multicenter AMBER 7+8 07:00-08:00 observational analysis Vito Giuseppe Di Lernia (ITALY) ADOI: Acne News IS CO-CHAIRS: Vincenzo Bettoli (ITALY), AMBER 4 07:00-08:00 Giuseppe Monfrecola (ITALY) 07:00 News on epidemiology GILD: Laser in rare and pediatric diseases Luigi Naldi (ITALY) IS CO-CHAIRS: Giovanni Cannarozzo (ITALY), 07:20 News on clinical aspects Stefania Guida (ITALY) Giuseppe Monfrecola (ITALY) SATURDAY 15 JUNE, 2019

07:40 News on therapy AMBER 2 08:00-10:45 Vincenzo Bettoli (ITALY) FELLOW FORUM 5 FF CO-CHAIRS: Maria Teresa Rossi (ITALY), AMBER 1 08:00-10:45 Eduardo Nagore (SPAIN)

Infestations, Bites and Stings 08:00 Cutaneous disseminated histoplasmosis in SY CHAIR: Olivier Chosidow (FRANCE) patients with acquired immunodeﬁciency CO-CHAIRS: Dirk Elston (UNITED STATES), syndrome Paulo Cunha (BRAZIL) A. Aguilar (MEXICO)

08:00 Introduction 08:15 Efficacy of Omalizumab in patients with Chronic Olivier Chosidow (FRANCE) Inducible Urticaria; clinical experience from a UCARE center 08:05 The Burden of Infestations, Bites and Stings in P. K. Can (TURKEY) Resource-Poor Countries Claire Fuller (UNITED KINGDOM) 08:30 Systemic complications in patients presenting with cutaneous vasculitis - A study of 101 08:20 Discussion patients 08:25 Infestations, bites, stings in the migrants T. Gupta (INDIA) Valeska Padovese (MALTA) 08:45 Gender and age-related patient needs in 08:40 Discussion psoriasis care J. Maul (SWITZERLAND) 08:45 Scabies: what’s new 2015-2019 Olivier Chosidow (FRANCE) 09:00 Clinical-pathologic comparison between acral melanomas and non-acral melanomas: Analysis 09:00 Discussion of a series of 122 patients 09:05 Head-lice-infestations in low-to medium resource L. Peruilh (CHILE) countries: example of the Dakar community in 09:15 A Study On The Role Of S100 Senegal Immunohistochemical Staining In Fatimata Ly (SENEGAL) Demonstrating Nerve Destruction Pattern And 09:20 Discussion Its Utility In Diagnosing Leprosy P. Karagaiah (INDIA) 09:25 Non-invasive diagnosis in infestations Giuseppe Micali (ITALY) 09:30 Skin in perspective of obesity: a case control study of 400 patients 09:40 Discussion D. Shukla (INDIA)

09:45 Travellers Tropical Dermatosis Caused by Insect 09:45 Comparative study of efficacy of intralesional Bites: Challenges and Interventions Puriﬁed Protein Derivative (PPD) versus Paulo Cunha (BRAZIL) intralesional Realses, Mumps and Rubella (MMR) 10:00 Discussion in management of multiple viral K. Bhalala (INDIA) 10:05 Infestations and vector-borne illness: an update in non-tropical countries 10:00 Sirolimus in the Treatment of Vascular Dirk Elston (UNITED STATES) Anomalies in Malaysian Children H. L. Wong (MALAYSIA) 10:20 Discussion 10:15 CXCL10 as Clinical marker of Vitiligo: a 10:25 Lyme Disease, Ehrlichiosis, and more prospective cohort study in 300 patients Kenneth J. Tomecki (UNITED STATES) L. Zhang (CHINA)

10:40 Discussion 10:30 Erosive lichen planus: beyond the nails M. A. Chessa (ITALY) SATURDAY 15 JUNE, 2019

AMBER 3 08:00-10:45 08:50 Lesbian, gay, and bisexual health for dermatologists Humanitarian Dermatology Kenneth Katz (UNITED STATES) SY CHAIR: Roderick Hay (UNITED KINGDOM) 09:05 Eliciting a sexual history and gender identity CO-CHAIRS: Guadalupe Estrada (MEXICO), history in a dermatology setting: why and how Margot Whitfeld (AUSTRALIA) Patrick McCleskey (UNITED STATES)

08:00 Introduction 09:20 Update on research on LGBT health in dermatology Roderick Hay (UNITED KINGDOM) Matt Mansh (UNITED STATES)

08:05 Training in the care of skin disease in rural areas 09:35 LGBT workforce issues in dermatology South Africa Howa Yeung (UNITED STATES) Ncoza Dlova (SOUTH AFRICA) 09:50 The role of the dermatologic surgeon in caring 08:22 Community Dermatology - The Mexican experience for LGBT persons Guadalupe Estrada (MEXICO) Sarah Arron (UNITED STATES)

08:39 Albinism and Fiji 10:05 Understanding sexual orientation and gender Margot Whitfeld (AUSTRALIA) identity and expression: lessons from the 08:56 Integrating NTDs in community programmes Philippines Claire Fuller (UNITED KINGDOM) Winlove Mojica (PHILIPPINES)

09:13 Skin disease and NTDs in West Africa 10:20 Q&A Yotsu Rie (JAPAN) 09:30 HIV care in rural Africa AMBER 5+6 08:00-10:45 Toby Maurer (UNITED STATES)

09:47 Sun protection and actinic dermatitis in rural Lupus erythematosus communities SY CHAIR: Victoria Werth (UNITED STATES) Isabel Casas (ARGENTINA) CO-CHAIRS: Aurora Parodi (ITALY), Qianjin Lu (CHINA) 10:04 Use of Telederm as distance support for underserved communities 08:00 Introduction Carrie L. Kovarik (UNITED STATES) 08:05 Translating Epigenetics into Clinic: Focus on 10:21 Extending dermatological services in difficult Lupus terrain Qianjin Lu (CHINA) Dwarika Shrestha (NEPAL) 08:20 Role of endogenous nucleic as drivers of the 10:38 Q&A lesional inﬂammation in CLE Jan Dutz (CANADA)

08:35 Classiﬁcation of CLE AMBER 4 08:00-10:45 Joseph F. Merola (UNITED STATES)

LGBT Health 08:50 Impact of CLE and concomitant systemic disease SY CHAIR: Kenneth Katz (UNITED STATES) on QoL CO-CHAIRS: Martin Tze Wei Chio (SINGAPORE), Ben Chong (UNITED STATES) Carmen Rodriguez Cerdeira (SPAIN) 09:05 Advances in pediatric lupus 08:00 Introduction Yvonne Chiu (UNITED STATES) Kenneth Katz (UNITED STATES) 09:20 Unusual forms of cutaneous lupus 08:05 Caring for LGBT patients in non-LGBT friendly areas erythematosus Martin Tze Wei Chio (SINGAPORE) Aurora Parodi (ITALY)

08:20 Skin cancer screening uptake for lesbian, gay, 09:35 Challenges in Treatment of SLE in a bisexual, and transgender (LGBT) people Dermatology Setting Carmen Rodriguez Cerdeira (SPAIN) Hai Long (CHINA)

08:35 Transgender health for dermatologists 09:50 Antimalarial treatment in CLE Brian Ginsberg (UNITED STATES) Clara De Simone (ITALY) SATURDAY 15 JUNE, 2019

10:05 Treatment for refractory skin lesions of lupus structures among experts: A pilot study erythematosus K. Liopyris (UNITED STATES) Danqi Deng (CHINA) 09:45 Clinical and dermoscopic characteristics of 10:20 New therapeutics and targets for CLE melanocytic lesions on the volar skin without Victoria Werth (UNITED STATES) typical dermoscopic patterns A. Minagawa (JAPAN) 10:35 Discussion 09:55 Dermoscopy of Topical Steroid Damaged Face (TSDF) - Diagnostic features validated from a AMBER 7+8 08:00-10:45 Cross Sectional study of 244 patients S. Sonthalia (INDIA) Dermatoscopy and Skin Imaging 2 10:05 The management of very small pigmented FC CO-CHAIRS: Marco Ardigò (ITALY), lesions Elvira Moscarella (ITALY) F. Persechino (ITALY) 08:00 Introduction 10:15 Dermoscopy of primary cutaneous B cell 08:05 Clinical characteristics and findings with Total lymphomas: a new series Body Photography and Digital Dermoscopy in S. Salim (MOROCCO) patients diagnosed with Large and Giant 10:25 Risk assessment of melanoma – a correlation of Congenital Melanocytic Nevi in the Hospital dynamic optical coherence tomography, Infantil Federico Góm histology and dermoscopy Z. F. Barragán-Estudillo (MEXICO) S. Schuh (GERMANY) 08:15 Noninvasive skin pathology evaluation: high 10:35 Photoaged skin and cacerization field: frequency ultrasound imaging and diagnotics distinctive features in confocal microscopy and A. Bezugly (RUSSIAN FEDERATION) optical coherence tomograp 08:25 Can Dermoscopy serve as a diagnostic tool in A. Paganelli (ITALY) dermatophytosis? A pilot study Y. J. Bhat (INDIA) BLUE 1 08:00-10:45 08:35 Neck melanoma: clinical, dermoscopic and confocal features Doing Phototherapy S. Borsari (ITALY) CO CHAIR: Tania Cestari (BRAZIL) 08:45 Gabor-Domain Optical Coherence Microscopy to CO-CHAIRS: Alessia Pacifico (ITALY) Aid in Mohs Resection of Basal Cell Carcinoma Peter Wolf (AUSTRIA) C. Canavesi (UNITED STATES) 08:00 Welcome and Introduction by the Chairs 08:55 In vivo and non-invasive imaging of the skin 08:03 The photobiology of phototherapy aging: new applications for the LC-OCT Sunil Kalia (CANADA) technology P. Tinguely (FRANCE) 08:17 Discussion 09:05 Dermoscopy plus reflectance confocal 08:21 Phototherapy in the time of biologics microscopy for the diagnosis of lentigo maligna Peter Wolf (AUSTRIA) D. Fiorani (ITALY) 08:35 Discussion 09:15 Multicentric retrospective study on non-invasive 08:39 UVA1: applications and limitations imaging for the diagnosisi the nipple and areola Heidi Jacobe (UNITED STATES) complex lesions E. Trovato (ITALY) 08:53 Discussion 09:25 Color Variability in Digital Dermoscopy 08:57 Side effects and risks of phototherapy B. Diricx (BELGIUM) John Koo (UNITED STATES)

09:35 Study to ascertain the level of agreement for the 09:11 Discussion presence and location of dermoscopic SATURDAY 15 JUNE, 2019

09:15 Excimer sources for phototherapy: vitiligo and Hidradenitis Suppurativa psoriasis Anna Michenko (RUSSIAN FEDERATION) Piergiacomo Calzavara Pinton (ITALY) 10:15 Sexual health in dermatology patients 09:29 Discussion Francesca Sampogna (ITALY) 09:33 Phototherapy to treat Photodermatoses 10:31 Concluding remarks Tsui Ling (UNITED KINGDOM) Uwe Gieler (GERMANY), Katlein Franca (UNITED STATES) 09:47 Discussion 09:51 Role of Phototherapy in the treatment of atopic dermatitis BROWN 1 08:00-10:45 Alessia Paciﬁco (ITALY) Pemphigus 10:05 Discussion SY CHAIR: Michael Hertl (GERMANY) 10:09 Phototherapy for CTCL CO-CHAIRS: Valeria Aoki (BRAZIL), Henry W. Lim (UNITED STATES) Pascal Joly (FRANCE)

10:23 Discussion 08:00 Immune pathogenesis of pemphigus Masayuki Amagai (JAPAN) 10:27 PUVA: current status John Hawk (UNITED KINGDOM) 08:14 Discussion 10:41 Discussion 08:18 Clinical spectrum of pemphigus Branka Marinovic (CROATIA)

BLUE 2 08:00-10:45 08:32 Discussion 08:36 Pemphigus foliaceus Psychodermatology Valeria Aoki (BRAZIL) SY CHAIR: Elise Kleyn (UNITED KINGDOM) 08:50 Discussion CO-CHAIRS: Katlein Franca (UNITED STATES), Uwe Gieler (GERMANY) 08:54 Paraneoplastic pemphigus Takashi Hashimoto (JAPAN) 08:00 Welcome and Introduction Elise Kleyn (UNITED KINGDOM) 09:08 Discussion 08:07 Psycho Neuro Endocrine Immune Dermatology: 09:12 Therapeutic B cell depletion in pemphigus what’s new, what’s true? Pascal Joly (FRANCE) Torello Lotti (ITALY) 09:26 Discussion 08:23 Psychosomatic approach to atopic dermatitis - 09:30 Btk inhibition in pemphigus stress behaviour and psychotherapy Dedee Murrell (AUSTRALIA) Uwe Gieler (GERMANY) 09:44 Discussion 08:39 Memorable cases from a Psychodermatology clinic Anthony Bewley (UNITED KINGDOM) 09:48 Therapeutic targeting of autoreactive T cells in pemphigus 08:55 New insights in Trichopsychodermatology Rudiger Eming (GERMANY) Katlein Franca (UNITED STATES) 10:02 Discussion 09:11 The Placebo Effect Andrea Evers (NETHERLANDS) 10:06 Etiology of endemic pemphigus Luis A. Diaz (UNITED STATES) 09:27 Psycho-oncological distress and support for melanoma patients 10:20 Discussion Aleksandra Vojvodic (SERBIA) 10:24 Dermatitis herpetiformis 09:43 Insights from Brain Imaging Emiliano Antiga (ITALY) Elise Kleyn (UNITED KINGDOM) 10:38 Discussion 09:59 Depression and Suicide in Psoriasis and SATURDAY 15 JUNE, 2019

10:42 Final remarks of the Chair 08:52 Q&A Michael Hertl (GERMANY) 08:57 Laser treatment for congenital melanocytic lesion BROWN 2 08:00-10:45 Henry Hin Lee Chan (HONG KONG) 09:09 Laser treatment for acquired melanocytic lesions Infantile Haemangiomas and Vascular Chee Leok Goh (SINGAPORE) SY Malformations 09:21 Laser treatment for tattoo CHAIR: Veronica Kinsler (UNITED KINGDOM) Moshe Lapidoth (ISRAEL) CO-CHAIRS: Eulalia Baselga (SPAIN), Aicha Salhi (ALGERIA) 09:33 Laser Hair Removal Valeria Campos (BRAZIL) 08:00 Clinical management of infantile haemangiomas: lessons learned since Propranolol 09:45 Q&A Eulalia Baselga (SPAIN) 09:50 Fractional resurfacing 08:20 The pathophysiology of infantile haemangiomas, Dieter Manstein (UNITED STATES) and the role of beta-adrenergic blockade 10:02 Laser for scar treatment Maria Buethe (UNITED STATES) Woraphong Manuskiatti (THAILAND) 08:40 Capillary malformations – when to worry and 10:14 Laser safety an update how to investigate Mathew Avram (UNITED STATES) Veronica Kinsler (UNITED KINGDOM) 10:26 Future direction 09:00 Capillary Malformation-Arteriovenous Rox Anderson (UNITED STATES) Malformations: clinical and molecular overview Gianluca Tadini (ITALY) 10:38 Q&A 09:20 The genetics of phakomatosis pigmentovascularis Satyamaanasa Polubothu (UNITED KINGDOM) RED 1+2 08:00-10:45 09:40 New drug therapies for vascular malformations Pierre Vabres (FRANCE) Emergency Room Dermatology CO CHAIR: Ronni Wolf (ISRAEL) 10:00 Extraordinary case reports in the ﬁeld of CO-CHAIRS: Eduardo Poletti (MEXICO), vascular anomalies Jennifer Parish (UNITED STATES) Aicha Salhi (ALGERIA) 08:00 Introduction 10:20 Q&A Ronni Wolf (ISRAEL)

08:10 Acute Skin Failure BROWN 3 08:00-10:45 Arun Inamadar (INDIA) 08:25 Discussion Advanced Laser Treatment SY CHAIR: Henry Hin Lee Chan (HONG KONG) 08:30 Recognizing Target Lesions in the ER CO-CHAIRS: Mathew Avram (UNITED STATES), Ronni Wolf (ISRAEL) Guilherme De Almeida (BRAZIL) 08:45 Discussion 08:00 Introduction 08:50 Skin Signs of Acute Life-Threatening Systemic 08:04 Laser treatment for congenital vascular lesions Diseases Roy Geronemus (UNITED STATES) Eduardo Poletti (MEXICO)

08:16 Laser and energy based devices for venous lesions 09:05 Discussion Christine Dierickx (BELGIUM) 09:10 Erythroderma: Diagnosing and Treating the 08:28 Laser and energy based devices for acne “Red Man” Fernanda Sakamoto (UNITED STATES) Lawrence-Charles Parish (UNITED STATES)

08:40 Laser treatment of psoriasis and vitiligo 09:25 Q&A Leihong Flora Xiang (CHINA) Lawrence-Charles Parish (UNITED STATES) SATURDAY 15 JUNE, 2019

09:30 Erythroderma: Diagnosing and Treating the 08:00 Introduction “Red Man” Marcia Ramos e Silva (BRAZIL) Jennifer Parish (UNITED STATES) 08:05 The examination of the oral cavity 09:45 Q&A Ginat Mirowski (UNITED STATES) Jennifer Parish (UNITED STATES) 08:25 Autoimmune bullous diseases and differential 09:50 Catastrophes in Cosmetic Procedures diagnoses Anthony Benedetto (UNITED STATES) Jane Setterﬁeld (UNITED KINGDOM)

10:05 Q&A 08:45 Allergic oral disorders Mirtha Cifuentes Mutinelli (CHILE) 10:10 Serious and Life-Threatening Cutaneous Conditions in Neonates and Children 09:05 Behçet's disease Maya El Achem (ITALY) Onder Meltem (TURKEY)

10:25 Q&A 09:25 Oral lichen planus Marcello Menta Simonsen Nico (BRAZIL) 10:30 Discussion 09:45 Differential Diagnosis of Oral Ulcers Julia S. Lehman (UNITED STATES) SPACE 1 08:00-10:45 10:05 Oral lesions in immunodepressed patients Beatriz Trope (BRAZIL) Medical management of Keratinocyte cancer: SY BCC and SCC 10:25 Oral pre cancer and cancer CHAIR: John Lear (UNITED KINGDOM) Marcio Serra (BRAZIL) CO-CHAIRS: David Zloty (CANADA), Alexandros Stratigos (GREECE) SPACE 3 08:00-10:45 08:00 Hedgehog pathway inhibitors for advanced and metastatic BCC Cicatricial Alopecia Update John Lear (UNITED KINGDOM) SY CHAIR: Elise Olsen (UNITED STATES) 08:25 Chemoprevention of keratinocyte cancers CO-CHAIRS: Matthew Harries (UNITED Alexandros Stratigos (GREECE) KINGDOM), Felipe Mardones (CHILE)

08:50 EGFR and PD1/PD1L inhibitor treatment of 08:00 Pathogenesis of PCA advanced and metastatic SCC Matthew Harries (UNITED KINGDOM) Chrysalyne Schmults (UNITED STATES) 08:22 Diagnosis of cicatricial alopecia (clinical with 09:15 Definition and epidemiology of advanced emphasis on scalp findings including ethnic keratinocyte cancers variation, dermatoscopic and pathologic Panagis Polyzois (GREECE) findings) Felipe Mardones (CHILE) 09:40 Topical treatment of keratinocyte cancers Eggert Stockfleth (GERMANY) 08:44 FFA: Etiology, nuances of the clinical exam (not just hair), prognostic features and assessment 10:05 Neoadjuvant use of hedgehog pathway measures inhibitors for BCC Elise Olsen (UNITED STATES) David Zloty (CANADA) 09:06 Treatment of the hair disorders characterized 10:30 Q&A pathologically as LPP ie FFA, LPP and fibrosing alopecia in a pattern distribution. To include SPACE 2 08:00-10:45 immunomodulators, 5-alfa reductase inhibitors, and skin directed treatment including PRP, topicals including calcineurin inhibitors and Oral Disorders minoxidil SY CHAIR: Marcia Ramos e Silva (BRAZIL) Sergio Vano-Galvan (SPAIN) CO-CHAIRS: Ginat Mirowski (UNITED STATES), Jane Setterfield (UNITED KINGDOM) 09:28 Q&A SATURDAY 15 JUNE, 2019

09:43 Hair loss in patients of African descent: CCCA, WHITE 1 08:00-10:45 marginal alopecia, and effect of various hair care techniques on follicle Aesthetic and Cosmetic Dermatology 2 Ncoza Dlova (SOUTH AFRICA) FC CO-CHAIRS: Hau Khang Tran (VIETNAM), 10:00 Neutrophil-mediated cicatricial alopecia Elda Giansante (VENEZUELA) Teri Greiling (UNITED STATES) 08:00 Introduction 10:17 Permanent chemotherapy related hair loss 08:05 A combination of fractional Q-switched 1,064 Juhee Cho (KOREA, REPUBLIC OF) nm with focused depth controlled technology 10:34 Q&A and Quasi long pulse 1064mn YAG for improvement of skin tone and texture L. Akerman (ISRAEL)

SPACE 4 08:00-10:45 08:15 Safety and Efficacy of Laser Permanent Hair Reduction Treatment in Skin Type VI Nigerian Wound healing Patients SY CHAIR: Karin Scharffetter-Kochanek (GERMANY) E. Anaba (NIGERIA) CO-CHAIRS: Jin Ho Chung (KOREA, REPUBLIC OF), Marco Romanelli (ITALY) 08:25 Efficacy of 755-nm alexandrite laser for the treatment of trichostasis spinulosa: a cross 08:00 Inﬂammation and metabolism in tissue repair sectional study and regeneration M. Goldust (IRAN) Sabine Eming (GERMANY) 08:35 Filling the periorbital hollows with hyaluronic 08:15 Wound Assessment acid gel: Long term review of outcomes and Marco Romanelli (ITALY) complications: An Indian experience 08:30 Mesenchymal stem cells in wound healing and P. Banodkar (INDIA) tissue regeneration 08:45 Novel Rotational Topical Treatment Provides Karin Scharffetter-Kochanek (GERMANY) Quantitative Evidence Of Progressive And 08:45 Why do we scar? A cell lineage perspective on Sustained Improvement In Facial Wrinkle scar tissue development and diversity Appearance Yuval Rinkevich (GERMANY) L. DiNatale (UNITED STATES)

09:00 Malignancy and chronic leg ulcers 08:55 Effects of Piezoelectric shockwaves on localized Patricia Senet (FRANCE) adiposity P. Froes Meyer (BRAZIL) 09:15 Extracellular matrices and tissue engineering Robert Kirsner (UNITED STATES) 09:05 Combined Picosecond Nd: YAG 532/1064 nm and Q-Switched Ruby 694 nm Laser for 09:30 Compression Bandages in Leg Ulcers Pigmented Lesions, Skin rejuvenation and Acne Valentina Dini (ITALY) Scars Treatments on Asian Skin 09:45 Hidradenitis suppurativa: diagnosis and P. Peng (CHINESE TAIPEI) management 09:15 Platelet rich plasma with microneedling and Francesco Lacarrubba (ITALY) trichloroacetic acid peel for treatment of striae 10:00 Why should a dermatologist be in wound care? distensae Jose Contreras (MEXICO) A. Jha (INDIA)

10:15 Early skin grafting in non-healing wounds 09:25 Microneedling of Scars: A Prospective Study Elena Conde Montero (SPAIN) with Long-Term Follow-Up M. K. Li (CANADA) 10:30 Discussion 09:35 Sculpting Six-pack Ab with Cryolipolysis T. Song Lim (MALAYSIA)

09:45 Low level laser therapy and hair regrowth A. Nassar (EGYPT)

09:55 Creating and restoring volume in patients with SATURDAY 15 JUNE, 2019

chin retrusion using an innovative hyaluronic YELLOW 1 08:00-10:45 acid ﬁller C. Sciuto (ITALY) Teledermatology 10:05 Plasma exeresis: cosmetic and clinical SY CHAIR: Amanda Oakley (NEW ZELAND) applications in Dermatology CO-CHAIRS: David Ramirez Moreno (SPAIN), E. Rossi (ITALY) Alexey Sergeev (RUSSIAN FEDERATION)

10:15 Beyond Surgery: A Non-Invasive Approach To 08:00 Successes and failures in teledermatology in the Tighten Facial Skin Through Combination United States Therapies+Eliminate Variable Results, Karen McCoy (UNITED STATES) Complications And Failure Of Skin Resurfacing 08:15 The hospital in 2030: will it still exist? Z. Obagi (UNITED STATES) Trilokraj Tejasvi (UNITED STATES)

10:25 The management of dermal ﬁller complications 08:30 Global Teledermatology and the Use of G. Trocchi (ITALY) Telepathology 10:35 Early Onset of Expression of Visible Signs of Carrie L. Kovarik (UNITED STATES) Facial Skin Ageing in Different Ethnic Groups 08:45 The age of Mobile Teledermatology is here, is it P. Matts (UNITED KINGDOM) safe and are we all doing it? Saul Halpern (UNITED KINGDOM)

09:00 Discussion WHITE 2 08:00-10:45 09:20 Teledermoscopy eTriage Tropical Dermatoses Amanda Oakley (NEW ZELAND) SY CHAIR: Sinesio Talhari (BRAZIL) 09:35 Teledermatology in Spain CO-CHAIRS: Ranthilaka Ranawaka (SRI LANKA), David Ramirez Moreno (SPAIN) Ousmane Faye (MALI) 09:50 Professional education inside dermatological 08:00 Providing Skin care to all: lessons from Mali social network Ousmane Faye (MALI) Alexey Sergeev (RUSSIAN FEDERATION)

08:15 Non dermatophyte mold are not pure 10:05 Artiﬁcial Intelligence for Teledermatology contaminants in onychomycosis in tropics Philipp Tschandl (AUSTRIA) Ranthilaka Ranawaka (SRI LANKA) 10:20 Discussion 08:30 Cutaneous Tuberculosis Shyam Verma (INDIA)

08:45 Leprosy - chemoprophylaxis and early YELLOW 2 08:00-10:45 diagnosis: state of the art Bernard Naafs (NETHERLANDS) History of Dermatology SY CHAIR: Michael Geiges (SWITZERLAND) 09:00 Leishmaniasis – new treatments CO-CHAIRS: Carlo Gelmetti (ITALY), Paulo Roberto Machado (BRAZIL) Nick Levell (UNITED KINGDOM)

09:15 Gnastomiasis – clinical aspects and treatment 08:00 History of picturing techniques Francisco Bravo (PERU) Michael Geiges (SWITZERLAND)

09:30 Cutaneous Manifestations Associated with EBV 08:25 Moulages and patient images: their impact on Martin Sangueza (BOLIVIA) dermatology past and present: USA 09:45 Injuries caused by aquatic animals and Lawrence-Charles Parish (UNITED STATES) cutaneous repercussions 08:50 Moulages and patient images: their impact on Vidal Haddad (BRAZIL) dermatology past and present: Italy 10:00 Mycetoma Carlo Gelmetti (ITALY) Mishrilal Khatri (INDIA) 09:15 Moulages and patient images: their impact on 10:15 Tropical dermatology around the world dermatology past and present: Spain José Manuel Rios Yuil (PANAMA) Natalie Curcio (UNITED STATES)

10:30 Discussion SATURDAY 15 JUNE, 2019

09:40 Moulages and patient images: their impact on 09:35 Diffuse non-frontotemporal miniaturization in dermatology past and present: United Kingdom male and female androgenetic alopecia: its Nick Levell (UNITED KINGDOM) existence independently and along with patterned alopecia 10:05 Moulages and patient images: their impact on R. Damisetty (INDIA) dermatology past and present: Switzerland Michael Geiges (SWITZERLAND) 09:45 Clinical results for skin rejuvenation with autologous conditioned serum 10:30 Q&A M. Kerscher (GERMANY) YELLOW 3 08:00-10:55 09:55 A real-life italian experience on efficacy and safety of dupilumab in adult patients with atopic Late Breaking News dermatitis FC CHAIR: Francesca Prignano (ITALY), M. C. Fargnoli (ITALY) Kiran Godse (INDIA) 10:05 Identifying and characterizing basal cell 08:00 Introduction carcinomas in the albino population of Tanzania M. Juhasz (UNITED STATES) 08:05 Sixteen novel COL7A1 mutations identiﬁed in patients with dystrophic epidermolysis bullosa 10:15 Efficacy of autologous serum injection in non from China: a Retrospective Study from a Single healing trophic ulcer of leprosy Center in Shanghai, China (2013-2018) M. Dash (INDIA) D. Dou (CHINA) 10:25 Laser treatment of epidermal nevi: a multicenter 08:15 Dermoscopy - A novel tool to assess disease retrospective study with long-term follow-up activity and explore possible 'hotspots' in A. Alkhalifah (SAUDI ARABIA) vitiligo: A Cross-sectional study in an Indian population 10:35 SNA-120, A Novel Topical Non-steroidal Therapy S. Poddar (INDIA) for Psoriasis and Associated Pruritus that Targets the NGF/TrkA Pathway: Results from a 08:25 Evaluation of QM1114, a novel ready-to-use Multicenter Phase 2b Study liquid botulinum toxin, in aesthetic treatment of P. Lizzul (UNITED STATES) glabellar lines J. Cohen (UNITED STATES) 10:45 Efficacy and Safety of Baricitinib in Moderate to Severe Atopic Dermatitis: Results of Two Phase 08:35 Topical β-blockers for the management of 3 Monotherapy Randomized, Double-Blind, paronychia and pyogenic granuloma-like lesions Placebo-Controlled 16-week Trials (BREEZE-AD1 of the periungual area secondary to therapy and BREEZE-AD2) with Epidermal Growth Factor Receptor Inhibitor E. Simpson (UNITED STATES) P. Sollena (ITALY) 08:45 Quo vadis, Mohs surgery? GOLD 11:00-12:30 D. Hartmann (GERMANY)

08:55 A prospective methodological case-control CO-CHAIRS: Jean L. Bolognia (UNITED STATES), study: the effect of systemic isotretinoin PL Alberto Giannetti (ITALY), treatment on ovarian reserve Carle Paul (FRANCE), T. Ozkok Akbulut (TURKEY) Lone Skov (DENMARK)

09:05 Real-world effectiveness of acitretin, 11:00 Autophagy ciclosporin, fumaric acid esters (FAE) and Tamotsu Yoshimori (JAPAN) methotrexate – does treatment history matter? Results from BADBIR 11:30 The past, the present and the future of K. J. Mason (UNITED KINGDOM) dermatologic surgery Gabriel Gontijo (BRAZIL) 09:15 Genital Laser Sculpture with punctual use of fractional CO2 laser 11:50 Important Advances in Skin Barrier Function A. C. Naves de Castro Rocha (BRAZIL) Masayuki Amagai (JAPAN)

09:25 Efficacy and Safety of Ruxolitinib Cream for the 12:10 The Shifting Spectrum of HIV Dermatology Treatment of Vitiligo: Results of a 24-Week Ncoza Dlova (SOUTH AFRICA) Randomized, Double-Blind, Dose-Ranging, Vehicle-Controlled Study D. Romarin (UNITED STATES)